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Glioblastoma (GBM) remains an incurable tumour fraught with a high probability of 
death. One of the key characteristic of GBM is the development of local immunosuppression 
that promotes immune evasion and lays a solid foundation for the tumour to progress. Break-
throughs in our understanding in cancer biology have shown that GBM have evolved unique 
mechanisms that influence infiltrating macrophages, a key immune cell type, to facilitate tu-
mour progression. Macrophages have been identified in many studies to promote angiogen-
esis, extra cellular matrix reorganisation, establishment of local immunosuppression and tu-
mour growth. Thus, there is great need to improve the clinical development of immunothera-
peutics that can address tumour-specific immune responses. Herein, we tested the capability 
of solidly supported Gold and Palladium nanoparticles as biorthogonal catalytic converters 
of prodrugs in a zebrafish U87 glioblastoma xenograft model. Intriguingly, we report that the 
implantation of Palladium and Gold bead into the zebrafish brain causes a potent anti-tumour 
responses that leads to U87 cell clearance, fragmentation and increased macrophage num-
ber. Further investigation revealed that Gold and Palladium beads did not cause aberrant 
necrosis when implanted in the zebrafish brain and that macrophages played a key role in 
mediating the associated anti-tumour response of Palladium and Gold bead implantation. 
The role of macrophages was investigated further using Next Generation RNA sequencing of 
macrophages isolated from Palladium bead implanted zebrafish. RNA sequencing results re-
vealed differentially expressed genes in Palladium bead implanted zebrafish with 389 genes 
upregulated and 361 genes downregulated. Enrichment analysis of these genes showed sig-
nificant enrichment of oxidation-reduction processes as a result of Palladium bead implanta-
tion. In addition, confirmatory RT-qPCR highlighted two key TLR signalling inflammatory 
genes, Cxcl8b.1 and TNF-𝑎	, to be overexpressed in macrophages of Palladium and Gold 
bead implanted zebrafish. Since Cxcl8b.1 is a potent attractant of neutrophils, we studied the 
dynamics of macrophages and neutrophil number in the zebrafish brain. Indeed, we detected 
an accumulation of neutrophils upon gold bead transplantation. Thus, we analysed the role 
of Cxcl8b.1 and TNF-𝑎	in	the	initiation of the  anti-tumour effect. This was achieved by com-
bining CRISPR-Cas9 knock out and genetic overexpression transgenesis techniques of 
Cxcl8b.1 and TNF-𝑎. The results here conclude that TNF-𝑎 were not key genetic mediators 
of the associated bead induced anti-tumour phenotype. Finally, this study opens new ave-
nues for the development of novel cancer immunotherapeutics. RNA sequencing results 
showed high number of other candidate genes that exploit the intrinsic capabilities of transi-
tions metals to initiate an anti-tumour response.  
 v 
Lay Abstract 
Glioblastoma is an incurable brain tumour fraught with a high probability of death. 
One of the key properties of glioblastoma is the ability to avoid the immune system and thus 
allowing it to grow. Breakthroughs in our understanding in cancer biology have shown that 
glioblastoma have evolved unique traits that interact with the immune system. These interac-
tions influence macrophages, a key immune cell type, to help the tumour growth. Macro-
phages have been identified in many studies to enter the site of the tumour to promote blood 
vessel development, reorganisation of surrounding tissue and immune system avoidance. 
Therefore, there is great need to improve the clinical development of treatments that can 
address these interactions between the tumour and the immune system. We do so by using 
a widely use animal model, the zebrafish. The zebrafish has many advantages and one of 
them is its optical transparency. This allows us to look into the brain of the zebrafish with a 
microscope to directly observe the interaction of immune cells and tumour cells. We have 
previously used this model to study immune interactions between macrophages and human 
brain tumours that were transplanted into zebrafish brains. To extend our previous study, we 
investigate the ability of solidly supported Palladium and Gold nanoparticles to stimulate mac-
rophages to kill brain tumours. To do so, Gold and Palladium beads were carefully implanted 
into the zebrafish brain and any anti-tumour responses were studied closely. The implantation 
of Gold and Palladium beads led to the clearance and break down of tumour cells. In addition, 
Gold and Palladium stimulated increased macrophage number in the zebrafish brain. Gold 
and Palladium did not cause direct cell death of these tumour cells, but induced an anti-
tumour response in macrophages. Genetic studies of these macrophages showed changes 
in the expression of many genes related to the oxidation-reduction processes. In addition, 
two key immune system activating genes, Cxcl8b.1 and TNF-𝑎	,	were confirmed to be over-
expressed in Palladium and Gold bead implanted zebrafish. Cxcl8b.1 and TNF-𝑎 are im-
portant genes that can influence how the immune system respond; Cxcl8b.1 is an important 
activator of neutrophil number, another key immune cell type. Therefore, we investigated the 
dynamics of how these genes can affect macrophages and neutrophil number to regulate 
anti-tumour effects in the zebrafish brain. In order to do so, we altered genetic expression of 
Cxcl8b.1 and TNF-𝑎	in the zebrafish brain, either by increasing or decreasing the expression 
of each gene. Our results conclude that TNF-𝑎 and Cxcl8b.1 were not key genetic effectors 
of the associated bead induced anti-tumour responses. Finally, this study here opens new 
avenues for the development of new anti-cancer drugs that exploit the innate properties of 
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1.1. The role of tumour associated macrophages and their impact on 
the tumour microenvironment in Glioblastomas  
1.1.1. Glioblastomas and its origins 
The advent of genomics within the last decade has accelerated the integration of 
phenotypic and genomic parameters to classify tumours of the central nervous system (CNS) 
(Louis et al., 2014 , Louis et al., 2016). Molecular insights into CNS tumours have led to the 
refinement of diagnostic categories that expanded the 2007 World Health Organisation (WHO) 
classification of tumours of the CNS (Louis et al., 2014, Louis et al., 2016). Gliomas are the 
most common malignant primary brain tumours (Gusyatiner and Hegi, 2018). Accurate clas-
sification of gliomas has significant implication for the patient in addition to having important 
ramifications in the interpretation of clinical and scientific experiments encompassing tu-
mours of the CNS (Louis et al., 2016). Today, the combination of diagnostic molecular testing 
Figure 1.Gliomas are classified based on histological and genetic features. 
Gliomas are classified based on morphology genotype such as IDH status, presence or absence of 1p/19q co-
deletion, ATRX loss and TP53 mutations. Glioma diagnosis consist of a histopathological name followed by a 
genetic feature (Diffuse astrocytoma, IDH-mutant). Tumour lacking a molecular diagnosis is termed NOS.  
 




and histological analysis is fundamental in the clinical classification of CNS tumour and guides 
the use of therapies (Summarised in Figure 1) (Louis et al., 2016).  
Glioma defines a heterogenous group of CNS cancers that are anatomically similar 
to each other but are diverse in the context of morphology and molecular biology (Crocetti et 
al., 2012, Ho et al., 2014). Glioma is a complex disease that presents a multitude of histo-
pathological features and resembles various neural cell types (Lu et al., 2019). High grade 
gliomas can display a high degree of heterogeneity between tumours and within cells of the 
same tumour (Alcantara Llaguno and Parada, 2016, Jiang and Uhrbom, 2012). Gliomas were 
thought to originate from glial cells due to the high proportion of expression of glial specific 
GFAP protein (Jones et al., 1981). However, histopathological classification have identified 
morphological resemblance of gliomas, such as astrocytomas, oligodendrogliomas, oligo-
astrocytomas and glioblastomas, to glial tissue. Gliomas can show morphological character-
istics similar to astrocytes and express astrocytic lineage markers such as GFAP and APO-E 
(Rousseau et al., 2006). Gliomas of astrocytic lineage are termed Astrocytomas (Rousseau et 
al., 2006). In contrast, Oligodendroglioma have morphological characteristics that resemble 
oligodendrocyte progenitor cells (OPC) and often express OPC markers that include Olig2, 
NG2 and PDGFR𝑎 (Rousseau et al., 2006, Zong et al., 2012). Gliomas with mixed cellular or 
anaplastic features have also been identified and these tumours are classified as oligoastro-
cytomas and glioblastomas (Zong et al., 2012).  
The cellular origins of gliomas are widely debated, however, studies have shown that 
glioma can originate from multiple cells. Neural stem cells and glial progenitors have been 
early contender as the cell origins of gliomas (Zong et al., 2012, Pollard et al., 2009). The 
inactivation of tumour suppressor (Nf1, p53 and Pten) in nestin expressing neural progenitor 
niches have been shown to induce high grade astrocytoma formation and premature death 
in mice (Alcantara Llaguno et al., 2009, Zhu et al., 2005). Likewise, the inactivation or deletion 
of tumour suppressors in oligodendrocyte precursor cells promotes the transformation from 




shown to dedifferentiate into multipotent progenitors that malignantly transformation into As-
trocytomas (Bachoo et al., 2002). There is a growing body of evidence to show that gliomas 
are maintained by a subpopulation of cancer cells displaying stem cell like characteristics; 
long term self-renewal and differentiation capabilities (Pollard et al., 2009, Hemmati et al., 
2003, Fleurence et al., 2019). These glioma cancer stem-like cells are generally not completely 
removed during surgery and are resistant to chemotherapy and radiotherapy; leading to the 
regeneration and recurrence of the GBMs (Fleurence et al., 2019). Altogether, gliomas can 
develop from many difference cell types and thus contributes to the complexity of glioma 
biology.  
Gliomas are clinically classified under the 2016 World’s Health Organisation classifi-
cation of tumour of the central nervous system from grade I to IV. It classifies gliomas based 
on morphology, histology grade, genotype such as IDH status and the presence or absence 
of 1p/19q co-deletion (Back et al., 2018). The less aggressive diffuse astrocytomas and oli-
godendrogliomas are designated as Grade II (Louis et al., 2016). Glioblastomas multiforme 
(GBM), the most aggressive form of gliomas, are classed under grade IV, the highest in se-
verity (Back et al., 2018, Louis et al., 2016). The most effective treatment includes maximal 
tumour resection followed by radiotherapy and temozolomide chemotherapy (Weller et al., 
2014). GBM remains an incurable tumour with a low survival rate of 14.4% at 3 years 
(Gramatzki et al., 2016). GBMs are histologically and genetically heterogenous (Pollard et al., 
2009). Transcriptomic and genomic analysis of GBM have identified distinct molecular sub-
types of GBMs and can be classified further. Four expression subtypes of GBMs have been 
reported, proneural, neural, classical and mesenchymal, each with unique genetic markers 
that indicate the cell of origin and distinct clinical outcomes (Verhaak et al., 2010). Oligoden-
drocytic signatures have been identified in the proneural subtype. The proneural subtype of 
GBM are predominantly secondary gliomas and occur at a younger age (Verhaak et al., 2010). 
Hallmark characteristics include PDGFRA abnormalities and IDH1 mutations (Verhaak et al., 
2010). IDH1 mutations have been inversely correlated with GBM grading affecting 71% in 




al., 2018). The Increase of PDGFRA expression in proneural subtypes are due to increased 
PDGFRA mutation and PDGFRA gene amplification (Verhaak et al., 2010). The PDGFRA gene 
is selectively expressed in OPC and is critical in stimulating the proliferation and migration of 
OPCs (Zong et al., 2012). The classical subtype is characterised by astrocytic gene signatures 
and epidermal growth factor receptor (EGFR) amplification, mutations and EGFRvIII intragenic 
deletions. EGFRvIII intragenic deletions of the epidermal growth factor (EGF) receptor leads 
to an in frame deletion and consequently results in the constitutively active kinase domain of 
the receptor (Zadeh et al., 2013, Li et al., 2009). EGFRvIII enhances cell proliferation, tumour 
growth and invasiveness in GBMs (Li et al., 2009). In contrast, neural subtypes are associated 
with gene of both astrocytes and oligodendrocytes but the strongest association are of gene 
associated with neurones (Verhaak et al., 2010). Neural markers such as NEFL and GABAA1 
are identifiers of the neural subtype of GBMs (Verhaak et al., 2010). Finally, macrophage 
markers such as CD68 and TNF are identified to be highly expressed in the mesenchymal 
subtype (Verhaak et al., 2010). In addition, the mesenchymal subtype had been correlated 
with genes associated with inflammation and has been linked to increased overall fraction of 
necrosis in tumours (Verhaak et al., 2010). The mesenchymal subtype of GBMs have been 
associated with high immune cell infiltration (microglia and macrophages) which has been 
shown to contribute to tumour progression (Prionisti et al., 2019, Gajewski et al., 2013, Noy 
and Pollard, 2014). Therefore, the tumour microenvironment constitutes malignant and non-
malignant cells, including immune and stromal cells, that provides tumour promoting func-
tions (Noy and Pollard, 2014, Balkwill et al., 2012). The complex network of signals between 
immune cells and GBMs establishes a tumour supporting environment that facilitates the 






1.1.2. The innate and adaptive immune system, a brief overview 
Vertebrates have evolved a highly complex immune system to recognise many com-
ponents of foreign organism and elicit an immediate defence. The immune system consists 
of two distinct levels, the adaptive and innate immune system. The cells of the innate and 
adaptive immune systems are distinct (macrophages, dendritic cells, neutrophils and natural 
killer (NK) cells are considered innate immune cells, and lymphocytes are considered adaptive 
immune cells) but are not isolated from each other (Renshaw and Trede, 2012, Janeway and 
Medzhitov, 2002, Riera Romo et al., 2016). Significant crosstalk exists between the innate 
and adaptive immune system and is vital for the proper recognition and the proper immune 
response to an invading pathogen, bacterial or cancerous cell (Renshaw and Trede, 2012, 
Janeway and Medzhitov, 2002, Riera Romo et al., 2016).  
The innate immune system is the first line of defence against invading pathogens or 
tissue injury. The mechanism of pathogen recognition by the innate immune system is exten-
sively studied. The recognition of conserved features of microbial pathogens by the innate 
immune system are mediated through pattern recognition receptors, such as toll like recep-
tors (TLRs), C-type lectin receptors (CLRs) and nucleotide-binding oligomerization domain 
(NOD) (Li et al., 2017, Iwasaki and Medzhitov, 2015). These receptors recognise pathogen-
associated molecular patterns (PAMPs) such as bacterial (LPS, flagellin), fungal cell-wall com-
ponent and viral nucleic acids (Beutler, 2009, Iwasaki and Medzhitov, 2015). In addition to 
recognising structural features, the innate immune system is also capable of detecting path-
ogens through changes in tissue homeostasis (Iwasaki and Medzhitov, 2015, Chovatiya and 
Medzhitov, 2014). Alterations in tissue homeostasis such as protein folding, level of reactive 
oxygen species (ROS) and nutrient availability are sensed by sensors such as ATF4, NRF2, 
and CHREBP respectively, which engages a stress response to restore homeostasis (Chova-
tiya and Medzhitov, 2014). Macrophages have been defined as key sensory cells that monitor 
and control tissue homeostasis under stress, infection and also during tissue development 




and Edwards, 2008). The advantages of this recognition system negates the requirement of 
a whole host of specific receptors against a diverse range of toxins, allergens, bacterial struc-
tures or virulent factors. The recognition of multicellular parasitic infections are detected by 
changes in tissue homeostasis as parasites lack structurally invariant targets that are detect-
able by pathogen recognition receptors (Iwasaki and Medzhitov, 2015). The innate immune 
system is also capable of discriminating self from non-self through inhibitory receptors. NK 
cells contain an immunoreceptor tyrosine-based inhibitory motif that detects major histocom-
patibility complex class I (MHC class I) molecules in order to avoid targeting healthy cells 
(Raulet, 2006). Indeed, normal cells from mice deficient in MHC class I were susceptible to 
NK cells (Raulet, 2006). Viral infection and cellular stress reduces the surface expression of 
MHC class I which rapidly flags these cells to be killed by NK cells (Iwasaki and Medzhitov, 
2015).  
 The detection of a pathogen by the innate immune system initiates a signalling cas-
cade that generates a phagocytic inflammatory responses. Neutrophils are one of the first 
responders of the immune system and migrate into tissue in response to injury or infection 
(Kim and Luster, 2015). Neutrophils are an important cell type of the innate immune system. 
Neutrophils develop in the bone marrow and form the majority, 50% – 75%, of circulating 
peripheral blood leukocytes (Kienle and Lammermann, 2016, Kim and Luster, 2015). They 
patrol the body and migrate into the brain or any tissue in response to an insult (Kienle and 
Lammermann, 2016, Kim and Luster, 2015). Neutrophils are potent innate immune cells that 
contain cytotoxic granules enriched with antimicrobial molecules such as cationic peptides, 
proteases and myeloperoxidase (MPO) (Rosales et al., 2016). One unique aspect that sepa-
rates neutrophils from other innate immune cells is their ability to release neutrophil extracel-
lular traps (NETs) (Brinkmann and Zychlinsky, 2012, Rosales et al., 2016). NETs are composed 
of decondensed chromatin material as well as cytoplasmic protein released into the extracel-
lular space (Garley et al., 2016, Brinkmann and Zychlinsky, 2012). These NETs binds micro-
organism to prevent their spread and releases a high local concentration of cytotoxic factors 




et al., 2013). MPO has been shown to kill melanoma cells and inhibit tumour progression 
(Odajima et al., 1996). Patients deficient in MPO have increased predisposition to cancer 
(Lanza et al., 1988). In addition, the uptake of neutrophil elastase, a serine protease expressed 
in neutrophil primary granules by breast cancer cells, promotes specific lysis by cytotoxic T-
lymphocytes (Mittendorf et al., 2012). Neutrophil release of NETs activates dendritic cells and 
primes T cells and marks a key step towards the activation of the adaptive immune system 
(Berger-Achituv et al., 2013, Brinkmann and Zychlinsky, 2012).  
Microglia, the resident macrophage of the brain, are derived from primitive macro-
phages that invade and differentiate in the brain during development (Ginhoux et al., 2010). 
Microglia and macrophages, are cells of the mononuclear phagocytic system derived from 
the bone marrow and are myeloid in origin (Simard and Rivest, 2004, Nayak et al., 2014, 
Pollard, 2009). Microglia and macrophages are phagocytic cells of the innate immune system 
and have key roles in the development and immune related functions against pathogens and 
injuries in the brain (Casano and Peri, 2015, Nayak et al., 2014, Greter and Merad, 2013, 
Pollard, 2009). The differentiation of microglia from primitive macrophages is regulated by 
various transcription factors such as PU.1, Irf8, TGF-β and colony stimulating factor (CSF)-
1R in the brain (Walton et al., 2000, Shiau et al., 2015, Lavin et al., 2014, Butovsky et al., 2014, 
Elmore et al., 2014). PU.1 is an essential transcription factor that regulates adult myelopoiesis 
and is expressed in macrophages, neutrophils, B cell, T cells and microglia (Olson et al., 1995, 
Walton et al., 2000, Nayak et al., 2014, McKercher et al., 1996, Pang et al., 2018). PU.1 has 
been identified as a key regulator of myeloid differentiation that promote lineage specific gene 
expression (Pang et al., 2018). Consequently, mice deficient in PU.1 expression are devoid of 
macrophage and microglia (Anderson et al., 1998). Likewise, the genetic knockout of TGF-β 
and pharmacological inhibition CSF-1R expression in mice abolishes microglia expression in 
the CNS (Butovsky et al., 2014, Elmore et al., 2014). In contrast, Interferon regulatory factor 
8 (irf8) is a key factor in early stage myelopoiesis of the immature zebrafish immune system 




acteristic development of a macrophage null background up to around seven days post fer-
tilization (Shiau et al., 2015). In addition, irf8-/- mutant mice have a reduction in the number 
of parenchymal microglia in the midbrain (Kierdorf et al., 2013).  
Although microglia and macrophages share a common lineage, these cell types can 
be functional distinct from one another. Studies have shown that infiltrating macrophages are 
capable of performing indispensable roles not provided by resident macrophages (Shechter 
et al., 2009, London et al., 2011). In one study, infiltrating monocyte derived macrophages 
was responsible for the neuroprotective secretion of anti-inflammatory cytokine, il-10, in a 
spinal cord injury mice model (Shechter et al., 2009). Therefore, the distinction between resi-
dent microglia and peripheral macrophages in the CNS will allow investigators to further in-
vestigate the differential role of microglia and macrophages functional contribution CNS dis-
eases. However, the shared lineage between differentiated microglia and macrophages of 
monocyte lineage means that these two cell types share many genetic markers such as Iba1, 
CD68, F4/80, PU.1 and mpeg1 (Brochhausen et al., 2017, Hendrickx et al., 2017, Ohsawa et 
al., 2004, Hsu et al., 2004, Ellett et al., 2011). In efforts to discriminate between microglia and 
macrophages researchers have identified key genetic markers that allowed separate identifi-
cation of these two closely related cell type in the CNS. Traditional approaches to differentiate 
microglia from invading macrophages relied on the use of CD45 antibody where resident mi-
croglia were CD45Lo and macrophages CD45Hi (Badie and Schartner, 2000). However new 
markers have been recently identified, the microglia specific protein 199 (TMEM119) was dis-
covered through comparative transcriptomic studies (Satoh et al., 2016) and was recently 
demonstrated to selectively label microglia (Kaiser and Feng, 2019). In addition, the P2 pu-
rinergic receptor (P2Y12) was also demonstrated to be a microglia specific marker in mice 
and zebrafish (Zhu et al., 2017, Butovsky et al., 2014, Sieger et al., 2012). Together these 
markers expanded the repertoire of biological tools to allow effective identification of micro-
glia from infiltrating macrophages in order to study CNS diseases. 
The maturation of dendritic cells and macrophages into antigen presenting cells re-




adaptive immunity (Li et al., 2017, Renshaw and Trede, 2012). Antigen presenting cells are 
important modulators of immunity that are capable of phagocytosis (Mantegazza et al., 2013, 
Broeke et al., 2013). Peptides derived from phagocytosis and subsequent cytosolic proteol-
ysis of pathogens associate intracellularly with either MHC class I or MHC class II molecules 
and are translocated to the plasma membrane (Mantegazza et al., 2013, Broeke et al., 2013). 
Peptide antigens are unique to each pathogen and the presentation of these peptides asso-
ciated with MHC molecules activate the adaptive immune system (Mantegazza et al., 2013, 
Broeke et al., 2013). These MHC-peptide complexes are recognise by T and B lymphocytes 
from the adaptive immune system (Hato and Dagher, 2015, Gajewski et al., 2013). The acti-
vation of T and B lymphocytes initiate cytotoxic activity and antibody production respectively, 
which specifically target the pathogen (Hato and Dagher, 2015, Gajewski et al., 2013). Unlike 
pattern recognition receptors of the innate immune system, antigen receptors on the adaptive 
immune system recognize individual classes of pathogens based on specific protein antigen 
presentation (Broeke et al., 2013). Therefore, the adaptive immune system is more versed in 
pathogen recognition than the innate immune system. The adaptive immune system is esti-
mated to recognise 107 or more antigens versus the 103 molecular patterns in the innate 
immune system (Janeway and Medzhitov, 2002, Hato and Dagher, 2015). Together, the innate 
and adaptive immune systems trigger an immune response that adapts to acquire long term 
immune memory against the pathogen for future rapid response.  
Tumours have evolved mechanisms that circumvent immune surveillance. These 
mechanisms exploit the ability of the innate immune system to influence the adaptive immune 
system in order to promote tumour progression. Substantial evidence has been provided in 
support of the view that the defence and immune functions are suppressed in gliomas (Biswas 
et al., 2013, Li and Graeber, 2012, Markovic et al., 2009). In particular, microglia and macro-
phages have been identified to play a key role in establishing an immunosuppressive milieu 





1.1.3. The environment regulates the functional plasticity of microglia and 
macrophages 
The functions of microglia are highly plastic and are stimulus dependent (Casano and 
Peri, 2015). A myriad of microglia functions have been identified in the brain that include 
phagocytosis of apoptotic neurons, synaptic refinement of neurones, vesicle patterning, in-
flammation and wound healing (For review see (Casano and Peri, 2015). Microglia are highly 
motile and are actively scanning their environment by extending and retracting their ramified 
processes without translocating the main cell body (Nimmerjahn et al., 2005). Microglia base-
line surveillance of the parenchyma is regulated by a two pore domain potassium channel 
called THIK-1 (Madry et al., 2018) while the convergence of microglia processes toward a 
damaged area are regulated by purinoreceptors of the P2Y12 receptor highly expressed on 
microglia (Haynes et al., 2006). Microglia transition from the surveillance state to the activated 
state in response to stimuli such as inflammation or disease. The activation of microglia initi-
ates a phenotypic change in addition to a change in its morphology (Nimmerjahn et al., 2005). 
Under the activated state, microglia attain an ameboid shape, are highly motile in their entirety 
and become morphologically indistinguishable from other macrophages (Prionisti et al., 
2019). The functional plasticity and rapid response to external stimuli make microglia a highly 
versatile cell type that has the ability to adapt to its environment.  
Microglia and macrophages are dynamic cell types that respond to cytokines re-
leased in their environment. The local microenvironment has an instructive role in directing 
the differentiation pathway primitive macrophages take, which ultimately shapes their func-
tion (Casano and Peri, 2015). Lavin et al. demonstrated that the transplantation of adult bone 
marrow derived macrophages into the lung, spleen and liver modified the chromatin land-
scape towards that of tissue-resident macrophages (Lavin et al., 2014). In addition, TGF-β 
was shown to regulate microglia differentiation and was required for the in vitro development 
of the microglia molecular signature characteristic of adult microglia. (Lavin et al., 2014, 
Butovsky et al., 2014). This plasticity is maintained in tissue macrophages to a certain extent, 




adapt their functions. The cytokines produced in the macrophage local environment can give 
rise to macrophages of distinct physiologies. Macrophages can respond to endogenous stim-
uli produced by immune cells of both the innate and adaptive immune system by altering their 
phenotype to facilitate anti-microbial activity, tissue repair or anti-inflammatory activities 
(Mosser and Edwards, 2008, Qian and Pollard, 2010, Rougeot et al., 2019). Figure 2 summa-
rises how different endogenous cytokines produced by cells of the innate and adaptive im-
mune system can shape macrophage phenotype. Interferon (IFN)-𝛾 and tumour-necrosis fac-
tor (TNF) produced by T helper 1 (TH1) cells, NK cells and antigen presenting cells (APC) 
polarises macrophages to secrete pro-inflammatory cytokines (Mosser and Edwards, 2008). 
The expression of Interleukin (IL)-4 by TH2 cells or by granulocyte promotes the development 
Figure 2. Endogenous cytokines produced by cells of the innate and adaptive 
immune system can shape macrophage phenotype. 
Interferon (IFN)-𝛾	and tumour-necrosis factor (TNF) produced by T helper 1 (TH1) cells, Natural Killer (NK) cells and 
antigen presenting cells (APC) polarises macrophages to secretes pro-inflammatory cytokine that enhances 
microbicidal and tumoricidal capacity. The expression Interleukin (IL)-4 by TH2 or by granulocyte promotes the 
development of the wound healing macrophage require for tissue repair. While IL-10 release by regulatory T-cells 
from the adaptive immunity promotes polarisation towards regulatory macrophages to suppress immune response. 
Regulatory macrophages can also be expressed by other stimuli including immune complexes, prostaglandins, 
GPCR ligands, gluococorticoids and apototic cells.  
 
Moser and Edwards, 2008 





of the wound healing macrophage involved in tissue repair (Loke et al., 2007, Gordon and 
Martinez, 2010). While IL-10 release by regulatory T-cells from the adaptive immunity pro-
motes polarisation towards regulatory macrophages to suppress immune response (Mosser 
and Edwards, 2008). The interaction between antigen specific T lymphocytes and microglia 
promotes wound healing functions of resident microglia following insult. The activation of 
microglia by IFN gamma facilitates glutamate clearance and contributes to a neuroprotective 
effect (Shaked et al., 2005). In addition, neurones have also be shown to secrete factors that 
regulated microglia activation. The secretion of CD22 and CD200 by neurones acted as an 
inhibitor of microglia proinflammatory cytokine TNF-𝑎 production and facilitate the mainte-
nance of an anti-inflammatory expression profile in microglia (Mott et al., 2004, Lyons et al., 
2009).  
These studies suggest that the local environment is critical in influencing the func-
tional identity of macrophages and result in a diverse range of macrophage subpopulation. 
Therefore, the microenvironment has a significant impact in modulating microglia and mac-
rophage function that can drive the polarisation of microglia/macrophage towards a pro or 
anti-tumoural phenotype. 
 
1.1.4. The tumour promoting functions of Tumour Associated Macrophages 
(TAMs) 
GBMs have evolved mechanisms that exploit the intrinsic functional plasticity of mac-
rophages to facilitate tumour growth (Hambardzumyan et al., 2016, Prionisti et al., 2019). The 
link between inflammation and GBM is well established. GBMs, like many other tumours, have 
evolved complex ecological mechanisms that promote the malignancy of tumours. The tu-
mour microenvironment is a convoluted web of interacting biological signals between differ-
ent cell populations that serves to enhance and promote the survival of tumours (Markovic et 
al., 2009, Wu et al., 2010, Li and Graeber, 2012). Innate immune cells are highly represented 
in the tumour microenvironment and macrophages are the most abundant cell type (Coniglio 




have been identified to contribute to GBM progression leading to tumour growth, tissue in-
vasion and chemotherapeutic resistance (Prionisti et al., 2019, Hambardzumyan et al., 2016, 
Jacobs et al., 2012, Coniglio et al., 2012, Zhai et al., 2011, Hamilton et al., 2016). In the dis-
eased CNS the compromised blood brain barrier leads to the infiltration of peripheral macro-
phages. Microglia and macrophages can contribute up to 50% of non-neoplastic cells (Ham-
bardzumyan et al., 2016). In agreement, a further study using genetical modified mice showed 
that infiltrating monocytes/macrophages constitutes 85% total TAM while microglia ac-
counted for the remaining 15% (Chen et al., 2017). The authors revealed that the genetic 
expression patterns between infiltrating monocytes/macrophages and resident microglia 
were unique when compared with each other thus highlighting a difference in functions (Chen 
et al., 2017). Furthermore, the authors concluded that there was a continuous transformation 
of infiltrating monocytes to mature macrophages and microglia-like cells in the tumour micro-
environment (Chen et al., 2017). The level of infiltration by macrophages and microglia in 
GBMs have been positively correlated with poorer prognosis (Bingle et al., 2002, Li and Grae-
ber, 2012). Under the influence cytokines such as CSF1, IL-4, IL-13 and IL-10, infiltrating 
monocytes can differentiated into tropic/developmental macrophages that downregulate tu-
moricidal activity (Noy and Pollard, 2014, Quail and Joyce, 2017, van Dalen et al., 2018). 
Therefore, microglia and macrophages in glioma have been described to resemble regulatory 
macrophages and wound healing macrophages possessing both anti-inflammatory activity 
and tissue repair capabilities (Mosser and Edwards, 2008).  
The infiltration of macrophages and microglia in tumours, known as tumour associ-
ated macrophages (TAMs), modifies the tumour microenvironment to facilitate immune sys-
tem avoidance and promote tumour progression. TAMs are capable of remodelling the tu-
mour microenvironment to release inhibitory mechanisms that otherwise would lead to an 
anti-tumour phenotype (Noy and Pollard, 2014). TAMs have been shown to regulate tumour 
angiogenesis, invasion, metastasis, extracellular matrix reorganisation and suppression of in-
flammatory responses (Qian and Pollard, 2010, Zhang et al., 2016). The transition from benign 




intrinsic capabilities of macrophages to influence the local tumour microenvironment (Li and 
Graeber, 2012, Reichel et al., 2019, Qian and Pollard, 2010). Therefore the tumour promoting 
role of macrophages and microglia are supported by crosstalk with the oncogenic microen-
vironment. Substantial evidence has been provided in support of the view that the defence 
and immune functions of macrophages and microglia are suppressed in gliomas (Li and Grae-
ber, 2012). The recruitment of macrophages and microglia into the tumour microenvironment 
are mediated by chemoattractant such as CC chemokine ligand 2 (CCL2) and soluble colony-
stimulating factor (sCSF-1) (Conti and Rollins, 2004, Noy and Pollard, 2014). These chemoat-
tracts are identified to be highly expressed in tumours including GBMs (Conti and Rollins, 
2004, Noy and Pollard, 2014). In addition, TGF-β, an immunosuppressive cytokine, is over-
expressed in tumours and plays an important role in the maintenance of an immunosuppres-
sive milieu in the tumour microenvironment (Zhang et al., 2016). The expression of TGF-β 
exploits capabilities of the innate immune system to influence the adaptive immune response 
by inhibiting antigen presentation thereby inhibiting the activation and differentiation of cyto-
toxic T-cells. (Flavell et al., 2010, Li and Graeber, 2012). Once in the local tumour microenvi-
ronment, TAMs secrete proangiogenic factor such as matrix metalloproteinase (MMP)-9 and 
vascular endothelial growth factor (VEGF) that promotes angiogenesis, tumour progression 
and metastasis (Chen et al., 2014, Kim et al., 2018). In addition, TAMs produce immunosup-
pressive factors like interleukin (IL)-10 and IL-13 that inhibit macrophage activation, T-cell 
proliferation and reduces the production of proinflammatory cytokine IL-12 (Zhang et al., 
2016). TAMs also produce epidermal growth factor (EGF) that increases tumour invasion by 
activating receptors on GBM (Coniglio et al., 2012). These TAMs are maintained by the glio-
mas through the secretion of glioma derived CSF-1 and IFN-𝛾 a well-known chemoattractant 
of microglia and promoter of microglia proliferation (Coniglio et al., 2012, Pyonteck et al., 
2013). Indeed, it was shown that the depletion of microglia by CSF-1 inhibition altered mac-
rophage polarisation and increased the survival of a mouse proneural GBM model (Pyonteck 
et al., 2013). In addition, we also previously showed that microglia and macrophages form 




in the zebrafish brain in vivo (Hamilton et al., 2016). The interactions between microglia/mac-
rophages and glioma cells can alter microglia phenotype. In vitro co-cultures of microglia and 
glioma cells showed that microglia lose their phagocytic activity when in contact with C6 
glioma cells (Voisin et al., 2010). Therefore, the close association of microglia and tumour 
cells suggests a symbiotic relationship that promotes tumour progression.  
While many studies support for the tumour promoting role of macrophage in tumours, 
studies have shown that macrophages retain tumoricidal capabilities and that repolarisation 
of TAMs can be achieved towards an anti-tumour phenotype. The delivery of IL-12 containing 
microspheres into the tumour microenvironment led to proinflammatory cytokine production 
of Tnf-𝑎, IL-15 and IL-18 and reduction in tumour promoting cytokines IL-10, MCP-1 and 
TGF-β (Watkins et al., 2007). Furthermore, toll like receptor (TLR) activation have been exten-
sively documented to polarise TAMs towards pro-inflammatory tumoural phenotype through 
the upregulation of IL-6, IL-12, Tnf-𝑎 and iNOS secretion and enhancement of antigen uptake 
and T-cell priming (van Dalen et al., 2018, Vidyarthi et al., 2018, Banerjee et al., 2015, Yang 
et al., 2015, Rodell et al., 2018b). These studies highlights the potential of immunotherapeu-
tics to repolarise TAM as a strategy to cancer treatment. 
 
1.2. Nanoparticles in the treatment of Glioblastomas 
The current standard treatment for GBM is surgery followed by adjuvant radiotherapy 
or chemotherapy. Even with multimodal treatment, modern medicine is still ineffective in in-
creasing the median survival of 15 months in GBMs (Stupp et al., 2017). The anti-tumour 
properties of radiotherapy are still widely debated (Reviewed in Vatner and Formenti, 2015). 
Radiotherapy of tumours have been shown to actively recruit myeloid derived cells, especially 
TAMs, into the tumour microenvironment through CSF-1R activation (Vatner and Formenti, 
2015). The recruitment of TAMs persists for years after radiotherapy and are detrimental to 
the patient (Vatner and Formenti, 2015). The anti-tumour effects of recruited macrophages 




menti, 2015). In addition, radiotherapy can repolarise existing macrophages towards the tu-
mour promoting, anti-inflammatory, phenotype (Vatner and Formenti, 2015). Chemotherapeu-
tic resistance to Temozolomide (TMZ), the first line of treatment against GBM, is commonly 
reported due to intrinsic or acquired resistance of the tumour to the drug (Yi et al., 2019). 
Thus a more effective treatment option is long overdue.  
One of the major challenge facing cancer therapy is the difficulty of homogeneous 
delivery of intravenous chemotherapeutics throughout the solid tumour mass. The high inter-
stitial pressures contribute to the suboptimal diffusion of drugs from blood circulation which 
prevents intratumor penetration (Stohrer et al., 2000). The problem is exacerbated by the 
clearance of intravenous drugs by the liver and kidneys which can lead to fatal organ toxicity 
(Hoop et al., 2018). Inadequate intratumoural delivery of chemotherapeutic agents cannot be 
solved by increasing systemic dose. In addition, conventional chemotherapy lacks target 
specificity and nontarget tissue distribution. Thus the use of nanoparticles as carriers of 
chemotherapeutic drugs have been explored as a more effective drug delivery system. The 
medical applications of nanoparticles as a therapeutic agent in the treatment of cancer is not 
a novel approach. Nanoparticles are defined as small particles (1000<nm diameter) com-
prised of metals or polymers or any other materials that usually contain a hydrophobic region 
that can trap a hydrophobic drug (Reichel et al., 2019). Nanoparticles have been tested as 
combination therapies to induce cellular death through thermal ablation or oxidative stress 
(Phillips et al., 2014). Nanoparticles have been used to improve the efficiency of thermal ab-
lation methods that includes radiofrequency, microwave, cryoablation and high intensity fo-
cused ultrasound (Manthe et al., 2010). In addition, nanoparticle-based drugs can be multi-
functional, possessing both therapeutic and theranostic (diagnostic imaging probe) proper-
ties (Phillips et al., 2014). A wide range of radiotherapeutic nanoparticles have been studied 
to deliver ionising radiotherapy to the tumour in combination with imaging platforms like mag-
netic resonance imaging (MRI), positron emission tomography (PET) and X-ray computed to-




Nanoparticles have also found new applications in the emerging field of bioorthogo-
nal catalytic reactions in cancer therapy (Adam et al., 2018). By design, bioorthogonal reac-
tions occur in a living organism without interfering with biological functions (Adam et al., 
2018). Solidly supported Palladium and Gold nanoparticles have been recently demonstrated 
to catalyse bioorthogonal reactions that generate active agents from inactivated precursors 
(Adam et al., 2018, Perez-Lopez et al., 2017). The chemical inactivation of compounds can 
dramatically reduce the bioactivity of the resulting derivative while maintaining catalytic chem-
istry with Palladium (Weiss et al., 2014b, Adam et al., 2018), Gold (Perez-Lopez et al., 2017, 
Tonga et al., 2015), Copper (Clavadetscher et al., 2016) or Ruthenium (Tonga et al., 2015). 
Chemotherapeutic agents such as Fluorouracil (5-FU), Vorinostat, doxorubicin and SN-38 
(active metabolite of irinotecan) can be synthesised from inactive precursors through 
bioorthogonal organometallic catalysis with Gold and Palladium nanoparticles (Adam et al., 
2018, Perez-Lopez et al., 2017). The highly selective reactions of these implantable devices 
confer spatiotemporal control of chemotherapeutic drug delivery, in addition to increasing the 
potency of drugs at the tumour site. It also has the potential to reduce side effects, since 
systemic circulating inactivated precursor, when chemically inactivated, would have dramat-
ically reduced bioactivity. A 44 fold reduction in cytotoxicity was achieved with SN-38 pre-
cursors on human colon rectal cancer cell line HCT116 and human glioblastoma cell lines 
U87 and U251 in vitro (Adam et al., 2018). Adam et al., demonstrated that Palladium mediated 
bioorthogonal catalytic release of SN-38 result in a dose dependent inhibition on HCT116, 
U87 and U251, cell viability (Adam et al., 2018). One study combined the magnetic properties 
of iron and bioorthogonal properties of Palladium to deliver chemotherapeutic 5-FU to a pre-
defined area in tumour xenografts using magnetism (Hoop et al., 2018). Nanorobotic Palla-
dium mediated bioorthogonal organometallic (BOOM) reactions result in a significant reduc-
tion in breast cancer cell growth in vitro and in vivo (Hoop et al., 2018). This technology pre-
sents a novel therapeutic approach combining nanorobotics and BOOM activation of pro-





1.2.1. Nanoparticle uptake polarises macrophages 
Recent evidence suggests that the uptake of nanoparticles is capable of polarising 
macrophages towards an anti-tumour phenotype. Nanoparticles, either implanted or system-
ically administered, readily accumulated within both TAMs and macrophages (Bastus et al., 
2009a, Reichel et al., 2019). The accumulation of nanoparticles in macrophages present the 
opportunity to enhance drug delivery to macrophages. Nanoparticles have also been used to 
enhance cancer immunotherapy (Rodell et al., 2018a, Huang et al., 2016, Wang et al., 2019). 
Drug loaded nanoparticles have been demonstrated to mediate synchronous biodistribution 
of drugs. The separate cell targeted delivery of chemotherapeutic agent and TAM repolarising 
agent was achieved using twin-like core-shell nanoparticles to cancer cells and TAMs respec-
tively (Wang et al., 2019). The co-delivery strategy exhibited anti-tumour efficacy on TAMs 
and tumours leading to decreased tumour size in vivo (Wang et al., 2019). A recent study 
demonstrated the utility of drug loaded nanoparticles. R848, a TLR7/8 agonist, was loaded 
onto β-cyclodextrin nanoparticles which accumulated in macrophages and consequently led 
to the biodistribution of R848 in macrophages (Rodell et al., 2018a). Nanoparticles have ex-
tensive clinical application in immunotherapeutic drug delivery that targets TAMs (Rodell et 
al., 2018a, Huang et al., 2016, Penn et al., 2018, Binnemars-Postma et al., 2017) 
The response of macrophage to nanoparticles is dependent on particle size, compo-
sition, dose, route of entry and surface properties (Reviewed in Reichel et al., 2019). These 
variables can modulate the efficacy of nanoparticle delivery and activity in macrophages. 
However, material composition and surface properties of nanoparticles are the most signifi-
cant determinant of macrophage polarisation. The exposure of nanoparticles to endogenous 
serum in an in vivo system results in the formation of what is known as a protein ‘corona’ on 
the surface (Kharazian et al., 2016). Endogenous proteins compete with one another to bind 
the surface of the nanoparticle leading to opsonization and subsequent endocytosis or phag-
ocytosis by macrophages (Ge et al., 2015). The most common method of blocking nonspe-




of poly(ethyleneglycol) (PEG) in a process known as PEGylation (Walkey et al., 2012). PEGyla-
tion of Gold nanoparticles blocks macrophage uptake and macrophage polarisation (Walkey 
et al., 2012). Thus the protein corona has significant implications in altering the bio-identity of 
nanoparticles (Cedervall et al., 2007, Ge et al., 2015, Kharazian et al., 2016, Walkey et al., 
2012). The surface composition of nanoparticles can be artificially manipulated to modulate 
macrophage uptake of nanoparticles. One study showed that by changing the surface stabi-
lizer of nanoparticles to either citrate or polyethylene imine from PEG, an increase in macro-
phage internalisation of nanoparticles was achieved (Zazo et al., 2017). As these nanoparti-
cles are not recognised as inert by macrophages, the uptake of these nanoparticle can initiate 
intracellular responses that lead to macrophage polarisation (Reichel et al., 2019). 
 
1.2.2. Harnessing the therapeutic potential of nanoparticle polarised macro-
phages and microglia in glioblastoma  
Silica, Gold, Palladium and Iron oxide nanoparticles have all been described to po-
larise macrophages towards the pro-inflammatory phenotype (Reichel et al., 2019, Leso and 
Iavicoli, 2018). The inhibition of macrophage uptake of nanoparticles by either PEGylation, 
increasing surface ionization, adding inert polymers on the surface or blocking macrophage 
endocytosis has a significant effect in reducing macrophage polarisation capabilities 
(Cedervall et al., 2007, Reichel et al., 2019, Walkey et al., 2012). Thus the intracellular transport 
of nanoparticles by macrophages is essential in initiating macrophage polarisation pathways. 
The uptake of nanoparticles by macrophages is mediated by cytoskeleton dependent path-
ways (Kusaka et al., 2014). The treatment of bone marrow derived macrophages (BMDM) with 
Cyto D, an inhibitor of actin polymerization, dramatically inhibited the internalization of Silica 
nanoparticles (Kusaka et al., 2014).  
The biological effects of nanoparticles on macrophage cytokine expression have 
been extensively investigated (Mukherjee et al., 2005, Hutter et al., 2010, Walkey et al., 2012, 
Niikura et al., 2013, Kusaka et al., 2014, Zanganeh et al., 2016, Alarifi et al., 2017, Leso and 




cleaves immature pro-IL-1β into mature IL-1β and leading to increased IL-1β secretion (Ku-
saka et al., 2014). In addition, increased ROS generation and increased IL-6, TNF-𝑎 and iNOS 
expression have been described in silica internalised macrophages. Likewise, Palladium na-
noparticles polarise macrophages and lead to increased TNF-𝑎, IL-6 and IL-8 expression 
(Schmidt and Goebeler, 2015, Leso and Iavicoli, 2018). However, significant ROS generation 
is considered as one of the key mechanisms responsible for the cytotoxic effect of metallic 
nanoparticles like Palladium (Leso and Iavicoli, 2018). Metallic nanoparticles such as Cobalt, 
Titanium and Palladium increase ROS generation in macrophages (Reichel et al., 2019, Alarifi 
et al., 2017). In addition, in one study, the treatment of Palladium nanoparticles on human 
skin malignant melanoma (A375) cells led to excessive production of ROS resulting in oxida-
tive stress induced apoptosis, DNA damage and cell cycle arrest (Alarifi et al., 2017). There-
fore, metallic nanoparticles like Palladium may have the potential to be used as a combination 
therapy that targets both TAMs and cancer cells. The effects of Gold nanoparticles on TAMs 
have also been previously investigated. Increased IL-1β, TNF-𝑎, IL-6, iNOS secretion have all 
been described in macrophages treated with gold nanoparticles, driving a shift in macro-
phage polarisation towards the anti-tumorigenic phenotype (Bastus et al., 2009a, Reichel et 
al., 2019). Gold nanoparticles have been shown to be effective vaccine adjuvants that en-
hance macrophage inflammatory cytokine production including IL-12 and granulocyte mac-
rophage colony stimulating factor (GM-CSF) (Hutter et al., 2010). In addition, Gold nanopar-
ticles have been reported to possess anti-angiogenic properties by selectively inhibiting VEGF 
induced proliferation of endothelial cells which can have major implications in inhibiting tu-
mour growth (Mukherjee et al., 2005). In contrast to Silica, Gold and Palladium, Iron oxide 
nanoparticles are currently used clinically as iron replacement therapies in the form of Fer-
umoxytol (Reichel et al., 2019, Toth et al., 2017). They also have imaging applications in con-
trast-enhanced magnetic resonance imaging and have been used as drug carriers in preclin-
ical and clinical setting (Zanganeh et al., 2016, Toth et al., 2017). Ferumoxytol nanoparticles 
have been shown to attract macrophages and enhance ROS production leading to adeno-




macrophages towards the pro-inflammatory phenotype, causing an increase in TNF-𝑎 and a 
decrease in IL-10 expression (Zanganeh et al., 2016, Kodali et al., 2013). The treatment with 
Ferumoxytol polarises infiltrating and existing TAMs towards the pro inflammatory phenotype 
(Zanganeh et al., 2016). In vivo, proinflammatory polarisation of macrophages by iron oxide 
nanoparticles inhibits mammary tumour growth (Zanganeh et al., 2016). The effects were con-
served to nanoparticle material composition, as alteration of surface chemistry had no effect 
on the inhibitory effect of macrophage on mammary tumour growth (Zanganeh et al., 2016). 
In addition, Iron oxide nanoparticles have a much greater impact on basal transcription in 
macrophages than silica nanoparticles (Kodali et al., 2013). Kodali et al. compared the effects 
of silica and iron oxide nanoparticles on macrophage polarisation. A total of 1029 genes and 
67 genes were differentially expressed in macrophages treated with iron oxide nanoparticles 
and silica nanoparticles respectively (Kodali et al., 2013). Kodali et al also report that iron 
oxide treated macrophages elicit a greater inhibition on IL-10 secretion than in silica nano-
particle treated macrophages (Kodali et al., 2013). Altogether, nanoparticles have significant 
benefits in improving existing cancer treatment by inducing tumour-suppressive macrophage 
polarisation within tumours. In particular, Gold and Palladium have been identified to polarise 
macrophages through activation of toll like receptor (tlr)-4 signalling (Bastus et al., 2009a, 
Rachmawati et al., 2013). However, the effects of Gold and Palladium repolarisation of TAMs 
in GBMs remain to be investigated. Significant knowledge gaps exist in regards to Gold and 





1.3. Toll Like Receptor Family 
1.3.1. Toll Like Receptor family signaling and its effects on macrophage polar-
isation 
Toll Like Receptors (TLRs) are pattern recognition receptors that recognize pathogen 
associated molecular patterns derived from microbial pathogens, including viruses, bacteria, 
fungi and damage associated molecular patterns such as ATP and double stranded DNA 
(dsDNA) (Brajer-Luftmann et al., 2019). TLR activation is the consequence of pathogenic in-
fection or cellular stress that leads to a cascade of signalling events that promote inflamma-
tion, macrophage polarization and priming of the adaptive immune system (Brajer-Luftmann 
et al., 2019, Barton and Kagan, 2009). The expression of TLRs on macrophages plays a cen-
tral role in host immunity against pathogens (Barton and Kagan, 2009). To date, eleven mem-
bers of the TLR family have been identified. tlr1, tlr2, tlr4, tlr5, tlr6, and tlr11 are expressed on 
the cell surface and tlr3, tlr7 tlr8 and tlr9 are localised to the endosomal and lysosomal com-
partments (Figure 3) (Barton and Kagan, 2009, Mandreka, 2009). Each member of the TLR 
family recognises a specific ligand that triggers TLR signalling cascades leading to TNF-𝑎, IL-
8 and IL-1β secretion in macrophages (Bastus et al., 2009a). In mammals, TLR are responsi-
ble for recognising lipopolysaccharide (LPS) from gram-negative bacteria (tlr4) and flagellin 
protein (tlr5) (Kawai and Akira, 2010). While tlr3,tl7 and tlr9 recognise dsRNA, pharmacological 
compounds (Imiquimod and Resiquimod) and unmethylated CpG DNA motifs, respectively 
(Kawai and Akira, 2010). Ligand binding to TLR on the extracellular domain leads to the di-
merization of TLRs which recruit and activate cytosolic adaptor proteins such as MyD88, 
TRIF, TRAM. MyD88 is a key protein in the TLR signal transduction pathways that recruits IL-
1 receptor associated kinase 4 (IRAK-4) to activate MAP kinases and nuclear factor (NF)-ⲕB. 
Additional modes of activation include the activation of TRAF6 by RIP1 and MyD88 independ-
ent TRIF and TRAF3 mediated activation of NF-ⲕB (Mandreka, 2009). Individual TLRs selec-
tively recruit distinct adaptor proteins that mediate signal transduction to tailor the response 




Although TLRs are important for their protective properties against infection, inappropriate 
TLR activation contributes to acute and chronic inflammation that promote the development 
of systemic autoimmune disease. Mutations in genes encoding for negative regulators of TLR 
signalling have been linked to the development of autoimmune diseases such as autoimmune 
glomerular nephritis and Crohn’s disease (Cario, 2010). Mice deficient in TANK protein, an 
inhibitor of TBK1 and IKKE  kinases, develop fatal glomerulonephritist as a result of excess 
inflammatory response (Kawagoe et al., 2009). Macrophages isolated from TANK-/- mutant 
mice have elevated NF-ⲕB activation, IL-6 and TNF production as a result of TLR overactiva-
tion (Kawagoe et al., 2009). In addition, genetic polymorphism of genes encoding TLRs or 
downstream signalling, have been identified as increasing the predisposition to sepsis in hu-
mans as a result of impaired inflammatory response to bacterial infections (Cook et al., 2004). 
The best characterized TLR polymorphism is an amino acid substitution from aspartic acid to 
glycine at position 299 (D299G) in TLR4 which has been linked to increased Gram-negative 
infections (Cook et al., 2004). Polymorphism have also been identified in the TLR2 and IRAK4 
that enhances the susceptibility to tuberculosis and infection from gram positive bacteria 
streptococcus pneumoniae (Cook et al., 2004). These studies demonstrate that the TLR sig-
nalling cascade plays a key role in the induction of inflammatory genes that has significant 
systemic consequence on the inflammatory response of immune cells.   
The TLR family is conserved from mammals to insects, however, TLR signal trans-
duction in fish exhibit notable differences than those in mammals (Li et al., 2017, Jault et al., 
2004). A total of 20 putative TLR variants have been identified in fish of which ten are orthologs 
of human TLR family and two are fish specific TLRs (tlr21 and tlr22) (Jault et al., 2004). Gene 
duplication events during evolution led to the development of isoforms of tlr-4 (tlr4ba/tlr4bb), 
tlr5 (tlr5a/tlr5b) and tlr8 (tlr8a/tlr8b) (Li et al., 2017). Both isoforms of tlr5a and tlr5b have been 
shown to respond to mycobacterial infection similarly in mammals but zebrafish tlr4 does not 
respond to LPS stimulation unlike its mammalian counterpart (Li et al., 2017). The knockdown 
of tlr4a, tlr4b and MyD88 did not alter the zebrafish response to LPS which suggests a differ-




(Jault et al., 2004, Li et al., 2017). Although homologs of tlr6 are absent from fish, it was 
reported that tlr14 in fish may be a functional substitute for tlr6 in mammals (Hwang et al., 
2011). In addition, tlr18 in zebrafish is the homolog of human tlr1 (Meijer et al., 2004). These 
studies highlight the interspecies diversification of TLR family proteins but also indicate a high 
Figure 3. Toll Like Receptor (TLR) Signalling 
To date, eleven members of the TLR family have been identified. tlr1, tlr2, tlr4, tlr5, tlr6, and tlr11 are expressed on the 
cell surface and tlr3, tlr7 tlr8 and tlr9 are localised to the endosomal and lysosomal compartments. TLR are responsible 
for recognising lipopolysaccharide (LPS) from gram-negative bacteria (tlr4) and flagellin protein (tlr5). While tlr3,tl7 and 
tlr9 recognise dsRNA, pharmacological compounds (Imiquimod and Resiquimod) and unmethylated CpG DNA motifs 
respectively. Ligand binding to TLR on the extracellular domain leads to the dimerization of TLRs which recruits and 
activate cytosolic adaptor proteins such as MyD88, TRIF, TRAM. MyD88 is a key protein in the TLR signal transduction 
pathways that recruits IL-1 receptor associated kinase 4 (IRAK-4) to activate MAP kinases and nuclear factor (NF)-ⲕB. 
Additional modes of activation include the activation of TRAF6 by RIP1 and MyD88 independent TRIF and TRAF3 
mediated activation of NF-ⲕB. Individual TLRs selectively recruit distinct adaptor proteins that mediates signal 
transduction to tailor the response to the infecting pathogen. 




conservation of TLR function between mammals and teleost. Nearly all TLRs described in 
mammals have been identified as orthologs or as TLRs with similar functions in fish.  
 
1.3.2. Toll Like Receptors family signaling; a target for Gold and Palladium na-
noparticles? 
The internalization of Gold and Palladium nanoparticles induced a pro-inflammatory 
response in macrophages which was reminiscent of the typical pattern of TLR mediated 
mechanisms; increased tnf-𝑎. il-6, il1-β and il-8 secretion. This strongly suggests that Gold 
and Palladium nanoparticles activate TLR signaling. Indeed, in one study, peptide conjugated 
Gold nanoparticles were identified to mediate its effects through tlr4 signaling in vivo (Bastus 
et al., 2009a). The knockout of tlr4 activity in mice abolished peptide conjugated gold nano-
particle mediated activation of macrophages (Bastus et al., 2009a). Studies have shown that 
metallic compounds like nickel and cobalt ions activate tlr4 by directly interacting with con-
served histidine residue exposed at the dimerization interface of opposing tlr4 monomers 
(Schmidt and Goebeler, 2015). These interactions trigger the formation of tetrameric tlr4 and 
md2 complexes that initiate downstream NF-ⲕB activation and tnf-𝑎, il-8 and il-6 secretion in 
macrophages (Schmidt and Goebeler, 2015). Monoclonal anti-tlr4 antibody inhibition of tlr4 
activity impaired cobalt mediate increase in pro-inflammatory il-8 expression (Lawrence et al., 
2016). Since Palladium metal is a close neighbor of cobalt and nickel in the periodic table, it 
also has been demonstrated to interact with tlr4. The stimulatory capacity of Palladium to 
activate tlr4 was confirmed in vitro in one study (Rachmawati et al., 2013). Palladium induced 
the secretion of il-8 in tlr4/md2 transfected HEK293 cell line and not in wild type, non-trans-
fected HEK293 cells (Rachmawati et al., 2013). Overall, there is strong evidence in support of 





1.4. Zebrafish model system  
1.4.1. Advantages of the zebrafish model system. 
The zebrafish represents a powerful model system for investigating cellular and mo-
lecular events in vivo. The utility of the zebrafish model for live imaging innate immune cells 
and investigating intimate interactions between host and pathogens has been extensively 
reviewed (Meijer et al., 2014, Harvie and Huttenlocher, 2015). The zebrafish model represents 
a viable alternative to mammalian models as they are easier and less expensive to house and 
care for. The genetic amenability and large sample size of the zebrafish model system makes 
it advantageous to study cancer through forward and reverse genetic approaches (Mione and 
Trede, 2010, White et al., 2013). The zebrafish larvae are optically transparent and develop 
externally which allows the use of in vivo live image techniques to track the consequences of 
genetic manipulation or chemical treatment (Garcia et al., 2016). By combining the ad-
vantages of optical transparency and the large availability of genetic tools, the zebrafish 
model system has the potential to significantly extend our understanding of the inflammatory 
response associated with infectious diseases.  
A key issue with any translational model, such as zebrafish, is identifying which bio-
logical interactions are conserved when compared to humans. Humans and zebrafish share 
many anatomical and physiological features due to a shared evolutionary ancestor (Garcia et 
al., 2016). In the brain, the neurotransmitter structure and systems such as GABA, serotonin, 
noradrenaline, histamine and acetylcholine in the zebrafish brain are well conserved and share 
many features with humans (Schmidt et al., 2013). In addition, many of the broad structures 
of the human brain have homologous structures identified in the zebrafish brain; cerebellum, 
telencephalon, diencephalon and spinal cord (Schmidt et al., 2013, Garcia et al., 2016). At the 
biochemical and genetic level, the zebrafish share 70% of human genes and at least one 
zebrafish orthologue has been identified in 82% of human disease related genes (Howe et al., 
2013). However, due to a genome duplication event during the evolution of the zebrafish, 





1.4.2. Development of zebrafish immune system 
 
Temporal-spatial resolved fate mapping analysis revealed that the development of 
zebrafish immune system occurred in successive waves originating from anatomically distinct 
locations (Xu et al., 2012, Bertrand et al., 2007). During zebrafish development, the first wave 
of haematopoiesis initiates at 11 hours post fertilisation (hpf) from the posterior lateral meso-
derm and the rostral blood island (Gore et al., 2018). Cells from the posterior lateral mesoderm 
contribute to embryonic erythrocytes vital for the survival of the embryo (Xu et al., 2012). In 
contrast, cells from the rostral blood island give rise to myeloid cells that differentiates into 
early innate immune cells such as macrophages and neutrophils (Xu et al., 2015). The second 
definitive wave originating from the ventral wall of dorsal aorta at 26-28 hpf produces hema-
topoietic stem cells capable of differentiating into all mature erythroid and myeloid lineage 
cells in the larvae and adult zebrafish (Xu et al., 2015, Xu et al., 2012). Finally a third or inter-
mediate wave at 30 hpf originating from the posterior blood island give rise to hematopoietic 
stem and progenitor cells responsible for myeloid and erythroid cells (Xu et al., 2015, Bertrand 
et al., 2007). In line with zebrafish haematopoiesis, the development of embryonic microglia 
was observed to originate from the rostral blood island whereas mature adult microglia orig-
inated from the ventral dorsal wall of aorta (Xu et al., 2015, Ferrero et al., 2018). Xu et al., 
showed that primitive microglia formation was PU.1 dependent and runx1 independent while 
mature adult microglia were runx1 dependent. The maturation of hematopoietic stem and 
progenitor cells seeds the caudal hematopoietic tissue (CHT), thymus and kidney marrow 
(Gore et al., 2018). The CHT serves as a source of embryonic macrophages, neutrophils and 
monocytes while the kidney, as in mammalian counterparts, provides a niche for hematopoietic 
stem and progenitor cells (Gore et al., 2018). Finally, the thymus serve to generate mature 
lymphoid T cells during adulthood (Langenau et al., 2004, Gore et al., 2018). The development 
of zebrafish immunity is unique in the sense that the innate and adaptive immune system are 
temporally separated. The zebrafish larvae only survives with the innate immune system up 




the adaptive immune system becomes mature where lymphocytes become functional (Novoa 
and Figueras, 2012, Lieschke and Currie, 2007, Davidson and Zon, 2004). Intriguingly, a re-
cent study challenged the biphasic nature of the innate and adaptive immune system. Tian et 
al., indicated that the first wave of haematopoiesis may also give rise to a larval population of 
T cells (Tian et al., 2017). The function of these early T cell population was unknown but was 
speculated to play an immune-repressive function (Tian et al., 2017). Nonetheless, it is still 
widely accepted that the adaptive immune system does not become functional until approx-
imate 4 weeks post fertilisation (Novoa and Figueras, 2012, Lieschke and Currie, 2007, 
Davidson and Zon, 2004). Therefore, the temporal separation makes it advantageous to study 
vertebrate innate immune responses in vivo independently from the adaptive immune re-
sponse (Hamilton et al., 2016, Tsarouchas et al., 2018, Li et al., 2017, Novoa and Figueras, 





1.4.3. The zebrafish as an established model system to study cancer biology 
The zebrafish has been proven to be an excellent tool in advancing our understanding 
of cancer biology. Zebrafish have been used in many studies to recapitulate tumours to in-
vestigate cellular and molecular signals governing tumorigenesis (Jung et al., 2013, Chia et 
al., 2018, Mayrhofer et al., 2017, Ju et al., 2014). The earliest application of zebrafish as tu-
mour models were developed using a range of carcinogenic compounds. Fish treated with 
N-methyl-N'-nitro-M-nitrosoguanidine (MNNG) develop a variety of mesenchymal neoplasms 
(Spitsbergen et al., 2000b). While other studies have also used 7,12-dimethylbenz(a)anthra-
cene (DMBA) and ethylnitrosourea (ENU) to induce tumour formation in zebrafish (Spitsbergen 
et al., 2000a, Beckwith et al., 2000). Many of the oncogenes and tumour suppressor genes 
found in mice and humans are conserved in fish, these include myc, ras, notch family mem-
bers, p53, mdm2, pten and bcl-2 (Gutierrez et al., 2011, Langenau et al., 2003, den Hertog, 
2016, Langheinrich et al., 2002, Schreiber-Agus et al., 1993, Berghmans et al., 2005). Con-
servation of these genes are crucial for the translational application of key findings from 
zebrafish to humans.  
The genetic amenability of zebrafish allows the generation of transgenic tumour-bear-
ing fish that serves as a platform for drug and genetic screens. Earlier transgenic models of 
T cell acute lymphoblastic leukaemia were generated by expressing mouse c-myc under the 
control of zebrafish Rag2 promoter and have been extensively used to model lymphoblastic 
leukemia (Langenau et al., 2003, Langenau et al., 2005, Gutierrez et al., 2011, Borga et al., 
2019). Transgene overexpression of Akt1 and HRASV12 signalling have also been used to in-
duced glioma formation in zebrafish (Jung et al., 2013, Mayrhofer et al., 2017). Moreover, the 
overexpression of these oncogenes led to the development of brain tumours resembling gli-
omas (Jung et al., 2013, Mayrhofer et al., 2017).  
The zebrafish is also frequently used in xenotransplantation assays (Eden et al., 2015, 
Welker et al., 2016). The combination of xenotransplantation, in vivo imaging and ability of the 
fish to absorb chemical compound from the water make the zebrafish model an ideal platform 




in an orthotopic transplantation GBM zebrafish model that microglia and macrophages per-
formed pro-tumoural activities (Hamilton et al., 2016). The ablation of tumour promoting mi-
croglia/macrophage by genetic and pharmacological means inhibited tumour growth 
(Hamilton et al., 2016). Other studies have shown that implanted mouse brain tumours cells 
were viable in zebrafish and that transplanted cells developed into tumours that recapitulate 
the histology of parent tumour (Eden et al., 2015). Eden et al., demonstrated the utility of the 
zebrafish model for pre-clinical drug testing as tumours in zebrafish responded to chemo-
therapeutic agents (Eden et al., 2015). Furthermore, zebrafish larvae xenotransplantation as-
says were observed to constitute highly sensitive differential therapy responses to different 
chemotherapeutic agents (Fior et al., 2017). This highlighted the significance of cancer xeno-
transplantation zebrafish models as a pre-clinical chemosensitive profiler to access drug tox-
icity for precision medicine (Fior et al., 2017). More recent advancement in xenotransplanta-
tion methodology included the utility of genetically immunocompromised zebrafish (Yan et 
al., 2019). The generation of prkdc (protein kinase DNA-activated catalytic polypeptide and 
il2rga (interleukin-2 receptor gamma a) mutant zebrafish, lacking T, B and NK cells, extended 
the capabilities of zebrafish xenotransplantation models into adult zebrafish without the need 
of dexamethasone treatment (Yan et al., 2019). Taken together, the zebrafish model system 






1.4.4. Inducible transgenic expression of transgenes in zebrafish 
The Tol2 transgenesis method has been applied in many studies to generate trans-
genic zebrafish that express fluorescent proteins in specific tissue and organs (Ellett et al., 
2011, Ballim et al., 2019). In addition, the Tol2 system has been shown to mediate reliable 
genetic expression of transgenes under a variety of regulatory elements. Heat shock promot-
ers (hsp70l) have been used to temporally and spatially control gene expression (Venero 
Galanternik et al., 2016, Shoji and Sato-Maeda, 2008). One of the advantages of the zebrafish 
model is the zebrafish’s ability to readily absorb compounds through the water (Garcia et al., 
2016). This allows the utility of chemical-inducible techniques to temporally control gene ex-
pression. Unlike conventional promoters, chemical inducible expression allows temporal con-
trol of genes, where early expression during development causes fatal or severely dysmorphic 
effects and, as a result, precludes the possible role of the gene of interest at later stages 
(Watanabe et al., 2007). The mifepristone inducible LexPR system is a hormone-response 
transcriptional activator that confers accurate spatiotemporal control of transgene expression 
(Emelyanov and Parinov, 2008). This system utilises a hybrid transcription factor (LexPR) en-
gineered by fusion of the DNA binding domain of the bacterial LexA repressor, a truncated 
ligand-binding domain of the human progesterone receptor, and the activation domain of the 
human NF- κB/p65 protein (Emelyanov and Parinov, 2008). The hybrid transcription factor 
(LexPR) is activated when bound to mifepristone and induces genetic expression of a gene 
of interest placed under the control of a synthetic operator-promoter sequence (LexOP) 
(Emelyanov and Parinov, 2008). This system has been shown to conditionally control the ex-
pression of oncogenic kras(V12) in zebrafish (Nguyen et al., 2016, Emelyanov and Parinov, 
2008). The versatility in inducible transgene expression systems extends the available trans-





1.4.5. CRISPR/Cas9 mediated mutagenesis  
The advent of clustered regularly interspaced short palindromic repeats (CRISPR)  
and CRISPR associated protein (Cas)9 genome modification has now made it easy to rou-
tinely and efficiently generate stable mutant organisms. The precise modification of specific 
genetic sites is a standard approach to study gene function and generate stable mutants (Wu 
et al., 2019, Ma et al., 2014). The ability to precisely alter gene function has significant thera-
peutic applications in nanomedicines to control cancers and treat genetic diseases such as 
cystic fibrosis (Jiang et al., 2019, Wu et al., 2015).  
The CRISPR/Cas9 system originates from the immune system of prokaryotes under 
infection. A fragment of the infecting phage is taken up and integrated into the CRISPR motif 
that is transcribed into CRISPR RNA (crRNA) and trans-activating crRNA (tracRNA) (Wu et al., 
2019, Ma et al., 2014). crRNA and tracRNA interact to form a crRNA/tracRNA duplex that 
directs the Cas9 protein to the matching sequence of the invading phage to introduce double 
strand breaks (Wu et al., 2019, Ma et al., 2014). Researchers exploit this system by introduc-
ing custom crRNA and tracrRNA and fusing them into a single guide RNA (sgRNA) in order to 
direct the Cas9 to a specific sequence in the genome (Wu et al., 2019, Ma et al., 2014). The 
custom sgRNA should contain a 20 nucleotide long sequence that is homologous to the tar-
get site followed by a protospacer adjacent motif (PAM) sequence (Wu et al., 2019). The PAM 
site is required for target site recognition. These engineered nucleases direct double strand 
breaks at the targeted genome locus which activates error prone nonhomologous end joining 
(NHEJ) or homology directed repair (HDR) (Ma et al., 2014, Wu et al., 2019). Error prone NHEJ 
induces frame shift mutations due to insertions-deletions (Indel) at the target site (Wu et al., 
2019). These short frame shift indels in the exonic sequences introduce premature stop co-
dons that are recognised and degraded by the nonsense mediated mRNA decay mechanisms 




gene knock-in can be achieved by co-injecting with single-strand oligodeoxynucleotides or 
double strand DNA as a donor for HDR (Wu et al., 2019) (Figure 4). 
The CRISPR/Cas9 system is versatile as multiple modifications can be introduced by 
providing multiple sgRNA, making it possible to simultaneous modify multiple genes in the 
Figure 4. Mechanisms of the CRISPR-Cas9 targeting system. 
The fusion of crRNA and tracrRNA into a single guide RNA (sgRNA) directs the Cas9 to a specific target sequence 
in the genome. These engineered nucleases direct double strand breaks three base pairs from protospacer adjacent 
motif (PAM) sequence. Double strand breaks at the targeted genome locus activates DNA repair machinery that 
facilitates error prone nonhomologous end joining (NHEJ) or homology directed repair (HDR). Error prone NHEJ 
induces frame shift mutations due to insertions or deletions (indel) at the target site. While on the other hand, precise 
gene knock-in can be achieved by co-injecting with single-strand oligodeoxynucleotides or double strand DNA (Wu 
et al. 2019) 
 





organism. Up to five genes have been modified simultaneously using the CRISPR/Cas9 sys-
tem in mice with an efficiency of 75% (Zhou et al., 2014). The high efficiency of CRISPR/Cas9 
system represents a rapid genome editing technique that allowed for the rapid establishment 
of clinical relevant disease model in zebrafish through the generation of transient loss of func-
tion animals (Crispants) (Naert and Vleminckx, 2018, Trubiroha et al., 2018). The generation 
of crispants forgoes the requirement of time-consuming genetic screening methodologies in 
order to generate stable transgenic mutant lines. However, one major limitation that limits 
CRISPR/Cas9 clinical application is off target effects. Mismatches in the sgRNA sequences 
may guide the Cas9 complex to sites of similar sequences and introduce off target mutations 
(Fu et al., 2013). Off target sites were identified to harbour up to five base pair mismatches 
that induced mutations comparable to those of intended target (Fu et al., 2013). Nonetheless, 
due to its simplicity, low cost, and high efficiency, the CRISPR/Cas9 system is widely used 
in many organisms to create loss of function alleles to study gene function in bacteria, ro-
dents, zebrafish and human cells (Wu et al., 2015, Ma et al., 2014, Zhou et al., 2014, Tsa-





1.5. Statement of Aims 
The aim of my PhD was to test the capability of Pd and Au for targeted drug delivery 
in a GBM model in the zebrafish using Gold and Palladium nanoparticles solidly supported 
on a polystyrene matrix (beads). We used a human glioblastoma (U87) xenotransplantation 
zebrafish model, previously established (Hamilton et al., 2016), as a platform to develop 
bioorthogonal chemotherapeutic drug screening assay. 
Over the course to the experiment, the aim of my PhD shifted to investigate the anti-
tumour properties initiated by Palladium and Gold bead implantation. This included investi-
gating the mechanisms involved in anti-tumour effects of Palladium and Gold and identifying 
genetic candidates that induced macrophage polarisation. To achieve these goals, the fol-
lowing aims were addressed: 
 
1. To develop a bioorthogonal chemotherapeutic drug screen platform in the zebrafish brain 
using Palladium and Gold nanoparticles solidly supported on a polystyrene matrix 
(beads). 
• To achieve this aim, the catalytic activity of Palladium and Gold bead will be 





2. To investigate the associated anti-tumour effects of Palladium and Gold bead implanta-
tion.  
• To achieve this aim, the effects of Palladium and Gold bead implantation on 
U87 cell survival, U87 cell fragmentation and macrophage number were eval-
uated. In order to investigate if macrophage function contributed to the anti-
tumour effects, bead induced anti-tumour activity was investigated in a mac-
rophage null zebrafish. We also investigated the effects on necrosis using 
propidium iodide staining in the zebrafish brain. 
 
3. To identify the intracellular signalling mediators of Palladium and Gold bead induced anti-
tumour effects in macrophages. 
 
• To achieve this aim, we isolated macrophages from Palladium bead im-
planted, U87 xenografted and Bead null zebrafish and conducted next gen-





4. To investigate if TLR signalling play a key role in mediating the anti-tumour effects of 
Palladium and Gold bead implanted zebrafish. 
 
• To achieve this aim we conducted in vivo experiments to establish if the phar-
macological inhibition of TLR signalling would promote U87 cell survival.  
 
5. To investigate the role of tnf-𝑎 and cxcl8b.1 in mediating the anti-tumour responses of 
macrophages and neutrophils in the zebrafish brain. 
 
• The role of tnf-𝑎 and cxcl8b.1 in mediating anti-tumour responses of macro-
phages will be investigate using CRISPR/Cas9 crispants and Tol2 mediated 





2. Material and Methods 
2.1. U87-nls-mKate2 cell culture 
2.1.1. Cell Culture Reagents 
Reagent Name Composition and Final Concentration 
DMEM (ThermoFisher Scientific, 
Loughborough, UK) 
 
Dulbecco’s modified Eagle’s medium 
(DMEM) containing 1% L-glutamine 10% 
(v/v) fetal calf serum. 
Penicillin/Streptomycin (ThermoFisher Scien-
tific, Loughborough, UK) 
 
100 mg/ml penicillin and 100 mg/ml strepto-
mycin 
Fetal Calf Serum (ThermoFisher Scientific, 
Loughborough, UK) 
Fetal Calf Serum 
1X Phosphate Buffer Saline (Sigma Aldrich, 
Dorset, UK) 
137 mM NaCl, 2.7 mM KCl, 10 mM 
Na2HPO4, 1.8 mM KH2PO4, pH 7.4. 
EDTA (ThermoFisher Scientific, Loughbor-
ough, UK)  
0.5 M EDTA (ThermoFisher Scientific, 
Loughborough, UK) 
suspended in 1X PBS 
Accutase (ThermoFisher Scientific, 
Loughborough, UK) 
1X Accutase in Dulbecco’s PBS containing 
0.5 mM EDTA and 3 mg/L Phenol Red 
Polybrene (ThermoFisher Scientific, 
Loughborough, UK) 
10 mg/ml polybrene 
 
2.1.2. U87 cell culture 
Human U87MG glioblastoma cells were kindly provided by Prof Tobias Pukrop (Uni-
versity Hospital Regensburg, Germany). U87 cells originated from the American Type Culture 
Collection (Manassas ,VA, USA) and were cultured in DMEM containing 1% L-glutamine, 1% 
(v/v) Penicillin/Streptomycin supplemented with 10% (v/v) fetal calf serum (FCS). U87 cells 





2.1.3. Thawing of cells from liquid nitrogen storage 
U87 cells were thawed at 37°C using a water bath after being removed from liquid 
nitrogen. The cells were mixed with 8 ml DMEM containing 1% L-glutamine, 1% (v/v) Penicil-
lin/Streptomycin supplemented with 10% (v/v) FCS and centrifuged at 200 g for 3 minutes. 
The supernatant was removed and cells resuspended in 10 ml DMEM medium and seeded 
into 25 cm2 cell culture flasks. 
 
2.1.4. Freezing of U87 cells into liquid nitrogen 
U87 cells cultured on cell culture flasks were lifted using 2 ml 1X Accutase solution 
and incubated at 37°C for 5 minutes. Cells were dissociated by agitation and 8 ml DMEM 
medium was added. The cell suspension was centrifuged at 200 g for 3 minutes. The super-
natant was removed and U87 cells were resuspended in 3 ml FCS containing 10% dimethyl 
sulfoxide (DMSO). Cell suspension with FCS was aliquoted in 1 ml volumes into screw top 
1.8 ml Nunc CryoTubeTM vials (Sigma Aldrich, Dorset, UK). The tubes were frozen in polysty-
rene boxes at -80°C and then transferred to liquid nitrogen storage at -150°C. 
 
2.1.5. Lentiviral transduction of human glioblastoma cell lines 
U87MG glioblastoma cells (4.5 x 105) cell were seeded into a 60 mm dish in a final 
volume of 5 ml DMEM for four hours at standard conditions of 100% humidity and 5% CO2 
at 37°C in DMEM containing 1% L-glutamine, 1% (v/v) Penicillin/Steptomycin supplemented 
with 10% (v/v) fetal calf serum. In order to increase transduction efficiency, the cells were 
incubated in 5 mM polybrene for 10 minutes. The Lv-cppt-IRES-NLS-mKate2-opre viral vec-
tor was generated by Pam Brown (shared university research facilities (SuRF), the University 
of Edinburgh, UK). A SV40 nuclear localizing signal sequence coding for Pro-Lys-Lys-Lys-
Arg-Lys-Val was cloned into the N-terminus of the protein leading to the nuclear transport of 
the fused nls-mKate2 fluorescent protein monomer (Kalderon et al., 1984). A multiplicity of 
infection (MOI) of ten viral vectors to infection targets was added to the existing media for a 
period of 48 hours. The transformed cells were then washed with 5 ml 1X PBS and lifted using 




for 3 minutes at 200 g between washes. The resulting cell pellet was re-suspended in 10 ml 
DMEM and a 1:5 split of the transduced U87 cell population (U87-nls-mKate2) was plated 
into a T75 cell culture flask. 
 
2.1.6. Routine culture of U87-nls-mKate2 human glioblastoma cell line for 
xenografts 
  U87-nls-mKate2 cells were initially cultured at standard conditions of 100% humidity 
and 5% CO2 at 37°C in DMEM. The cultured U87-nls-mKate2 were then incubated at 34°C 
for a 2 week equilibration period. One of the limiting factor in xenotransplantation was the 
temperature. Zebrafish were routinely maintained at 28°C which differed by nine degrees from 
that of standard cell culture temperature for U87 cells (37°C). As a compromise solution, to 
optimize the temperature for U87 cell proliferation and zebrafish survival, an incubation tem-
perature of 34°C was chosen. Thus all cell culture procedures following the 2 weeks equili-
bration period was conducted at 34°C to allow habituation of the cells at the same tempera-
ture as the zebrafish (34°C). The cells were passaged when approximately 80% confluent. 
First, the cells were washed once with 10 ml 1X PBS and incubated in 2 ml 1X Accutase. 
Cells were dissociated by agitation and the Accutase inactivated by adding 8 ml DMEM me-
dium. Cells were pelleted at 200 g for 3 minutes and passaged into a 75 cm2 cell cultured 
flask at a 1:10 ratio with 20 ml DMEM medium.  
 
2.1.7. U87-nls-mKate cell preparation for xenografts 
 Cells were harvested on the same day as xenograft experiments. U87-nls-mKate2 
cells were washed with 10 ml 1X PBS followed by an 8 minute incubation in 2 ml 2.5 mM 
EDTA-PBS. DMEM (8 ml) was added to the cell suspension and centrifuged for 3 minutes at 
200 g. Cell pellet was washed in 10 ml DMEM and centrifuged for 3 minutes at 200 g. The 
resulting cellular pellet was supplemented with 1:10 (v/v) phenol red and immediately used 





2.1.8. U87-nls-mKate2 cell preparation for fluorescent activated cell sorting 
(FACS) 
U87-nls-mKate2 cells cultured in T75 flasks were dissociated from the surface of the 
flask using 2 ml Accutase after a 10 ml 1X PBS wash. The cell suspension was spun down at 
200 g for 3 minutes then resuspended in 2% FCS/DMEM medium at a density of 7.5 million 
cells/ml. All procedures were conducted at room temp.  
 
2.2. Zebrafish Husbandry and In-vivo experiments 
2.2.1. Zebrafish Husbandry 
 Zebrafish were housed in a purposed built zebrafish facility in the Queen’s Medical 
Research Institute (QMRI, the University of Edinburgh, UK) maintained by the University of 
Edinburgh Biological Resources. All adult zebrafish were kept at 28°C on a 14 hours light/10 
hours dark photoperiod. All zebrafish embryos were obtained through pair mating conducted 
in the facility. Animal experimentation was approved by the home office (PPL P5042DEFB) in 
accordance with the Animals (Scientific Procedure) Act 1986. Zebrafish embryos were treated 
with 140 µM 1-phenyl 2-thiourea (PTU) in E3 embryo media (6.4 mM KCl, 0.22 mM NaCl, 0.33 
mM CaCl2 2H2O, 0.33 mM MgSO4 7H2O) continuously to inhibit pigmentation. Zebrafish em-
bryo were house in no more than 50 embryos in 50 ml E3 in 9 cm2 petri dishes. During exper-
imentation, zebrafish embryos were housed individually in 12 well plates in 1 ml E3 containing 
140 µM PTU. 
 
2.2.2. Transgenic Zebrafish Lines 
Tg(mpeg1:EGFP) zebrafish were generated by cloning the 1.86 kb mpeg upstream 
sequence in front of EGFP. Tol2 mRNA and the tol2-flanked Tg(mpeg1:EGFP) construct were 
co-injected into the AB wildtype zebrafish embryos at the single cell stage. Germ line trans-
mission of the transgene was screened for by outcrossing to the AB strain. The mpeg1 pro-
moter, a macrophage lineage promoter sequence, expressed EGFP fluorescent protein in 




in vivo and have been used to study a diverse range of macrophage related processes (Ellett 
et al., 2011, Rougeot et al., 2019).  
 Tg(mpeg1:EGFP:mpeg1:Kal4/UAS:nls-E2-Crimson) were generated by co injecting 
Tol2 mRNA and the tol2-flanked Tg(mpeg1:Kal4/UAS:nls-E2-Crimson) construct into 
mpeg1:eGFP embryo at the single cell stage. mpeg1:Kal4/UAS:nls-E2-Crimson construct 
contained the mpeg1 promoter in addition to Kal4/UAS transcriptional activator system and 
a zebrafish nuclear localisation signal fused to the N-terminal of E2-Crimson. Double 
transgene germ line transmission was confirmed by outcrossing to the AB strain. The mpeg1 
promoter drove the expression of cytoplasmic EGFP and nuclear E2-Crimson in macro-
phages. 
 Tg(mpo:EGFP), may also be known as Tg(mpx:GFP) was generated by BAC 
transgenesis (Renshaw et al., 2006). EGFP with an SV40 polyadenylation site (Clontexh, Palo 
Alto, CA) was inserted at the mpo ATG start site. The myeloperoxidase (MPO) enzyme is a 
neutrophil specific granule protein. Thus the mpo promoter was used to drive EGFP in neu-
trophils. 
 
2.2.3. Zebrafish screening of fluorescent proteins  
 All zebrafish larvae between 3 to 5 days post fertilization (dpf) used for the experi-
ments were first screened for the expression of transgene using a Leica MZ16FA optical flu-
orescence microscope (Leica, Houston, USA). Zebrafish larvae were anaesthetised in 2.5mM 
tricaine in E3 medium and screened for the highest level of expression of the fluorescent 
protein of interest. Zebrafish expressing the highest level of fluorescence intensity in the brain 
were selected for further experimentation. 
 
2.2.4. Zebrafish Larvae imaging 
 Time lapse and still images were acquired using an Andor spinning disk confocal 
microscope (Oxford Instruments, Belfast) with a 20X/NA 0.75 Olympus air objective lens . The 




melting point agarose in E3 medium on a 35 mm glass bottom MatTex petri dish (MatTek, 
Ashland, USA), and submerged in E3 medium containing 2.5 mM tricaine. Green (GFP), 
mCherry and E2-Crimson fluorescent proteins were excited using 488 nm, 561 nm and 561 
nm wavelength lasers respectively . The emission spectrums were reflected through a Sem-
rock quad multi-band filter (IDEX Health and Science, LLC, Rochester, USA) depending on 
the excitation wavelength. Laser exposure and intensity was calibrated for each experiment 
to obtain best possible image resolution at the same time minimising exposure of the samples 
to the laser. The filtered emitted spectrum was detected using a TuCam multi wavelength 
imaging camera (Oxford Instruments, Belfast, UK) with image gain set at 50 for all acquisi-
tions. Acquired Z stacks were set accordingly to encompass all regions of interest within the 
zebrafish brain. 
 
2.2.5. Palladium, Gold and Naked bead preparation 
Palladium, Gold and Naked beads were kindly provided by collaborators (Unciti-
Broceta’s Lab, Edinburgh Cancer Research Centre, IGMM). Solidly supported Gold (Perez-
Lopez et al., 2017) and Palladium (Weiss et al., 2014a) nanoparticles were prepared within a 
polystyrene matrix of 75 microns in diameter. Palladium (5 nm) and Gold (30nm) nanoparticles 
were uniformly distributed across the polystyrene matrix. Non-functionalised resin (Naked 
bead) were untreated and represented the precursors used for Palladium and Gold bead syn-
thesis. 
 
2.2.6. Zebrafish xenografts and bead implantation 
mpeg1:EGFP and mpo:EGFP zebrafish (3 days post fertilised (dpf)) were anaesthetised with 
2.5 mM tricaine and immobilised in 1.5% low melting point agarose in E3 medium. The frontal-
dorsal section of the zebrafish head was carefully exposed from the agarose (Figure 5, A1-
A2). Cell suspension (10 µl) were loaded into borosilicate glass capillary needles (1 mm O.D 




forceps to expose a sharp tip. The left optic tectum of the zebrafish larvae (3 dpf) were xen-
ografted with U87-nls-mKate2 cells (n = 40-100) using a Femtojet micro-injector (Eppendorf, 
Hamburg, Germany) (Figure 5, B1 - B4). After cell transplantation, the zebrafish larvae were 
liberated from the agarose and maintained in E3 medium containing 140 µM PTU at 34 °C for 
a period of 24 hours before bead implantation.  
 
Figure 5. Schematic diagram of zebrafish U87-nls-mKate2 xenograft and bead implan-
tation. 
(A1) Zebrafish larvae (3-4 dpf) anaesthetised in 2.5 mM tricaine were immobilised in 1.5% low melting point agarose in E3 
medium and submerged in E3 medium.  
(A2) The frontal dorsal section of the zebrafish brain was exposed from the agarose allowing access to the brain.  
(B1-B4) U87-nls-mKate2 human glioblastoma cell lines were loaded into borosilicate glass capillaries and the ends broken 
to expose a sharp tip. The needle was inserted into the left optic tectum of the zebrafish brain (3 dpf) and U87-nls-mKate2 
cells were xenografted into the brain using a Femtojet micro-injector. A 24 hour recovery period followed xenografting prior 
to bead implantation.  
(C1) Zebrafish larvae (4 dpf) were remounted in 1.5% low melting point agarose in E3 and submerged in E3 medium . 
(C2) The dorsal frontal section of the head was exposed. A small incision was then made on the medial dorsal frontal section 
of the zebrafish head, between both optic tectums, using an ophthalmic scalpel mounted on a micro-manipulator.  
(C3 and C4) Using a borosilicate glass capillary with negative pressure palladium/gold/naked beads were manipulated into 
position above the incision and were inserted into the zebrafish brain (4 dpf). The negative pressure was released and the 
glass capillary was extracted.  
(D) Zebrafish larvae were xenografted with U87-nls-mKate2 cells at 3 dpf. Bead implantation procedure occurred at 4 dpf. 




 On the day of bead implantation, 4 dpf mpeg1:EGFP or mpo:EGFP zebrafish larvae 
were  anaesthetised in 2.5 mM tricaine in E3 medium and immobilised in 1.5% low melting 
point agarose in E3 medium. The frontal dorsal section of the zebrafish head was exposed 
from the agarose to facilitate bead implantation (Figure 5, C1-C4). A small incision was made 
on the medial dorsal frontal section of the zebrafish head, between both optic tectums, using 
an ophthalmic scalpel (PFM medical, Germany) mounted on a micro-manipulator as shown 
in Figure 5, C2. Following incision, the gold/naked/palladium bead was carefully moved into 
position above the incision site and the bead was surgically placed between both hemi-
spheres of the optic tectum (Figure 5, C3 - C4). To replicate an implantation injury, a Naked 
bead was implanted and immediately removed. A negative pressure was created between 
the bead and the needle using tubing connected to 10 ml Eccentric luer slip tip syringe (BD 
Plastipak, Franklin Lakes, USA) to allow for careful manipulation of bead. After bead implan-
tation, the zebrafish larvae (4 dpf/0 dpt) were liberated from the agarose and remounted in 
1.5% low melting point agarose in E3 for imaging. 
 
2.2.7. Zebrafish Gold bead in-vivo catalytic assays 
To investigate the chemical capabilities of gold as a catalyst to mediate prodrug ac-
tivation, we studied gold bead’s catalytic properties to convert nonfluorescent precursor into 
fluorescent Rhodamine in-vivo. The lipophilic properties of prodye precursor allowed diffusion 
of the reagent in the media via ingestion or absorption via the skin and distributed systemically 
(Perez-Lopez et al., 2017). Under physiological conditions the prodye precursor is catalytically 
Figure 6. Pulse treatment of Au bead implanted zebrafish with 20 µM Pro-dye 
Pulse treatment of Au bead implanted zebrafish occurred from 0 days post transplantation (dpt) to 1 dpt at an age of 3 days 
post fertilisation (dpf) to 4 dpf. Prodye (20 µM) was added to the E3 medium with 1% DMSO. In between pulse treatment, the 
zebrafish was washed in E3 and incubated in fresh E3 containing 140 µM PTU without prodye or DMSO. Pulse treatment of 





converted by the gold bead into fluorescent Rhodamine which was visible under excitation 
by 488 nm wavelength laser (Perez-Lopez et al., 2017). This study was the first time that 
biorthogonal organometallic reaction was tested locally in an in-vivo system in the zebrafish 
brain. Nonfluorescent prodye (10 mM) suspended in DMSO was kindly provided by Unciti-
Broceta lab (Cancer Research UK Edinburgh Center, Edinburgh, UK). Wild type (WIK) 
zebrafish embryos (3 dpf) were each implanted with a Gold coated resin bead (Au beads). 
The experiment comprised four groups: (1) Wild type zebrafish implanted with Au beads and 
continuously treated with 20 µM prodye in 1% DMSO (3 dpf – 7 dpf) (2) Zebrafish implanted 
with Au beads pulsed with 20 µM prodye in 1% DMSO. Pulse treatment of Au bead implanted 
zebrafish occurred from 0 days post transplantation (dpt) to 1 dpt and at 3 dpt to 4 dpt (Figure 
6). Zebrafish embryos were wash with E3 containing 140 µM PTU in between pulse treat-
ments. (3) A negative control where zebrafish without gold beads were pulsed with 20 µM 
prodye in 1% DMSO from 0 days post transplantation (dpt) to 1 dpt and at 3 dpt to 4 dpt 
(Figure 6). (4) A background control where zebrafish transplanted with Au beads and were not 
treated with prodye. Zebrafish were imaged at 1 day post transplant (dpt), 3 dpt and 4 dpt 
and analysed using Imaris (Bitplane, Zurich, Switzerland) and p values calculated using two 
tailed unpaired student t-test. 
 
2.2.8.  Zebrafish Propidium Iodide assays 
Wild type (WIK) zebrafish (3 dpf) were incubated with 1 mg/ml Propidium iodide (BD 
Biosciences, Wokingham Berkshire, UK) and 1% DMSO in E3 medium containing 140 uM 
PTU at 34°C 20 minutes before imaging. There were three conditions for this assay: (1) WIK 
zebrafish without bead (2) WIK zebrafish implanted with Naked bead (3) WIK zebrafish with 
Gold bead. Zebrafish were imaged at 0 dpt, 1 dpt and 3 dpt using the spinning disk confocal 
microscope excited using the 488 nm laser. Zebrafish larvae were incubated in 1 mg/ml Pro-





2.2.9. IRAK-4-IN-1 inhibitor treatment 
For qPCR studies, a total of 200 mpeg1:EGFP embryos (4 dpf) were treated with 10 
µM IRAK4-IN-1 inhibitor (MedChemExpress LLC, New Jersey, USA) and 1% DMSO in E3 
medium containing 140 uM PTU for a period of 24 hours in a 9 cm2 petri dish incubated at 
34°C. At 5 dpf, the zebrafish were anesthetised with 2.5 mM tricaine in E3 medium and 
washed in 50 ml 4°C E3 media containing 140 uM PTU and 2.5 mM tricaine. Anesthetised 
embryos were then incubated in 50 ml 4°C E3 media containing 140 uM PTU and 2.5 mM 
tricaine on ice in preparation for macrophage isolation protocol (See section 2.3.1 for details) 
mpeg1:EGFP zebrafish (4 dpf) were treated with 1 ml 10 µM IRAK4-IN-1 inhibitor and 
1% DMSO in E3 medium containing 140 uM PTU individually house in 12 well plates for the 
duration of the experiment. On the day of imaging, mpeg1:EGFP embryos were anesthetised 
with 2.5 mM tricaine and immobilised in low melting point agarose onto a Matek glass bottom 
petri dish. Post imaging, zebrafish embryos were liberated from agarose and incubated in 1 
ml 10 µM IRAK4-IN-1 inhibitor and 1% DMSO in E3 medium containing 140 uM PTU individ-
ually house in 12 well plates until required.  
 
2.3. Isolation of zebrafish macrophage for RNA sequencing 
2.3.1. Zebrafish macrophage isolation 
 The zebrafish macrophage was isolated using protocols previously developed in the 
Sieger laboratory (Mazzolini et al., 2018). Briefly, mpeg1:EGFP zebrafish larvae (5 dpf) were 
anaesthetised in 2.5mM tricaine in E3 medium prior to being transferred into cold E3 medium 
and maintained at 4°C. For each macrophage isolation protocol, about 200 zebrafish larval 
heads were isolated. The larvae heads were transected above the yolk-sac using surgical 
micro-scissors and transferred into a glass homogeniser filled with 1 ml Media A (15 mM 
Hepes, 25 mM D-Glucose in 1X HBSS). The larvae heads were homogenised and strained 
through a 40 µM cell strainer. The homogenized tissue were distributed into two 1.5 ml mi-
crotubes and centrifuged at 300 g for 10 minutes at 4°C. The supernatant was removed and 




by 0.5 mL of ice chilled 1X DPBS. The tubes were spun at 950 g, with slow acceleration and 
without brake, for 30 min at 4°C. After the spin the supernatant was removed and the cells 
were resuspended in 1 ml 2% normal goat serum (NGS) in media A. The cell suspension was 
spun again at 300 g for 10 minutes at 4°C. The final cell pellet was resuspended in 1 ml 2% 
NGS in Media A and the macrophage were isolated by flow cytometry (Section 2.3.2 ). 
 
2.3.2. Flow cytometry sample acquisition  
 Fluorescent Activated Cell Sorting (FACS) was facilitated by in-house service pro-
vided by Shared University Resource Facility (SURF, QMRI). Macrophage samples were ac-
quired using FACS AriaII (BD Biosciences, Oxford, UK) with the temperature maintained at 
4°C throughout the sort. U87-nls-mKate2 glioblastoma cells were acquired using FACS Fu-
sion at room temperature (BD Biosciences, Oxford, UK). Robust and replicable cell sort was 
first achieved by calibrating and setting gating parameters using unstained wild type (WIK) 
Figure 7. Fluorescence Activated Cell Sorting (FACS) of mpeg1:EGFP positive 
macrophages 
(A1-A6) FACS calibration of FACS AriaII (BD Biosciences, Oxford, UK) using homogenized wild type unlabeled 
zebrafish brain tissue. (A2) Cell doublets were first gated against by plotting the height of the forward scatter (FSC-
H) against the area of the forward scatter (FSC-A). (A3) Further refinement of cell singlets was achieved by gating 
for proportionate cells along the axis of height of the side scatter (SSC-H) vs the area of the side scatter (SSC-
A).(A4) Cell debris were gated against and macrophage cell population gate for. (A5) Live and dead cells were 
identified by adding 3 µM DAPI (Thermofisher Scientific, Loughborough) counter stain into the cell suspension. (A6) 
Final gating parameter denoting boundary of GFP positive cells. Note unstained cell population is outside this 
boundary.  
(A7) mpeg1:GFP expressing macrophages are sorted for using calibrated FACS parameter based on wild type 





zebrafish brain tissue (Figure 7A) and unstained U87 glioblastomas cell. The following method 
being described follows the workflow of a typical fluorescent activate cell sort for 
mpeg1:EGFP positive zebrafish. However, FACS for U87 glioblastomas cells followed identi-
cal gating strategies with the difference in the final gate which gated using the excita-
tion/emission spectrum of 588/633 nm for mKate2 fluorophore. Two strategies was employed 
to gate against cell doublets. First, cell doublets were first gated against by plotting the height 
of the forward scatter (FSC-H) against the area of the forward scatter (FSC-A). Cell doublets 
will double the FSC-A values thus FSC-H/FSC-A values would be disproportionate (Figure 
7A2). Further refinement of cell singlets were achieved by plotting the height of the side scatter 
(SSC-H) against the area of the side scatter (SSC-A) (Figure 7A3). Again, cell doublets will 
double the area of SSC-A and will have greater SSC-A values than SSC-H. Generally, cellular 
debris is considered to be forward scatter (FSC) low thus gate was drawn around cells with 
higher FSC (Figure 7A4). Live and dead cells were identified by adding 3 µM DAPI (Ther-
mofisher Scientific, Loughborough) counter stain into the cell suspension (Figure 75). Using 
the gated unstained sample as a guide (Figure 7A6), final gating parameters were defined to 
specifically select for GFP expressing macrophages (Figure 7A7). 
 
2.3.3. RNA Extraction of fluorescent activated cell sorted macrophage 
 RNA extraction was achieved using a commercially available RNeasy Mini Kit (Qi-
agen, Manchester, UK). The protocol was performed following the manufacture’s instructions 
with optimization for the processing of less than 100,000 cells. Briefly, sorted macrophage 
cells were lysed by adding 75 µl buffer RLT and the resulting lysate was pipetted directly into 
a QIAshredder spin column and centrifuged for 2 minutes at 9000 g. The flowthrough was 
transferred to a gDNA Eliminator spin column and centrifuged for 30 seconds at 9000 g. Next, 
70% ethanol was added to the flowthrough and the sample was transferred to an RNeasy 
MinElute spin column. Several wash steps followed using supplied buffer RW1 and RPE and 





each wash. RNA content was finally eluted by adding 14 µl RNase free water to the centre of 
the spin column membrane. The resulting total RNA content was stored at -80 °C in prepa-
ration for RNA amplification for sequencing or First Strand cDNA synthesis. 
 
2.4. RNA preparation and quantitative reverse transcription PCR 
2.4.1. First Strand cDNA Synthesis of RNA Isolated from Macrophage 
 The SuperScript III First-Strand Synthesis system (ThermoFisher Scientific, Waltham) 
was used to synthesis first strand cDNA from isolated total RNA before RT-qPCR. In order to 
ensure replicability in all RT-qPCR reactions, the amount of starting total RNA material in first 
strand synthesis reactions was set at 0.5 µg. cDNA synthesis was performed in the first step 
using total RNA primed with 1 µl Oligo(dT) mixed with 1 µl 10 mM dNTP at 65°C for five 
minutes. cDNA synthesis mix containing 1 µl 10X RT buffer, 4 µl 25 mM MgCl2, 2 µl 0.1 M 
DTT, 1 µl 40 U/µl RNaseOUT and 1 µl 200 U/µl SuperScript III reverse transcriptase was added 
to each reaction and incubated for 50 minutes at 50°C. The reaction was terminated after the 
50 minutes period by incubating at 85°C for five minutes. RNA template from the cDNA:RNA 
hybrid molecule was digested with RNase H after first strand synthesis by adding 1 µl of 
RNase H to each reaction and incubated at 37°C for 20 minutes. The resulting cDNA product 
was stored at -20°C ready for use in qRT-PCR analysis. 
Table 1 quantitative RT-PCR Primers Table  
 Primer name Primer Sequence 5’ - 3’ 
1 Arg-1 Forward TCCGTTCTCCAAAGGACAGC 
2 Arg1-Reverse GACTCGTCGTTGGGAAGGTT 
3 IFN-y Forward CACATGATGGGCTTTGCCTG 
4 IFN-y Reverse GATTCGCAGGAAGATGGGGT 
5 il4/13b Forward CTGTTGGTACTTACATTGGTCCCC 
6 il4/13b-Reverse AGTGTCCTGTCTCATATATGTCAGGT 
7 il4/13a Forward GCACTGTATTCGTCTCGGGTTTTA 
8 il4/13a Reverse TTTTCCCCAGATCTACAAGGAAGA 





2.4.2. Quantitative RT- PCR 
 Quantitative RT-PCR was achieved using SsoAdvanced universal SYBR Green su-
permix (Biorad, Watford) and quantified using Roche Lightcycler 96 system Roche Diagnos-
tics, West Sussex, UK). Each 20 µl reaction contained 10 µl SsoAdvance universal SYBR 
Green supermix, 250 nM of each forward and reverse primers (Table 1) and 1 µl of cDNA 
template from the first strand synthesis reactions of the RNA product. Due to the nature high 
sensitivity of qPCR kit, variations in cycle threshold (CT) values can arise from differences in 
loading, extraction, mRNA-quality and reverse transcriptase efficiency. To control for such 
variations two technical replicates were loaded onto the plate for each gene of interest and 
the resulting pair of CT values averaged. A total of three biological replicates were used to 
analyse each gene on interest. Samples loaded on qPCR plates were analysed using a Roche 
Lightcycler 96 system (Roche Diagnostics, West Sussex, UK) running the thermal cycling 
protocol described in Table 2. Melting curve analysis followed the amplification phase and 
was important in assessing if the qPCR assay had produced single specific product. Melt-
Curve analysis was conducted by increasing the temperature from 65-95°C at 0.5°C incre-
ments every 2 seconds in between steps. Assays producing multiple or non specific products 
were excluded in analysis. 
Table 2 qPCR Thermal cycling protocol 
Step Thermal cycler settings Description 
1 Polymerase Activation and DNA Denatur-
ation 
95°C - 3 mins 
10 Beta Actin Reverse CGTACAGAGAGAGCACAGCCTGG 
11 Cxcl8b.1 Forward GCCAATGAGGGTGAAGCTCTA 
12 Cxcl8b.1 Reverse AATCACCCACGTCTCGGTAG 
13 TNF-a Forward ACCCAGGGCAATCAACAAGA 
14 TNF-a Reverse CAAGCCACCTGAAGAAAAGGC 
15 IL1-b Forward GGCATGCGGGCAATATGAAG 




Step Thermal cycler settings Description 
2 3 Step Amplification for 45 cycles 95°C - 10 secs 
56°C - 20 secs 
72°C - 20 secs 
3 Melting-Curve Analysis 65-95°C at 0.5°C increments 
every 2 seconds 
4 Cooling 40°C - 10 secs 
 
 
 In order to quantify fold change in gene expression the delta-delta CT method was 
used. This delta-delta CT formula, 2-ΔΔCT, is well describe and widely used in qPCR analysis 
(Livak and Schmittgen, 2001). Of note, the delta-delta CT method normalises each gene of 
interest to a housekeeping gene, beta actin (bactin1), to calculate relative fold change. Bac-
tin1 gene was chosen as the house keeping gene as it was shown to be stably expressed in 
zebrafish development and most stably expressed following chemical treatment (McCurley 
and Callard, 2008). ΔCT is equal to the cycle threshold of the gene of interest minus the cycle 
threshold of the housekeeping gene, and ΔΔCT is equal to the difference between the ΔCT 
values of treated sample and untreated sample.  
 
2.5. RNA Preparation for RNA Sequencing  
2.5.1. RNA quality assessment and RNA amplification 
 RNA Quality assessment was performed by Dr. Pamela Brown (shared university re-
search facility SuRF, The University of Edinburgh) using a LabChip GX24 Nucleic Acid Ana-
lyzer (PerkinElmer, Seer Green, UK). LabChip GX24 Nuclei Acid Analyzer utilized a combina-
tion of microfluidic chips, voltage induced size separation in gel filled channels and laser in-
duced fluorescence detection of RNA of different molecular weight to determine RNA integrity 
number (RIN) of RNA samples (Schroeder et al., 2006). In addition, LabChip GX24 was also 
capable of quantifying separated RNA product by laser induced fluorescence where the 




GX24 allowed reproducible RNA quality and quantity analysis using a small volume (2 µl) of 
final RNA product. A RIN score of 7 or greater is considered high quality. A RIN score of less 
than 7 indicated poor RNA quality and RNA degradation thus any RNA product with a RIN 
score of less than 7 were discarded from all experiments.    
RNA amplification was conducted using the commercially available OvationⓇ RNA-
seq System V2 (Nugen, California). A dedicated sterilised pre-amplification and amplification 
area was assigned prior to starting the protocol to minimise risk of cross contamination. RNA 
amplification was performed following manufacture protocol (OvationⓇ RNA-seq System V2, 
Nugen). The seven key steps are as follows: 
 
Pre amplification :  A. First Strand cDNA synthesis 
   B. Second Strand cDNA synthesis 
   C. Purification of cDNA 
 
Amplification:  D. Single Primer Isothermal Amplification 
E. Purification of SPIA cDNA (QIAGEN MinElute Reaction Cleanup 
Kit) 
   F. Nano Drop cDNA Yield 
 
Table 3 Thermal cycler programs for RNA amplification 
Program Thermal cycler 
settings 
  
1 Primer Annealing 65°C - 2 mins, hold at 4°C 
2 First Strand Syn-
thesis 
4°C - 1 min, 25°C - 10 mins, 42°C - 10 
mins, 70°C - 15 mins, hold at 4°C 
3 Second Strand 
synthesis 
4°C - 1 min, 25°C - 10 mins, 50°C - 30 
mins, 80°C - 10 mins, hold at 4°C 
4 SPIA Amplification 4°C - 1 min, 47°C - 60 mins,  80 °C - 20 





 During the first strand cDNA synthesis, 5 µl of RNA sample was added to 2 µl of first 
strand primer mix to allow annealing of primers in a thermal cycler programmed to run pro-
gram 1 (Table 3). Once primer annealing was complete first strand cDNA synthesis was initi-
ated by mixing 2.5 µl first strand buffer mix with 0.5 µl first strand enzyme mix in each reaction. 
Samples were then placed in a thermal cycler programmed to run program 2 (Table 3). After 
which the samples were removed from the thermal cycler, spun to collect condensation and 
placed on ice before proceeding with second strand cDNA synthesis. 
  Second strand cDNA synthesis was initiated by adding 9.7 µl second strand buffer 
mix and 0.3 µl second strand enzyme mix into each reaction tube. The tubes were placed 
back into the thermal cycler programmed to run Program 3 (Table 3). 
 Purification of cDNA was achieved using paramagnetic bead based chemistry to re-
moved contaminants. At room temperature, 32 µl of the Agencourt purification bead (Beck-
man Coulter, CA, USA) suspension, supplied with the Ovation RNA-Seq System V2, was 
added to each reaction and mixed well by pipetting. The tubes were then transferred to a 
magnetic stand and left to stand for 5 minutes to completely clear the solution of the beads. 
The exposure of the DNA to polyethylene glycol in the solution causes the negatively charged 
DNA to bind with the carboxyl groups on the surface of the paramagnetic beads (DeAngelis 
et al., 1995). These beads were immobilised by the magnetic field of the magnetic stand al-
lowing purification of cDNA product (DeAngelis et al., 1995). Keeping the tubes on the mag-
net, 45 µl of the binding buffer was removed and discarded. 70% Ethanol (200 µl) was added 
and allowed to stand for 30 seconds. The wash was repeated two more times before air 
drying the beads on the magnet for 15 to 20 minutes to allow all ethanol to evaporate. When 
all ethanol has been removed, cDNA was amplified by single primer isothermal amplification 
(SPIA) protocols.         
  The amplification of double strand cDNA bound to the dried beads began by the 




10 µl SPIA enzyme mix. The samples were then placed in tubes in a thermal cycler pro-
grammed to run program 4 (Table 3). The tubes were then transferred to the post-amplifica-
tion workspace back onto the magnet and left to stand for 5 minutes to completely clear the 
solution of the beads. The clear supernatant containing the SPIA cDNA was transferred to a 
fresh tube and purified using QIAGEN MinElute Reaction Cleanup Kit (Qiagen). Briefly, the 
entire volume (40 µl) of the SPIA reaction was added to 300 µl of buffer ERC and mixed by 
pipetting. The sample/buffer mix was added into a MiniElute spin column and centrifuged for 
1 minute at maximum speed in a microcentrifuge. The flow through was discarded and 750 
µl Buffer PE was added and centrifuge at 10,000 g Care was taken to ensure all residual 
Buffer PE was completely removed. The DNA was eluted with 22 µl room temperature Buffer 
EB and centrifuged for 1 minute at 10,000 g. The concentration of the purified SPIA cDNA 
sample was measured using a Nanodrop (NanoDrop One, ThermoFisher Scientific) and 
stored at -20°C until required. 
 
2.5.2.  RNA sequencing and analysis of amplified cDNA product 
 RNA sequencing and differential analysis was performed by Edinburgh Genomics 
(Edinburgh, UK). Nine samples were sent for analysis and are shown in Table 4. Quality con-
trol of cDNA samples was performed prior to cDNA library generation. 
 
Table 4 Table of samples and associated conditions 
Number Sample Name Condition 
1 Pdbead1D0305  Pd bead + U87 
2 PdBead3D1705  Pd bead + U87 
3 PdBead4D2405  Pd bead + U87 
4 Control2D0305  No Bead 
5 Control5D2405  No Bead 
6 Control6D1005  No Bead 




Number Sample Name Condition 
8 U877D0706  No bead + U87 
9 U878D2806  No bead + U87 
 
 DNA library of each cDNA samples were prepared using TruSeq DNA Nano gel free 
library before sequencing. Sequencing reads data generation was performed using HiSeq 
4000 75PE system (Illumina). All reads were trimmed using Cutadapt (Martin, 2011) based on 
a quality threshold of 30 and for TruSeq adaptor sequences (AGATCGGAAGAGC). The reads 
were aligned to the Danio Rerio reference genome (GRCz10, annotation version 84) from 
Ensmble using STAR (Spliced Transcripts Alignment to a Reference) (Dobin et al., 2013). Read 
counts were mapped to exon features that were grouped by gene_id in the zebrafish refer-
ence genome using featureCounts (Liao et al., 2014) program. The number of read counts 
were preprocessed by removing genes with near zero counts. The data was then normalised 
to the library depth to avoid artefacts of RNA sequencing to give the counts per million value 
(CPM) for each gene. A principal component analysis was performed to identify patterns as 
a result of experimental factors before differential analysis. Differential analysis was per-
formed using edgeR package comparing the three conditions with each other to give log fold 
changes. Once a list of differentially expressed genes for each condition were collated, an 
enrichment analysis was performed to highlight differentially regulated biological process as-
sociated with each condition.  
 
2.6. Nucleic acid techniques 
2.6.1. REDTaq ReadyMix PCR  
 Each 20 µl PCR reaction contained 10 µl REDTaq ReadyMix PCR mix (Sigma, Ger-
many),  200 nM forward, 200 nM reverse primers, 0.4 µl of template DNA and PCR grade 
water up to a final volume of 20 µl. The PCR reactions were transferred to a BioRad T100 





Table 5 PCR program conditions for routine PCR 
 Temperature Duration 
Initial Denaturation 94 °C 2 minutes 
Denaturation 94 °C 30 seconds 
Annealing Primer dependant  30 seconds 
Extension 72 °C 1 minute/kb 
Number of cycles  35  
Final Extension 72 °C 7 minutes  
Hold  4 °C ∞ 
 
 
2.6.2. Agarose gel electrophoresis 
 PCR products were loaded into horizontal 2% w/v agarose 1X TAE gels containing 
1X SYBR™ Safe. Samples were electrophoresed in 1X TAE at 130 V for 25 minutes. DNA 
fragment sizes were determined using either a 100 bp ladder (Invitrogen, Paisley UK) or a 1 
kb ladder (Invitrogen, Paisley UK) and visualised using a UV transiluminator (UVITECH, Cam-
bridge). 
 
2.7. Multisite GatewayⓇ Cloning system 
2.7.1. Generation of pDONR™ clones by BP recombination 
 pDONR™ entry clones for Cxcl8b.1 (ENSDART00000166280.4) and Tnf-ɑ 
(ENSDART00000025847.9) were created by generating PCR products of the gene of interests 
with flanking attB1 and attB2 sequences using primers listed in Table 6. attB1/attB2 flanked 
PCR products were purified using the QIAquick PCR Purification Kit following manufacturers 
guidelines (Qiagen, Manchester UK) and confirmed by gel electrophoresis . 
 




 Primer Primer Sequence 5’ - 3’ 
1 Cxcl8b.1 attB1 Forward GGGGACAAGTTTGTACAAAAAA-
GCAGGCTTCATGATGAAGTTGAGCGTTTCAGC 
2 Cxcl8b.1 attB2 Reverse GGGGACCACTTTGTACAAGAAA-
GCTGGGTTTTAATTCGTGGTCATTATTGTT-
GAAAATGTTGTTGT 
3 Tnf-ɑ attB1 Forward GGGGACAAGTTTGTACAAAAAA-
GCAGGCTTCATGAAGCTTGAGAGTCGGG 
4 Tnf-a attB2 Reverse GGGGACCACTTTGTACAAGAAAGCTGGGTTTCAG-
CAATGTACAGATGTGTTGG 
   
 
 The attB flanked PCR products were cloned into the pDONR™ 221 vector, by BP 
reaction, to generate TNF-a and Cxcl8b.1 entry clones for Multisite GatewayⓇ Cloning. In 
each 10 µl BP recombination reaction, 50 femtomoles (fmoles) of each attB flanked PCR 
product and pDONR™ 221 vector, 1 µl BP Clonase™ II enzyme and TE buffer, pH 8.0 to a total 
volume of 10 µl was incubated at 25°C for 1 hour. The reaction was terminated by addition of 
0.5 µl proteinase K solution and incubated for 10 minutes at 37°C. Final BP reaction product 
was used immediately and transformed into One ShotⓇ TOP10 Competent E. coli cells. 
 
2.7.2. Generation of pDEST™ expression clones by LR recombination 
 The Multisite GatewayⓇ Cloning system was used to generate the final pDEST™ ex-
pression vector required for over-expression assays. LR recombination reactions were per-
formed according to the manufacturer’s instructions. For each reaction, 10 fmoles of five 
prime entry, middle entry and three prime entry vectors was mixed with 20 fmoles of pDEST™ 
Cry:ECFP destination vector with TE buffer (pH 8.0) to a final volume of 8 µl, LR Clonase™ (2 
ul) was added to the reaction, mixed by vortex and incubated overnight at 25°C. The reaction 
was terminated by adding 1 µl of Proteinase K solution and incubated at 37°C for 10 minutes. 






2.7.3. Transformation of One ShotⓇ TOP10 and DH5α Competent E. coli cells 
pDONRTM entry clones and pDestTM expression clones were amplified by transform-
ing BP reaction products into One ShotⓇ TOP10 (ThermoFisher Scientific, Loughbrough UK) 
and DH5𝑎 Competent E. coli cells (ThermoFisher Scientific, Loughbrough UK) respectively. 
The whole reaction volume (10 µl) from previous BP reaction was incubated with 50 µl One 
ShotⓇ TOP10 Competent cells on ice for 30 minutes. While on the other hand, 1 µl LR reac-
tion product was incubated with DH5α competent E. coli cells for 30 minutes on ice. Cells 
were then transformed by heatshock at 42°C for 45 seconds and returned to ice for 1 minute. 
Lysogeny broth (LB) broth, 250 µl, was added to each vial of cells and placed in a shaking 
incubator at 37°C for 1 hour. The transformed cells were plated and evenly spread on LB-
agarose plates containing 50 µg/ml Kanamycin for BP reactions and 50 µg/ml Ampicillin for 
LR reactions. Two volume of transformed cells were plated, 200 µl and 50 µl, in order to 
ensure even distribution of bacterial colonies. Agarose plates were incubated overnight at 
37°C. 
 
2.7.4. Isolation of plasmid DNA using QIAprep Spin Miniprep Kit 
 A single bacterial colony was used to inoculate 5 ml of LB-broth containing 50 µg/ml 
Kanamycin or Ampicillin; the choice of antibiotic was dependent on the selection marker of 
the plasmid DNA target being isolated. The inoculated LB-broth medium was incubated over-
night at 37°C with orbital shaking at 250 rpm. The plasmid DNA from the bacterial culture-
swere isolated using the QIAprep Spin Miniprep Kit (Qiagen, Manchester, UK) according to 
the manufacturers instructions. Plasmid DNA was eluted in 50 µl of elution buffer and quan-






2.7.5. Plasmid DNA Sequencing 
 DNA sequencing was conducted using a Sanger Sequencing service provided by the 
commercial company Source Bioscience (Source BioScience, Nottingham UK). Plasmid DNA 
was aliquoted into 5 µl volume at a concentration of 100 ng/µl. M13 forward (5’ GTAAAAC-
GACGGCCAG 3’) and reverse (5’ CAGGAAACAGCTATGAC 3’) primers included in the ser-
vice were used in all sequencing reactions. Sequence reads were analysed using Snapgene 
software (GSL Biotech LLC, Chicago USA). 
 
2.8. Image Analysis 
2.8.1. U87-nls-mKate2 automated cell counting 
 Automated U87-nls-mKate2 cells counts were analysed using custom integration of 
MatLab (MathsWorks, Cambridge, version 2018b) scripts into Imaris (Bitplane, Oxford, ver-
sion 9.2.1). Cell counting scripts used Imaris Bitplane’s proprietary automated cell counting 
packages that exports data into MatLab for processing. The integration of custom MatLab 
scripts allows for batch processing of image data thus speeding up image processing, elimi-
nating unconscious biases and facilitates reproducibility. A custom ‘quality’ threshold was set 
for each experimental group to control for variability in image acquisition parameters and 
fluorophore expression patterns. This same ‘quality’ threshold was applied on all imaged 
samples from the same experimental group for batch processing in cell counting.  
 
2.8.2. Macrophage sum of intensity 
 The macrophage sum of intensity is defined as the sum of all pixel intensity values 
defined in a specific region of interest. Macrophage sum of intensity was used as a read out 
for the level of macrophage responses to a specific experimental stimuli. Custom MatLab 
scripts were coded to evaluate macrophage sum of intensity. The script integrates MatLab’s 
proprietary surfacing tool to define a region of interest based on mpeg1 promoter driven fluor-
ophore expression (Ellett et al., 2011). The mpeg1 promoter is a macrophage lineage specific 




incorporates surface detail smoothing and background subtraction in order to achieve a re-
gion of interests that best reflects the borders of macrophage labelling. Custom upper inten-
sity threshold was set for each experimental group to control for variability in image acquisi-
tion parameters and fluorophore expression patterns. The upper intensity threshold was set 
to achieve maximum surfacing of fluorophore signal. The surfaced images were filtered by 
the ‘number of triangles’ to remove surface noise. This same upper intensity threshold and 
‘number of triangle’ filter was applied to all imaged samples from the same experimental 
group for batch processing to evaluate macrophage sum of intensity. 
  
 
2.9. CRISPR-mediated genome editing of TNF-α and Cxcl8b.1 in 
zebrafish 
2.9.1. CRISPR-mediated genome mutagenesis 
 All CRISPR guide RNA (gRNA) were designed using Snapgene (GSL Biotech LLC, 
Chicago USA), a commercially available software. Trans-activating CRISPR RNA (tracrRNA) 
and CrRNA for Tnf-𝑎 BSL1 (target sequence: 5’ ACAAAATAAATGCCATCATC 3’), Tnf-𝑎 
MWO1 (target sequence: 5’ GCTCCTGCGTGCAGATTGAG 3’), Cxcl8b.1 Alu1 (target se-
quence: 5’ GACCATTCACCGAGCAGCTG 3’), Cxcl8b.1 Rsa1 (target sequence: 5’ ATTCC-
TAAACGACAAGTACT 3’), Cxcl8b.1 Bsl1 (target sequence: 5’ GTCTCAATCCTACCGAGACG 
3’) and scrambled (target sequence: 5′-CCTCTTACCTCAGTTACAATTTATA-3′) were ob-
tained from Merck KGaA (Darmstadt, Germany,). Knock out of TNF-ɑ expression was 
achieved using an injection mix containing a mixture of 1 µl tracrRNA, 1 µl phenol red, 1 µl 
Cas9 protein ,1 µl Tnf-ɑ MWO1 gRNA and 1 µl Tnf-𝑎 BSL1 gRNA (Table 7). The partial knock-
out of Cxcl8b.1 and knock out of Tnf-ɑ expression was achieved by injecting a mix containing 
a 1ul tracrRNA, 1 µl phenol red, 1 µl Cas9 protein ,1 µl Cxcl8b.1 Alu1 gRNA, 1 µl Tnf-ɑ MWO1 
gRNA and1 µl Tnf-𝑎 BSL1 gRNA (Table 7).  





Reagent Composition/Final Concentration 
tracrRNA SygRNA Cas9 Synthetic tracrRNA 250 ng/µl  
Phenol Red phenolsulfonphthalein 5.6 µM 
Cas9 Cas9 Nuclease, S.pyrogenes 6.66 µM 
Tnf-ɑ Bsl1 gRNA SpCas9 crRNA HPLC 20 µM gRNA 
Tnf-ɑ Mwo1 gRNA SpCas9 crRNA HPLC 20 µM gRNA 
Cxcl8b.1 Alu1 gRNA SpCas9 crRNA HPLC 20 µM gRNA  
Cxcl8b.1 Rsa1 gRNA SpCas9 crRNA HPLC 20 µM gRNA  
Cxcl8b.1 Bsl1 gRNA SpCas9 crRNA HPLC 20 µM gRNA  
Scrambled gRNA SpCas9 crRNA HPLC 20 µM gRNA  
 
2.9.2. Isolation of genomic DNA from zebrafish tissue 
 Genomic DNA from zebrafish tissue was isolated using the NaOH method. This pro-
tocol was modified from the HotSHOT method used previously in murine models (D Meeker 
et al., 2007). Live zebrafish were euthanised by 15.3 mM Tricaine overdose post imaging at 
the end of each experiment. The genomic DNA of zebrafish tissue was isolated from the U87 
human glioblastoma cells by transecting above the yolk-sac using surgical micro-scissors. 
Zebrafish heads containing U87 human glioblastoma cells were removed and genomic DNA 
was isolated from the remaining zebrafish tissue. Individual zebrafish main body tissue were 
heated to 95°C in 100 µl of 50 mM NaOH for ten minutes. A volume of 10 µl of 1 M TRIS pH 
8.0 was added to each tissue digest, vortexed to mix and cooled to 4°C. The resulting ge-
nomic DNA extract was used immediately for PCR reaction. 
 
2.9.3. Restriction fragment length polymorphism (RFLP) analysis 
 The efficiency of CRISPR induced mutagenesis was accessed by restriction fragment 
length polymorphism analysis (Tsarouchas et al., 2018). To accomplish this, CRISPR gRNAs 
were specifically designed to introduce mutations to a restriction site in the exon. Introduction 
of a mutation at the restriction site abolishes restriction enzyme activity and thus causes frag-




CRISPR gRNA is paired with a specific pair of primers to amplify a region of the genome with 
a restriction enzyme site of interest (Table 8). 
Table 8 Crispant Verification Primer Pairs 
 Primer Pair Exon Tar-
get 
Primer Sequence 5’ - 3’ Enzyme 
1 Tnf-ɑ Bsl1 For-
ward 
Exon 4 ACCAGGCCTTTTCTTCAGGT  Bsl1 
2 Tnf-ɑ Bsl1 Re-
verse 
Exon 4 AGCGGATTGCACTGAAAAGT  Bsl1 
3 Tnf-ɑ Mwo1 For-
ward 
Exon 4 CATCAGCTGCACGTCTGAAC  Mwo1 
4 Tnf-ɑ Mwo1 Re-
verse 
Exon 4 TGCCCAGTCTGTCTCCTTCT  Mwo1 
5 Cxcl8b.1 Alu1 
Forward 
Exon 4 ACCAGCACAGACAACAACAACA Alu1 
6 Cxcl8b.1 Alu1 
Forward 
Exon 4 AGGTCAGGTAAAGTCACAGTGA Alu1 
7 Cxcl8b.1 Bsl1 
Forward 
Exon 3 TTTTCAACAGCGCCACACTT Bsl1 
8 Cxcl8b.1 Bsl1 Re-
verse 
Exon 3 TGTTGTGAGGAGGGAAGTGT Bsl1 
9 Cxcl8b.1 Rsa1 
Forward 
Exon 2 TGCTTCTGATCTGCACGACTG Rsa1 
10 Cxcl8b.1 Rsa1 
Reverse 
Exon 2 TTCTGCAGTGTGATCCAGCA Rsa1 
 
 Each PCR reaction contained 10 µl REDTaq ReadyMix PCR mix (Sigma, Dorset, UK), 
200 nM final concentration of each forward and reverse primers, 0.4 µl of template DNA iso-
lated for tissue digest and PCR grade water up to a final volume of 20 µl. The PCR mix was 
transferred to a thermal cycler running a three step protocol previous described in Table 5. 
 The resulting PCR product was digested by the respective paired restriction enzyme 
(Table 8). Restriction enzyme, 3.3 units, was directly added to the PCR product and was 
incubated at the enzyme’s incubation temperature for a period of two hours; Rsa1 (37°C), 
Bsl1 (55°C) and Mwo1 (60°C) Horizontal gel electrophoresis was conducted on digested PCR 






2.10. Genetic overexpression of TNF-α and Cxcl8b.1 in zebrafish    
2.10.1. Zebrafish Genetic Transgenesis 
 Zebrafish embryo microinjections were conducted at the one cell stage in order to 
maximise transgenesis efficiency. The overexpression of Cxcl8b.1 was achieved by injecting 
a solution containing a final concentration of 40 ng/µl pDest_mpeg:Cxcl8b.1 plasmid, 100 
mM KCl, 200 ng/µl Tol2 transposase and 2.5 µM Fast Green FCF Dye in a final volume of 10 
µl. Similarly, the overexpression of TNF-a was achieved by injecting a solution containing a 
final concentration of 40 ng/µl pDest_mpeg:TNF-a plasmid, 100 mM KCl, 200 ng/µl Tol2 
transposase and 2.5 µM Fast Green FCF Dye in a final volume of 10 µl. The co-expression of 
both mpeg:TNF-a and mpeg-Cxcl8b.1 was achieved by injecting a solution containing 40 
ng/µl pDest_mpeg:TNF-a plasmid, 40 ng/µl pDest_mpeg:Cxcl8b.1 plasmid, 100 mM KCl, 200 
ng/µl Tol2 transposase and 2.5 µM Fast Green FCF Dye in a final volume of 10 µl. All overex-
pression assays were conducted in GFP labelled macrophages in the transgenic 
mpeg1:EGFP zebrafish. 
 
2.10.1. Zebrafish tissue homogenisation and RNA extraction 
 The zebrafish tissue was isolated using adapted protocols developed in the lab pre-
viously described (Mazzolini et al., 2018). Zebrafish larvae were euthanised with 15.3 mM 
Tricaine prior to being transferred into cold embryo medium at 4°C. For each sample group 
of transgenic zebrafish, 100 zebrafish larvae were used. Whole larvae were transferred into a 
glass homogeniser filled with 1 ml Media A (15 mM Hepes, 25 mM D-Glucose in 1X HBSS). 
The larvae were homogenised using a glass homogeniser and distributed into two 1.5ml mi-
crotubes and centrifuged at 300 g for 10 minutes at 4°C. The supernatant was removed and 
the cell pellet from both tubes were pooled into a single 1.5 ml microtube with 1 ml media A. 
Homogenized tissue was centrifuged at 300 g for 10 minutes at 4°C and the resulting pellet 
was used for RNA extraction. RNA extraction was achieved using the RNeasy Mini Kit (Qi-




by adding 350 µl buffer RLT and homogenised by pipetting directly into a QIAshredder spin 
column (Qiagen, Manchester UK. Genomic DNA was removed from the lysate by passing 
through a gDNA Eliminator spin column, leaving only total RNA content. Next, 350µl 70% 
ethanol was added to the flowthrough and the sample was transferred to an RNeasy MinElute 
spin column. The sample was washed with 700 µl buffer RW1 followed by 500 µl buffer RPE 
and finally 500 µl 80% ethanol. Samples were centrifuged at 9000 g for 1 minute in between 
each wash steps. RNA content was finally eluted by adding 14 µl RNase free water to the 
centre of the spin column membrane, allowed to sit for 1 minute and centrifuged at 9000 g 
for 1 minute. Isolated total RNA content was quantified using nanodrop and 1 µg RNA for 
each sample was used immediately for First Strand cDNA synthesis, described in section 
2.4.1, in preparation for Reverse Transcription PCR (RT PCR).  
 
2.10.2. Reverse transcription polymerase chain reaction (RT-PCR) 
 RT PCR of DNA fragments is a powerful yet straight forward technique to qualitatively 
evaluate mRNA expression levels in genetic overexpression assays. Total RNA content was 
isolated from whole embryos using method described in section 2.10.1. RNA was extracted 
from mpeg1:EGFP zebrafish injected with pDestTM_mpeg1:tnf-𝑎,	mpeg1:EGFP zebrafish in-
jected with pDestTM_mpeg1:cxcl8b.1 and from wild type (WIK) zebrafish. First strand cDNA 
synthesis was performed on extracted RNA and RedTaq PCR method (Section 2.6.1) was 
performed with an amended number of PCR cycles set at 28 cycles. RedTaq PCR was per-
formed using forward and reverse primers for tnf-a, cxcl8b.1, β-actin and GFP listed in Table 
9 on each RNA sample. RT-PCR was visualized by agarose gel electrophoresis (Section 
2.6.2). 
 
Table 9. RT-PCR Primer list 
Primer name Primer Sequence 5’ - 3’ 
Beta Actin Forward CACTGAGGCTCCCCTGAATCCC 
Beta Actin Reverse CGTACAGAGAGAGCACAGCCTGG 




Primer name Primer Sequence 5’ - 3’ 
Cxcl8b.1 Reverse AATCACCCACGTCTCGGTAG 
TNF-a Forward ACCCAGGGCAATCAACAAGA 
TNF-a Reverse CAAGCCACCTGAAGAAAAGGC 
GFP Forward ACGTAAACGGCCACAAGTTC 
 








3.1. Biorthogonal catalytic uncaging of inactive caged compounds in 
the zebrafish brain 
3.1.1. Caged drug, POB-Vorinostat, trials reveal palladium mediated anti tu-
mour effects in zebrafish 
One of the major challenge facing cancer therapy is the difficulty of homogeneous 
delivery of intravenous chemotherapeutics throughout the solid tumour mass. The high inter-
stitial pressures contribute to the suboptimal diffusion of drugs from blood circulation which 
prevents intratumor penetration (Stohrer et al., 2000). This problem is exacerbated by the 
clearance of intravenous drugs by the liver and kidneys which can lead to fatal organ toxicity 
(Hoop et al., 2018). Thus a more effective drug delivery system is required. Herein, we ex-
plored the capabilities of solidly supported Gold (Perez-Lopez et al., 2017) and Palladium 
(Adam et al., 2018) nanoparticles to mediate local delivery of chemotherapeutic agent, Vori-
nostat, in zebrafish. In conjunction with in-vivo live imaging technologies, the efficacy of a 
newly designed drug delivery system to deliver chemotherapeutic Vorinostat into the 
zebrafish brain was studied. Vorinostat has been previously shown to be a potent chemo-
therapeutic in-vitro and was released upon biorthogonal catalytic reaction with Palladium 
beads leading to uncaging of inactive caged drug POB-Vorinostat (Figure S1) into its active 
form. The benefits of a biorthogonal catalytic drug delivery system allowed for site specific 
drug delivery that has the potential to significantly increase drug potency. Thus, in order to 
investigate the viability of biorthogonal catalytic drug delivery system in an in vivo setting, we 
utilised the zebrafish animal model to develop a Palladium bead in vivo assay. mpeg1:EGFP, 
macrophage labelled, zebrafish were xenografted with U87-mCherry cells at 3 days post fer-
tilisation (dpf) and Palladium beads implanted into the brain at 4 dpf. These zebrafish were 
subsequently treated with either 100 µM inactive caged drug POB-Vorinostat in 1% DMSO 







Figure 8. Palladium mediated anti-tumour effects observed in all palladium im-
planted zebrafish samples 
(A-D) Human derived U87-mCherry (White) were xenografted into macrophage labelled (Green), 3 days post fertilized 
(dpf), mpeg1:EGFP zebrafish. Xenografted zebrafish were implanted with Palladium bead at 4 dpf (0 dpt). Palladium 
bead implanted zebrafish were treated with 1% DMSO in E3 medium or 100 µM POB-Vorinostat in E3 containing 
1% DMSO. Images from left to right are in chronological order showing 0 and 3 day post bead transplantation (dpt).  
(A) U87-mCherry cells engrafted in the brain of the zebrafish. An increase in glioma cell mass was observed when 
comparing 0 dpt and 3 dpt. (B-D) The implantation of Palladium bead elicits a potent anti-tumour effect leading to 
a strong inhibition of U87-mCherry cell proliferation in all zebrafish samples. The implantation of Palladium bead in 
all zebrafish samples lead to a decrease in glioma cell mass in the zebrafish brain. All Images were captured using 
an Andor spinning disk confocal microscope with a 20X/NA 0.75 objective. Scale bars are set at 20 um  
(E) U87-mCherry cell numbers are expressed as a ratio calculated by the number of cells at 1 or 3 day post 
transplantation (dpt) divided by the number of cells at 0 dpt. mpeg1:EGFP zebrafish xenografted with U87-mCherry 
(No bead) showed an increase in U87-mCherry cell number by 1.3 fold at 3 dpt. A potent anti tumour effect was 
observed in all zebrafish implanted with palladium bead. A significant, p < 0.0001, decrease in U87 cell number by 
90% was recorded by 3 dpt. 
(F) Brightfield image is representative of the orientation and imaging field of the fluorescent images shown in images 
A-D. 
One way ANOVA statistical analysis and Tukey’s multiple comparisons test were conducted to calulate p values. p 
values were indicated where statistically significant (p < 0.05). Error bar indicated standard error.  
 




In the absence of the Palladium bead we observed the engraftment and proliferation 
of U87-mCherry cells in the brain. Although no cellular division was directly observed, U87-
mCherry cell numbers increased by 1.3 folds by 3 days post bead transplantation (dpt). In 
addition, an increase in glioma mass was observed when comparing 0 dpt and 3 dpt (Figure 
8A,E). In contrast, the implantation of Palladium bead into the brain of U87-mCherry trans-
planted mpeg1:EGFP zebrafish induced a strong inhibition of U87-mCherry cell proliferation. 
The impairment of U87-mCherry cells ability to engraft in the zebrafish brain was observed 
(Figure 8). The implantation of Palladium bead alone, in the absence of Vorinostat, resulted in 
a significant decrease in U87-mCherry cell count by 90% (p < 0.0001) at 3 dpt (Figure 8B, E). 
In addition, a decrease in glioma cell mass was observed in the zebrafish brain (Figure 8B, E). 
The same anti-tumour effect was replicated in all zebrafish samples implanted with the palla-
dium bead including zebrafish treated with 1% DMSO and 100 µM Vorinostat (Figure 8C-E). 
Furthermore, the implantation of Palladium bead in the mpeg1:EGFP zebrafish initi-
ated a macrophage response that made distinguishing individual macrophages from one an-
other difficult. Thus, a robust and reliable method was required to evaluate macrophage num-
ber as a result of Palladium bead implantation. Therefore, a correlative study was conducted 
to correlate the sum of intensity with the number of macrophages in the zebrafish brain. The 
sum of intensity was defined as the sum of pixel values of EGFP signals within the define 
sampling area. It was hypothesised that macrophage number would correlate with the sum 
of mpeg1:EGFP signal intensity values. To do so, double transgenic mpeg1:EGFP and 
mpeg1:nls-Crimson, nuclear labelled macrophages, zebrafish were implanted with Palladium 
beads and the effect on macrophage number and mpeg1:EGFP were evaluated  
A positive correlation between the number of macrophage within the zebrafish brain 
and mpeg1:EGFP sum of intensity was demonstrated. A positive correlation coefficient (r) of 
0.561 with a reported p value of 0.0016 was recorded when evaluating the number of 
mpeg1:nls-Crimson nuclear labelling and sum of intensity of mpeg1:EGFP signals. Thus the 




of macrophages. Evaluating the sum of mpeg1:EGFP intensity facilitated rapid and reliable 
quantification of macrophage number in the mpeg1:EGFP zebrafish brain.  
 
This initial study highlighted a novel mechanism that initiated anti-tumour responses 
as a result of Palladium bead exposure. The implantation of Palladium bead altered the 
zebrafish brain’s physiological condition and led to U87-mCherry cell clearance. However, 
there were several questions that were raised as a result of this study. Was Palladium metal 
the effector of the associated anti-tumour responses or were these the effects of a reaction 
with the polystyrene matrix (bead) upon which the Palladium metal was bound to? How were 

























Figure 9. mpeg1:EGFP sum of intensity shows strong correlation with macro-
phage cell count. 
Double transgenic tg(mpeg1:EGFP:mpeg1:Kal4/UAS:nls-Crimson), zebrafish were implanted with Palladium beads 
and the effect on macrophage number and mpeg1:EGFP signal intensities were evaluated. A positive correlation 
between the number of macrophage within the zebrafish brain and macrophage sum of intensity was demonstrated. 
A positive correlation coefficient (r) of 0.561 with a reported p value of 0.0016 was recorded when correlating the 
number of mpeg1:Kal4/UAS:nls-Crimson nuclear labelling and sum of intensity of mpeg1:EGFP signals. Images 





U87-mCherry cells being cleared? We hypothesised that Palladium bead implantation initi-
ated an anti-tumour response in the zebrafish brain. To test this, we confirmed Palladium 





3.1.2. Palladium bead implantation recruits macrophages which initiates U87-
mCherry cell clearance and engulfment.  
To associate the anti-tumour phenotype directly to Palladium bead implantation, the 
anti-tumour effect of Palladium bead implantation was compared to an injury model. To rep-
licate an implantation injury, Naked beads were implanted into the brain and immediately 
removed. This study aimed to test the hypothesis that Palladium bead implantation initiated 
an anti-tumour response in the zebrafish brain.  
 The implantation of Palladium bead initiated a potent anti-tumour phenotype in the 
zebrafish brain. Implantation of Palladium bead into mpeg1:EGFP zebrafish led to a signifi-
cant decrease in U87-mCherry cell count by 73.4% at 3 dpt (Figure 10A-B). However, a pro-
portion of the anti-tumour phenotype, could be attributed to the bead injury during implanta-
tion procedure. The injury model resulted in a significant decrease of 28.5%(p < 0.0001) in 
U87-mCherry cell count at 3 dpt when compared to no bead controls. This indicated that the 
injury caused by the bead implantation procedure contributed to a proportion of the anti-
tumour responses (Figure 10C-D). However, when comparing Palladium bead implanted 
(73.4% )and injured (28.5%) zebrafish, Palladium bead implantation led to a significantly (p < 
0.0001) potent antitumor effect by 3 dpt (Figure 10). Intriguingly, a significant increase in mac-
rophage number was observed in Palladium bead implanted zebrafish when compared to 
injured and bead null zebrafish. A four fold (p < 0.0001) increase in macrophage number in 
Palladium bead implanted zebrafish was observed by 3 dpt. In contrast, a two fold increase 
in macrophage number was observed in injured and bead null zebrafish. The increase in mac-
rophage number coincided with high level of U87-mCherry cellular fragmentation in macro-
phages (Figure 10A, Pd Bead, Red arrows). U87-mCherry fragments were defined by pockets 
of mCherry fluorescent signal originating from mCherry cytoplasmic labelling encompassed 
by macrophage GFP signals (Figure 10A, Pd Bead, Red arrows). These fragmented signals 
originated from within macrophage when analysed closely in 3D using Imaris. It was highly 
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were atypical in size when compared to live U87-mCherry cells (20 to 30 µm). Thus, these 
fragments were most likely products of engulfed U87-mCherry cells by macrophages. Quan-
tification of these fragments indicated that they were significantly (p < 0.0001) increased only 
in Palladium bead implanted zebrafish at 1 dpt and 3 dpt (Figure 10D). In addition, an increase 
in macrophage intensity as a result of Palladium bead implantation in the brain was detected 
(Figure 10C). A significant (p < 0.0001) increase by 4.2 fold in macrophage signal intensity 
was recorded when comparing Palladium bead implanted zebrafish to the injured and the 
bead null zebrafish conditions (Figure 10C). This increase in macrophage intensity levels was 
sustained for the duration of the experiment and thus may indicate that Palladium bead im-
plantation recruited macrophages.  
In conclusion, this study confirmed Palladium bead mediated anti-tumour phenotype 
in the zebrafish. The implantation of Palladium bead led to the recruitment of macrophages 
Figure 10. Palladium bead implantation initiates U87-mCherry cell clearance and 
fragmentation. 
(A-C) Human derived Lv-cppt-IRES-mCherry-opre transformed U87-mCherry cells (White) were xenografted into 
macrophage labelled (Green), 3 days post fertilized (dpf), mpeg1:EGFP zebrafish. Xenografted zebrafish were 
implanted with Palladium bead or injured with Naked beads at 4 dpf or 0 dpt. Images from left to right are in 
chronological order showing 0 and 3 day post bead transplantation (dpt). (A’’-C’’) The red box denotes the boundary 
for the higher magnification region of interest shown in the images on the far right column. (A) U87-mCherry cells 
engrafted in the brain of the zebrafish. An increase in glioma cell mass was observed when comparing 0 dpt and 3 
dpt. (B) The implantation of Palladium bead recruited macrophages, initiated U87-mCherry cell clearance and 
fragmentation of U87-mCherry cells (B’’, Red Arrows). U87-mCherry fragments were defined by pockets of mCherry 
fluorescent signal, originating from U87-mCherry cytoplasmic labelling, encompass by macrophage GFP signals (B’’, 
Red Arrows). (C) The injury caused by the bead implantation procedure contributed to a proportion of the anti-tumour 
responses. U87-mCherry cells survived in the brain but did not proliferate. Images were captured using an Andor 
spinning disk confocal microscope with a 20X/NA 0.75 objective. Scale bars set at 50 µm 
(D) U87-mCherry cell numbers are expressed as a ratio calculated by the number of cells at 1 or 3 day post 
transplantation (dpt) divided by the number of cells at 0 dpt. Injured zebrafish resulted in a significant (p < 0.0001) 
decrease of 28.5% in U87-mCherry cell count by 3 dpt when compared to no bead controls. However, implantation 
of Palladium bead led to the greatest decrease (p<0.0001) in U87-mCherry cell count of 80% by 3 dpt. 
(E) A significant (p < 0.0001) increase by 4.2 fold in macrophage signal intensity was recorded when comparing 
Palladium bead implanted zebrafish to injured and bead null zebrafish conditions.  
(F) High level of U87-mCherry cellular fragmentation in macrophages (Red arrows) was observed. Quantification of 
these fragments indicated that they were significantly (p < 0.0001) increased only in Palladium bead implanted 
zebrafish at 1 dpt  
and 3 dpt. 
One way ANOVA statistical analysis and Tukey’s multiple comparisons test were conducted to calulate p values. p 





in the vicinity of the bead in addition to U87-mCherry cell clearance. The recruitment of these 
macrophages led to the engulfment of U87-mCherry cells, recorded in our study as an in-
crease in U87-mCherry cellular fragmentation. This implies that macrophages played a key 
role in mediating the observed anti-tumour phenotype. Thus we hypothesized that macro-





3.1.3. irf8-/- zebrafish reveals a possible role of macrophages in mediating Pal-
ladium bead induced anti-tumour phenotype. 
In order to test the hypothesis that macrophages are key mediators of the Palladium 
bead induced anti-tumour phenotype, the same Palladium bead and injury experiments were 
repeated in the Interferon regulator factor 8 mutant (irf8-/-) zebrafish. Interferon regulatory fac-
tor 8 (irf8) is an important regulatory factor for the development of macrophage in mammals 
and teleosts (Shiau et al., 2015). irf8 is a key factor in early stage myelopoiesis of the immature 
zebrafish immune system during development (Shiau et al., 2015). Knock out of irf8 in the 
zebrafish leads to the characteristic development of a macrophage null background up to 
around seven days post fertilization (Shiau et al., 2015). However, it is important to note that 
elevated neutrophils levels have also been reported in the irf8-/- mutant line (Shiau et al., 2015). 
Nonetheless, the irf8-/- zebrafish is an ideal candidate to facilitate the study of macrophage’s 
contribution to Palladium induced anti-tumour activity.  
 The xenograft of U87-mCherry cells into irf8-/- zebrafish highlighted a strong impact 
of macrophages on tumour progression. We have previously reported that microglia, the 
brain’s resident macrophages, and macrophages play an important role in promoting U87 
cell growth and that the ablation of macrophage leads to tumour regression (Hamilton et al., 
2016). Survival of U87-mCherry cells was significantly reduced in a microglia/macrophage 
null background irf8-/- zebrafish (Hamilton et al., 2016). Indeed, when analysing U87-mCherry 
cell count in irf8-/- bead null zebrafish versus mpeg1:EGFP bead null zebrafish, an impairment 
of 31.5% in U87-mCherry tumour progression was observed, p < 0.001(Figure 11E). Macro-
phage function was critical for U87 cell to engraft. Thus, this inherent disability of U87-
mCherry cells to survive in the irf8-/- zebrafish would have affected all xenografted irf8-/- 
zebrafish (Figure 11D). Even so, a trend (p = 0.109) indicated that the Palladium mediated 
anti-tumour phenotype was attenuated in the irf8-/- zebrafish (Figure 11E). No significant dif-
ference was observed in U87-mCherry cell count of irf8-/- zebrafish of all three conditions, No 






Figure 11. irf8-/- zebrafish reveal a possible role for macrophages in mediating 
Palladium bead induced anti-tumour phenotype. 
Human derived U87-mCherry cells (White) were xenografted into 3 dpf irf8-/- zebrafish. At 4 dpf, irf8-/- U87-mCherry 
xenografted zebrafish were injured and Palladium beads were implanted. Images from left to right are in 
chronological order showing 0 and 3 day post bead transplantation (dpt).  
(A-C) The xenograft of U87-mCherry cells in irf8-/- zebrafish highlighted a strong impact of macrophage on tumour 
progression. (D) No significance difference was observed in U87-mCherry cell count of irf8-/- zebrafish of all three 
conditions. (E) An impairment of 31.5% in U87-mCherry tumour progression was observed in irf8-/- bead null 
zebrafish versus mpeg1:EGFP bead null zebrafish. A trend (p = 0.109) indicated that the Palladium mediated anti-
tumour phenotype was attenuated in the irf8-/- zebrafish. Images were captured using an Andor spinning disk 










implantation of Palladium bead in wild type background (mpeg1:EGFP zebrafish), led to a 
significant decrease (p<0.0001) in U87-mCherry cell count by 73.4%  at 3 dpt (Figure 10D, 
Figure 11E). A 73.4% decrease in U87-mCherry cell count was detected for Palladium bead 
implanted mpeg1:EGFP zebrafish versus the 35.1% in Palladium bead implanted irf8-/- 
zebrafish (Figure 11E). This indicated that the anti-tumour effect of Palladium bead was at-
tenuated in the macrophage null background irf8-/- zebrafish. Thus implying that macrophage 
function was required in order to elicit the anti-tumour effect of Palladium bead implantation. 
However these results were not statically significant (p = 0.109). Therefore, this study only 
indicate a trend to support microglia/macrophage role in Palladium bead induced anti-tumour 
phenotype. 
 The aforementioned studies have shown Palladium beads as potent anti-tumour ef-
fectors. In addition, Palladium beads were seen to initiate an immune response that recruited 
macrophages to the brain. There was strong evidence to suggest that the recruitment of these 
macrophages coincided with increased U87-mCherry cell engulfment, fragmentation and 
clearance (Figure 10). In addition, a trend indicated that macrophage function was required 
in order to elicit the anti-tumour effects of Palladium bead implantation. Therefore, we spec-
ulated that Palladium bead implantation initiated an indirect effect on U87 cells mediated by 
macrophages to elicit an anti-tumour effect. Thus, we hypothesised that macrophages con-








3.1.4. Implantation of Palladium beads in the zebrafish brain did not cause ab-
errant necrosis in surrounding tissue. 
To address if U87 cell death were the direct or indirect consequences of Palladium 
implantation, the necrotic effects of Palladium and Naked bead implantation in the surround-
ing tissue were investigated. Naked beads served as a ‘foreign body’ control to study the 
immune and anti-tumour response of the polystyrene bead independent of Palladium metal. 
Toxic consequences of Palladium bead implantation would have had significant effect on 
surrounding tissue necrosis detectable using in-vivo Propidium Iodide (PI) staining techniques 
(See section 2.2.8 for details). This study aimed to strengthen the argument that the anti-
tumour effects mediated by Palladium bead implantation were initiated by in direct conse-
quences mediated by macrophages. Propidium iodide is a membrane-impermeant nucleic 
acid stain that does not permeate live cells. The binding of propidium iodide to nucleic acids 
enhances fluorescence by 20 to 30 folds and thus has been widely used to stain necrotic 
cells (Sawai and Domae, 2011, Unal Cevik and Dalkara, 2003). Propidium iodide was applied 
to the zebrafish media solution of Palladium, Naked and Injured mpo:EGFP zebrafish (4 dpf) 
and imaged at 0, 1 and 3 days post bead transplantation (dpt).  
The implantation of Palladium and Naked beads resulted in an increase in propidium 
iodide labelling when compared to injured zebrafish (Figure 12) Propidium iodide staining for 
bead implanted zebrafish at 0 dpt were observed to localize at the site of incision and vicinity 
of the beads (Figure 12A, Red Cicles). A three fold (p = 0.0012) increase in the number of 
propidium iodide labelled nuclei was recorded for Palladium bead implantation. While a two 
fold (p = 0.0665) increase in propidium iodide labelled nuclei was recorded for Naked bead  
implantation at 0 dpt (Figure 12C). The results here indicated that the trauma associated with 
the bead implantation procedure caused cellular necrosis of surrounding tissue. This was not 
surprising when considering a large incision was made during the procedure. It was also im-
portant to take into account the tissue damage caused by the bead implantation due to its 







































































































































Injury (n = 5)
Naked Bead (n = 4)
Palladium Bead (n = 5)
B. C. D. 
A. 
Figure 12. Implantation of Palladium and Naked beads did not initiate aberrant 
necrosis in the zebrafish brain. 
(A) Images from rows top to bottom, mpo:EGFP zebrafish, 4 days post fertilized (dpf), were implanted with 
Palladium and Naked beads. Red circles in the images denote the boundary of the implanted beads. Injured 
zebrafish underwent the same bead implantation procedure where a naked bead was inserted but was removed 
immediately. Zebrafish were treated with 1 µg/ml propidium iodide in embryo media throughout the experiment. 
Images from left to right, time lapse imaging indicated that high level of propidium iodide necrotic cell labelling 




cause the loss of membrane integrity and cellular necrosis which were detected through pro-
pidium iodide labelling. The recovery and clearance of propidium iodide nuclei cells was evi-
dent by 1 dpt in all bead implanted zebrafish (Figure 12A). Albeit, Palladium bead implanted 
zebrafish showed slower recovery to injury control levels when compared to Naked bead 
implanted zebrafish (Figure 12D). Nonetheless, a 60% decrease in propidium iodide labelled 
cells was observed by 1 dpt for Palladium bead implanted zebrafish. In addition, by 3 dpt, the 
decrease of propidium iodide labelling to injury control levels was recorded for all bead im-
planted zebrafish (Figure 12B). This indicated the clearance of necrotic cells and the recovery 
from the initial bead implantation procedure. 
 
In conclusion, Palladium and Naked bead implantation did not cause aberrant cellular 
necrosis. Although, cellular necrosis was recorded in the surrounding tissue, these necrotic 
cell bodies were a direct consequence of the injury caused by the bead implantation proce-
dure and not a reaction to the Palladium bead. Time lapse imaging indicated that the clear-
ance of necrotic cell bodies was evident by 3 dpt for Palladium and Naked bead implanted 
zebrafish. In addition, despite the zebrafish being in constant incubation in 1 µg/ml Propidium 
iodide, no significant development of additional necrotic cell bodies was detected. Thus these 
results support our conclusion that bead implantation does not cause aberrant cellular ne-
crosis. Therefore the anti-tumour effects observed were not a direct reaction to Palladium 
0 day post transplantation (dpt). A clearance of propidium iodide labelling was evident by 3 dpt for all bead 
implanted zebrafish. All Images were captured using an Andor spinning disk confocal microscope with a 20X/NA 
0.75 objective. Scale bars set at 50µm. 
(B) Palladium and Naked bead implantation induced an increase in the number of propidium iodide labelling at 0 
dpt when compared to injured controls. Clearance of propidium iodide labelling occurred within 24 hours. 
Although, Palladium showed slower recovery. Propidium iodide labeling returned to injury control levels by 3 dpt 
indicating clearance of necrotic cells and recovery from initial bead implantation procedure.  
(C) Palladium (p = 0.0012) showed significantly higher number of propidium iodide labelled cells at 0 dpt. 
Although not statically significant (p = 0.0665), a trend inidicates that the implatation of Naked bead increased 
propidium iodide cell labelling at 0 dpt. 
(D) Palladium bead implanted zebrafish show significantly slower recovery from bead implantation procedure. 
Elevated propidium iodidie labelling was recorded at 1 dpt for Gold and Palladium implanted zebrafish when 
compared to both injury controls and naked bead implanted zebrafish.  
One way ANOVA statistical analysis and Tukey’s multiple comparisons test were conducted to calulate p values. 





metal on the polystyrene beads. These results in turn strengthens support for the hypothesis 





3.2. RNA sequencing of macrophages isolated from palladium im-
planted zebrafish showed significant differentially expressed 
genes. 
Macrophages have been well established to play a pivotal role in glioma formation in 
cancer biology (Graeber et al., 2002, Coniglio et al., 2012, Hamilton et al., 2016) (van Dalen et 
al., 2018, Prionisti et al., 2019). Macrophages infiltrate gliomas to promote tumour progres-
sion and can account for 30% of the glioma mass (Graeber et al., 2002, Coniglio et al., 2012, 
Li and Graeber, 2012). Infiltration of tumour associated macrophages also act to establish an 
immunosuppressive microenvironment that facilitates immune system avoidance of cancer 
cells (van Dalen et al., 2018). However, studies have shown that the polarisation of tumour 
associated macrophages from a pro-tumour to an anti-tumour phenotype can also occur as 
a result of the biological interactions with nanoparticles (Reichel et al., 2019). Consequently, 
tumour associated macrophages represent an attractive clinical target for immunotherapeutic 
strategies. Thus the discovery that Palladium bead implantation recruited macrophages and 
induced a potent anti-tumour phenotype may have profound contribution to our understand-
ing of cancer biology. Therefore, to understand the genetic mechanisms underlying the as-
sociated anti-tumour responses in macrophages, RNA sequencing with next-generation se-
quencing was employed. It was hypothesised that Palladium bead implantation would polar-
ise macrophages towards an anti-tumour genetic expression profile. The following differen-





3.2.1. Isolation of macrophages from mpeg1:EGFP zebrafish via Fluorescence 
Activated Cell Sorting (FACS). 
Macrophages were isolated from mpeg1:EGFP transgenic zebrafish using Fluores-
cent Activated Cell Sorting techniques (FACS) (See section 2.3.2 for details). Macrophage 
were sorting for by gating for EGFP positive cells. It is important to note that the macrophages 
were isolated from approximately 200 individual embryonic brain tissue for each experiment. 
Zebrafish larvae were transected at the yolk sac and the heads isolated from the body. The 
heads were homogenised and macrophages isolated from the homogenised tissue. The total 
number of individual embryonic brain tissue used for each experimental group was 200 mul-
tiplied by the number of biological replicates, n (Figure 13A) Macrophages were isolated from 
three experimental groups: 1) mpeg1:EGFP zebrafish, 2) mpeg1:EGFP, U87-mCherry xeno-
grafted zebrafish, 3) mpeg1:EGFP, U87-mCherry xenografted, Palladium bead implanted 
zebrafish (Figure 13A, See also Table 4). Comparisons were made between each of the ex-
perimental groups to understand the underlying transcriptomic changes that Palladium beads 
induced. An average of 29,000 mpeg1:EGFP positive cells were sorted for each biological 
replicate. RNA was extracted from the sorted cells yielding a range of between 0.126 ng/µl to 
0.830 ng/µl of total RNA product. RNA quality assessment was conducted for each sample 
with RNA Integrity Numbers (RIN) ranging between 8.3 and 10. The results here validated the 
macrophage isolation protocols and RNA extraction techniques used to isolate macrophage 
total RNA from homogenised zebrafish brain tissue. Each of the nine RNA sample was am-
plified using OvationⓇ RNA-seq System and sent to Edinburgh genomics. Further quality 
controls were conducted by Edinburgh Genomics to confirm high quality cDNA post amplifi-
cation before DNA library preparation. DNA library preparation was conducted by Edinburgh 






Figure 13. Fluorescence Activated Cell Sorting (FACS) of macrophages from 
the zebrafish brain. 
(A) Macrophage, GFP positive cells, were isolated from homogenised brain tissues from three experimental 
groups: (A1) mpeg1:EGFP zebrafish. (A2) mpeg1:EGFP, U87-mCherry xenografted zebrafish. (A3) 
mpeg1:EGFP, U87-mCherry xenografted, Palladium bead implanted zebrafish. An average of 29,000 
mpeg1:EGFP positive cells were sorted for each biological replicate. FACS was facilitated by in-house service 
provided by Shared University Resource Facility (SURF, QMRI) using FACS AriaII (BD Biosciences, Oxford, UK). 
The n number represents the number of biological replicates conducted for each experiment. Total number of 





3.2.2. Principal component analysis of expression data reveal observable pat-
ters with respect to experimental factors. 
Principal component analysis was conducted in order to study the level of structure 
in the data. Principal component analysis is a statistical tool that can be used to explore high-
dimensional data (Ringner, 2008). Key to principal component analysis is reducing the dimen-
sionality of the data without changing recorded variations in the data set (Ringner, 2008). This 
allowed visualization of complex data set, like those of large gene expression data sets, to 
identify clusters of highly similar data sets. PCA was applied to explore large data sets where 
thousands of variables had been measured. It allowed the visualization of samples to detect 
dominant patterns of gene expression of the expression data sets; Palladium versus Bead 
null versus U87 xenografted. 
Initial Principal Component Analysis (PCA) revealed two distinct clusters of data sets 
and an outlier as shown in Figure 14A. The PCA plot of the first two principal components 
showed the clustering of RNA seq dataset from Palladium bead implanted zebrafish and clus-
tering of control (mpeg1:EGFP, Palladium bead null and U87-mCherry null) with bead null 
U87 xenografted zebrafish. However, on further analysis of PCA plots of principal component 
2 (PC2) and principal component 3 (PC3), only datasets from Palladium bead implanted 
zebrafish remained as a cluster (Figure 14B). Controls and bead null U87 xenografted 
zebrafish only clustered along the PC2 axis but were dispersed along the PC3 axis. This in-
dicated that Palladium bead datasets were more related to one other than U87 and Control 
data sets were. These were early confirmatory signs that Palladium bead implantation initiated 
a change in genetic expression in macrophages before differential analysis was conducted. 
In addition, the PCA plots clearly identified an outlier that showed that the genetic expression 
data of Control6D1005 was far more different than any of the other samples were to each 
other (Figure 14A-B, Red Square). Further statistical investigation also concluded that Con-
trol6D1005 was an outlier as illustrated in a heatmap and hierarchal clustering dendrogram 




mask underlying differentially expressed genes. Indeed when looking back at the experi-
mental notes, it was discovered that a fungal infection of the zebrafish housing had taken 
hold. A fungal infection of the embryo media in the zebrafish housing can have significant 
impact on zebrafish health and consequently alterations in immune responses. Alterations in 
immune responses would contribute to the genetic drift of macrophages in Control6D1005 
from all other samples. Therefore, the sample was removed from the analysis. Filtering and 
normalization was re-performed and new PCA plots was generated (Figure 15). 
The revised PCA biplot (Figure 15A-B) showed the clustering of RNA seq dataset 
from Palladium bead implanted zebrafish in both plots (PC1 vs PC2 and PC2 vs PC3). This 
once again reinforces the similarity in expression data from Palladium bead implanted 
zebrafish and thus differential analysis could be conducted with high confidence of identifying 
differentially expressed genes. The removal of the outlier revealed underlying variations in 
expression datasets for both U87 and Control zebrafish (Figure 15A-B). PCA plots of the first 
two principal components showed that Control and U87 dataset no longer clustered together 
and were dissimilar from each other; an attribute that could be related to the date of experi-
ment and genetic variability between clutches (Figure 15A). PCA plots of PC2 and PC3 only 
reinforced differences in expression datasets for Control and U87 as evident by a wide shot-
gun dispersal pattern of data sets (Figure 15B). Heatmap and hierarchical dendrogram sup-
ported observations from revised PCA plots showing clustering of datasets from Palladium 
bead implanted zebrafish (Figure 15C). Datasets from control and U87 zebrafish were shown 
to form a secondary cluster but similarities between Palladium bead implanted zebrafish were 
greater than similarities between U87 and Control datasets (Figure 15C). No discernible dif-
ferences was evident to distinguish RNA expression dataset between U87 and Controls (Fig-
ure 15C) reflected by hierarchal structure of dendrogram. 
The clustering of Palladium bead datasets in the principal component analysis indi-
cated high probability of differentially expressed genes when comparing between groups. 
PCA analysis indicated early evidence that there may be no differences between Control and 




useful application of pre-processing techniques in this study. Inclusion of Control6D1005 into 
differential analysis would have skewed the results and likely masked differential expressed 
genes. Thus, the exclusion of the dataset allows meaningful data to be extrapolated from 






Figure 14. Principal component analysis (PCA) biplot, heatmap and hierar-
chical clustering dendrogram of expression data reveal outlier and patterns 
with respect to experimental conditions. 
(A) PCA plots of the first two principal components (PC1 vs PC2) showed clustering of RNA seq dataset from 
Palladium bead implanted U87-mCherry xenografted mpeg1:EGFP zebrafish (Green, PdBead) and clustering 
of mpeg1:EGFP, Palladium bead null, U87-mCherry null controls (Red, Control) with bead null U87-mCherry 
xenografted mpeg1:EGFP zebrafish (Blue, U87). Prominent outlier, Control6D1005 (Red Square), sits outside 
the two clusters. 
(B) PCA plots of principal component 2 and principal component 3 showed clustering of expression data sets 
from Palladium bead implanted samples (Green, PdBead). Datasets from Controls (Red, Control) and U87 (Red, 
U87) clustered along the PC2 axis but were dispersed along the PC3 axis. With one exception, Control6D1005 
was plotted outside Control and U87 cluster and dispersed along the PC2 axis. Control6D1005 was an outlier 
when compared to dataset of Control and U87. In addition, PCA plot indicated that variations in genetic 
expression was as a result of experimental conditions and not due to variations in biological replicates 
conducted on different dates. Dates are reflected as D0305 where 0305 represents the third of May. 
(C) Heat map and heirarchical clustering of dendrogram reinforces observations from PCA plots. The darker the 
colour the greater the difference in gene expression data. Control6D1005 showed highest variability in gene 
expression represented by the height of the dendrogram branch. Palladium bead implanted samples clustered 
together and showed strong similarities in genetic expression data. A secondary cluster formed showing 








































































































































































































Figure 15. Revised Principal Component Analysis, heatmap and hierarchical 
clustering dendrogram of expression patterns with respect to experimental 
conditions. 
(A) PCA plots of the first two principal components (PC1 vs PC2), without outlier Control6D1005, showed 
clustering of RNA seq datasets from Palladium bead implanted U87-mCherry xenografted mpeg1:EGFP 
zebrafish (Green, PdBead). PCA plots of dataset from Palladium bead null, U87-mCherry null controls 
mpeg1:EGFP zebrafish (Red, Control) and bead null, U87-mCherry xenografted mpeg1:EGFP zebrafish (Blue, 
U87) were dispersed along the PC2 axis showing little similarity.  
(B) PCA plots of principal component 2 and principal component 3 again showing clustering of expression 
data from Palladium bead implanted samples (Green, PdBead). The PCA plot indicated that variations in 
genetic expression was as a result of experimental conditions and not due to variations in biological replicates 
conducted on different dates. Dates were reflected as D0305 where 0305 represents the third of May. 
(C) Heat map and heirarchical clustering of dendrogram reinforced observations from PCA plots. The darker 
the colour the greater the difference in gene expression data. Palladium bead implanted samples clustered 
together and showed strong similarities in genetic expression data. A secondary cluster formed showing 





3.2.3. Differential analysis of RNA seq expression data reveal differentially ex-
pressed genes in Palladium bead implanted zebrafish. 
To investigate if Palladium bead implantation induced alterations is genetic expres-
sion in macrophages, differential analysis of RNA seq expression data was conducted. Dif-
ferential analysis, when filtered by a minimum fold change of 2 and a maximum False Discov-
ery Rate of 0.05, revealed many genes to be significantly differentially expressed. The False 
Discover Rate (FDR) is a unit of measure used to evaluate the statistical significance (p values) 
of a differentially expressed gene corrected to the number of times the t-test was conducted. 
FDR is a better representation of significance than p values as it corrects for sample depth 
and decreased the probability of false positive or negatives. In total 750 genes were differen-
tially expressed in Palladium bead implanted zebrafish when compared to controls; 389 
genes upregulated vs 361 genes downregulated (Figure 16A). In contrast, 1014 genes were 
differentially expressed in Palladium bead implanted zebrafish when compared to U87; 524 
genes upregulated vs 490 genes downregulated (Figure 16C). No significant differentially ex-
pressed genes were detected when comparing U87 and Control indicating that expression 
datasets of Control and U87 were very similar; an attribute previously predicted in PCA anal-




















Contrast Name Genes upregulated Genes downregulated 
A) Condition: PdBead vs Control 389 361 
B) Condition: U87 vs Control 0 0 
C) Condition: U87 vs PdBead 524 490 
Figure 16. Differential expressed genes for each contrast according to a thresh-
old of a minimum fold change of 2 and a maximum false discovery rate of 0.05. 
Volcano Plots illustrating log(2) fold change vs -log(10) false discover rate. The horizontal dashed line represented 
the specified FDR thresehold significance value set at 0.05, vertical dotted lines represented the specified fold 
change threshold of 2 in both the positive and negative directions. Points passing through the thresholds were 
coloured in red. The table of statistics shows the numbers of differentially expressed genes for each contrast 





3.2.4. Gene ontology enrichment analysis of differentially expressed genes in 
Palladium bead implanted versus Control zebrafish macrophages reveal 
shift in macrophage inflammatory polarisation.  
To gain further insight into the functional consequences of the differentially expressed 
genes, gene ontology (GO) enrichment analysis was conducted. GO enrichment analysis is a 
genome wide statically tool that is useful to investigate if the differentially expressed genes 
were associated with certain biological process or molecular pathways. GO enrichment anal-
ysis compares the frequency of individually annotated differentially expressed genes against 
the zebrafish genome in order to identify enriched functional pathway that may explain the 
mechanisms leading to the anti-tumour phenotype in Palladium bead implanted zebrafish. 
GO enrichment analysis of differentially expressed genes indicated greatest enrich-
ment of pathways associated with oxidation-reduction process when comparing expression 
data of Palladium bead implanted zebrafish with Controls. Figure 17A illustrates a pie chart 
of all differentially expressed genes with a FDR of less than 0.05. The pie chart was catego-
rised by the proportion of genes differentially expressed in each gene ontology category. As 
evident from Figure 17A, 42% of the genes that were differentially expressed were associated 
with the oxidation reduction process. Further investigation revealed differential expression in 
23% of the 634 genes in the oxidation-reduction process (FDR = 0.039). In general, a greater 
proportion of these genes were upregulated than down regulated. Several key genes associ-
ated with cell redox homeostasis like homxa1, txn and nos1 were upregulated in Palladium 
bead implanted zebrafish (Figure 17B). The enrichment of oxidation-reduction processes in 
macrophages can alter macrophage activation profile and response to external stimuli as a 
result of Palladium bead implantation (Brune et al., 2013). However, redox signal regulation, 
despite contributing to a large proportion of the enriched pathways, would most likely be part 
of a larger network of signalling systems initiating the anti-tumour response. As expected, 
enrichment of pathways that responded to metals were up regulated (FDR = 0.0399). In par-
ticular, a three fold increase in genetic expression of the HSP70 family were recorded, hsp 
70.1, hsp70.2, hsp70.3 and hsp70l. The HSP70 family of heat shock proteins are vital molec-




addition, a 1.4 fold increase in expression of atp7a was recorded. atp7a is an important pro-
tein in the regulation of mitochondrial redox balance (Bhattacharjee et al., 2016). When com-
bined, these proteins serve as a buffer for cells to tolerate environmental stresses, hypoxia 
and, most importantly, heavy metal exposure. An enrichment in protein transport pathways 
was also recorded in the macrophages of Palladium bead implanted zebrafish. An upregula-
tion of 25% of 189 protein transport genes analysed was recorded. Enrichment of these 
genes made up 15% of the overall enrichment profile (Figure 17A). Upregulation of genes 
linked to protein transport described an increase in a whole host of generalised intracellular 
function ranging from cellular differentiation (vps11, ap2a1) to endocytosis (ap1b1,snx9b) and 
endosomal transport (snx1a). A large majority of the upregulated genes were genes predicted 
to form part of the clarthrin complex involved in vesicular transport of intracellular proteins. In 
addition, the upregulation of pro-inflammatory genes cxcl8b.1(4.5 fold) and tnf-𝑎 (3 fold) and 
downregulation of anti-inflammatory gene il-4 (1.4 fold) were recorded. tnf-𝑎 is a key cell sig-
nalling cytokine that is involved in systemic inflammation and responsible for acute phase 
reactions (Ciebiera et al., 2018). tnf-𝑎 had been described as an antineoplastic and antiangi-
ogenic agent that can stimulate immune cells to kill cancer cells (Ciebiera et al., 2018). While 
on the other hand, cxcl8b.1 is an orthologue of il-8 in humans and is a potent attractant of 
neutrophils (Manfroi et al., 2017). Thus, the increase in cxcl8b.1 expression may indicate the 
recruitment of neutrophils by macrophages. The combination of decreased il-4 and increase 
tnf-𝑎 and cxcl8b.1 signalling would suggest a pro-inflammatory phenotype of macrophages 
in Palladium bead implanted zebrafish. Altogether, these signalling molecules would initiate 
a potent acute phase inflammatory response of macrophages and perhaps neutrophils in the 
brain of the zebrafish. The evidence presented here provides early evidence that a stress 






Heatmap and hierarchal dendrogram of the top 50 differentially expressed genes in 
Palladium bead versus Control illustrates clustering of genes described in oxidation-reduction 
process and metal ion sensing/responses (Figure 18). This again highlights a strong relation-
ship between the two processes. In addition, hierarchal dendrogram classification of genes 
like eno1a and txn, genes associated in oxidative-reduction process, showed similarities with 
genes of unknown or predicted functions. For example, the genetic expression of 
ch211−241c24.3 and zgc:198419 were identified to be upregulated in Palladium bead 
zebrafish (Figure 18). Genetic functions of these genes were poorly documented. 
ch211−241c24.3 had no documented function while zgc:198419 was only predicted to se-
quester iron ion; Iron is a by-product of the uncoupling of oxygen atoms from iron during 
Figure 17. Gene ontology enrichment analysis of differentially expressed genes 
of isolated macrophages from Palladium bead implanted zebrafish versus con-
trol.  
(A) Pie chart illustration of all differentially expressed genes with a FDR of less than 0.05. The pie chart is 
categorised by the proportion of genes differentially expressed in each gene ontology category expressed as a 
percentage. 
(B) Heatmap of the top 20 upregulated and top 20 downregulated genes in the oxidation-reduction process. 
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oxidation processes (ZFIN, 2013). Multiple instances of significantly differentially expressed 
genes with undocumented functions showed strong relationship with either oxidative-reduc-
tion (Figure 18, Blue Text) or metal sensing (Figure 18, Red Text). This study, may for the first 
time, highlight a function for these undocumented genes in either of the described processes. 
Together, the genes associated with oxidative-reduction and metal response processes 
made up to 11 out of the top 50 differential expressed genes. This was strong evidence that 
these genes contributed to a significant proportion of the genetic expression profile that 
shaped macrophage inflammatory responses in Palladium bead implanted zebrafish.  
Figure 18. Heatmap and hierarchal dendrogram of top 50 differentially 
expressed genes in Palladium bead implanted versus Control zebrafish. 
Genes described in oxidation-reduction process (blue text) and metal ion sensing/responses (red text) 
made up 11 out of top 50 differentially expressed genes. Values in heatmap were expressed as log fold 
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3.2.5. Differential expressed genes in macrophages isolated from Palladium 
bead implanted and U87 xenografted zebrafish revealed an inflammatory 
anti-tumour phenotype.  
Further analysis of macrophage expression data comparing Palladium bead im-
planted zebrafish with bead null U87 xenografted zebrafish depicts an anti-tumour inflamma-
tory profile in Palladium bead implanted zebrafish. Heatmap of the top 50 differentially ex-
pressed genes identified pro-tumoural inflammatory genes, sema4D, sox7 and apoc1 to be 
significantly expressed in U87 xenografted zebrafish and downregulated in Palladium bead 
implanted zebrafish (Figure 19). Both sema4D and sox7 are reported to be proangiogenic 
factors that promotes high-grade gliomas (Zhang et al., 2012, Sierra et al., 2008, Kim et al., 
2018). A three fold increase in sema4D and four folds increase in sox7 expression was rec-
orded in U87 xenografted zebrafish. Expression of sema4D and sox7 had both been linked 
to tumour associated macrophages (TAMs). TAMs were identified to be the main producers 
of sema4D in the tumour microenvironment and had been identified as novel immunothera-
peutic target for cancer (Sierra et al., 2008, Wu et al., 2016). In addition, increased sox7 ex-
pression had been implicated to increase TAM recruitment and metastasis. Thus the down 
regulation of these protumoural genes in Palladium bead implanted zebrafish would have 
significant impact on tumour progression.  
Differential analysis of Palladium bead versus U87 also indicated an increase in ex-
pression of genes associated with oxidative-reduction, stress tolerance, metal exposure and 
inflammation. The results here corroborate previous observations made in differential analysis 
of Palladium bead implanted versus Control zebrafish. The upregulation of hsp70l, hsp70.2 
and hsp 70.3 proteins from HSP70 family were identified in the top 50 differentially expressed 
genes when comparing Palladium versus U87 zebrafish. In addition, evidence for oxidative 
stress was reported as moxd1, porb, aoc2 and ahnak, genes in the oxidative-reduction pro-
cess, were all reported to be in the top 50 differentially expressed genes. An upregulation of 
ten folds for cxcl8b.1 was recorded (FDR<0.0001) however, no significant differential expres-




To gain further insight into the functional consequences of the differentially expressed 
genes in Palladium bead implanted versus U87 xenografted zebrafish, gene ontology enrich-
ment analysis was conducted. Gene ontology enrichment analysis of oxidation-reduction pro-
cess indicated an up regulation of the 28% of the 634 associated genes in Palladium bead 
implanted zebrafish. However it was not statistically significant with a reported FDR value of 
0.0964. The greatest enrichment of pathways was associated with calcium ion transmem-
brane transport, accounting for 30% of the statistically significant enriched pathways where 
FDR < 0.05 (Figure 20). ARF protein signal transduction was the second most enriched path-
ways accounting for 11% of the significantly differential expressed genes. (Figure 20). The 
pie chart diagram in Figure 20 lists all the enriched pathways categorised proportionately by 
the number of significantly differentially expressed genes in each gene ontology category. 
In conclusion, the combination of expression data from two distinct differential anal-
ysis (Palladium versus Control, Palladium versus U87) revealed different aspects of the ge-
netic expression profile of macrophages exposed to Palladium beads. Macrophage exposure 
to external environmental stressors like Palladium metal stimulates an enrichment of path-
ways that increased its ability to tolerate stress. This was evident by the upregulation of 
HSP70 family proteins critical in protein homeostasis, stress tolerance and metal responses 
(Murphy, 2013) in addition to the enrichment of oxidative-reductive pathways that were char-
acteristic of macrophages under cellular stress. This study also presented new evidence to 
indicate the possible involvement of neutrophils as increase cxcl8b.1 was detected. This, 
combined with the upregulation of classical inflammatory cytokine tnf-𝑎, and the downregu-
lation of anti-inflammatory cytokine, il-4, depicted a pro-inflammatory profile of macrophage. 
Altogether, RNA sequencing data revealed a complex web of interconnected network of sig-
nalling systems that led to the polarisation of macrophage genetic profile towards a proin-







Figure 19. Heatmap and hierarchal dendrogram of top 50 differentially ex-
pressed genes in Palladium bead implanted versus U87 Xenografted zebrafish. 
Expression data comparing Palladium bead implanted zebrafish with bead null U87 xenografted zebrafish 
depicts an anti-tumour inflammatory profile in Palladium bead implanted zebrafish. Pro-tumoural inflammatory 
genes, sema4D, sox7 and apoc1 are significantly expressed in U87 xenografted zebrafish and downregulated 
in Palladium bead implanted zebrafish Genes associated with oxidation-reduction process, moxd1, porb, aoc2 
and ahnak were all significantly expressd. The upregulation of hsp70l, hsp70.2 and hsp 70.3 proteins from 
HSP70 family were also identified in Palladium bead implanted zebrafish. Values in heatmap were expressed 
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Figure 20. Gene ontology enrichment analysis of differentially expressed 
genes of isolated macrophages from Palladium bead implanted versus U87 
xenografted zebrafish. 
Pie chart diagram lists all significantly (FDR < 0.05) enriched pathways categorised proportionately by the 
number of significantly differentially expressed genes in each gene ontology category. Enrichment of 
pathways associated to calcium ion transmembrane transport accounted to 30% of the statistically 
significant enriched pathways. ADP-ribosylation factors (ARF) signal transduction was the second most 
enriched pathways accounting for 11% of the significantly differential expressed genes. Gene ontology 
enrichment analysis of oxidation-reduction process indicated an up regulation of the 28% of the 634 
associated genes in Palladium bead implanted zebrafish. However it was not statistically significant with a 




3.3. Palladium and gold bead mediated anti-tumoral responses of mac-
rophages 
3.3.1. Gold triggered biorthogonal catalytic uncaging of fluorescent Rhoda-
mine 
The inherent anti-tumour effect of Palladium bead implantation made the Palladium 
bead incompatible for the development of biorthogonal catalytic chemotherapeutic assays in 
the zebrafish brain. Thus we explored the capability of another metal, Gold, as replacement 
for Palladium for the development of a robust biorthogonal catalytic drug delivery system. 
Gold has received enormous attention in recent years. Gold base products are safe to handle 
and has clinical applications in the treatment of rheumatoid arthritis (Pope et al., 2002). How-
ever, in chemistry, Gold is known for its catalytic properties and is able to mediate catalytic 
oxidative reactions at or below ambient temperature (Corma and Garcia, 2008, Stratakis and 
Figure 21. Gold bead catalyses prodye conversion to locally release fluorescent 
Rhodamine in the zebrafish brain. 
(A) Images from left to right showed GFP emission spectrum excited by 488 nm wavelenth laser and corresponding 
bright field images with white arrow indicating Gold bead. Images from top to bottom showed zebrafish embryos 
treated with 20 µM prodye precuror and 1% DMSO. The incubation of 20 µM prodye precursor for 24 hours resulted 
in a strong green fluorescent signal observable only in the gold bead implanted zebrafish larvae. All Images were 
captured using an Andor spinning disk confocal microscope with a 20X/NA 0.75 objective. Scale bars set at 100 
µm. Error bar indicated standard error. 
(B) Zebrafish treated with 20 µM Prodye precursor (n = 5) resulted in a significant increase in fluorescent intensity 
when compared to 1% DMSO (n = 3) treated zebrafish. Intensity values for each fish were expressed as a sum of 
intensity values of GFP signal. 






Garcia, 2012). These properties has made Gold an attractive target in the development of 
nanotherapeutics (Takale et al., 2014, Yeo et al., 2018). 
To investigate the chemical capabilities of gold as a catalyst to mediate prodrug ac-
tivation, we studied Gold beads’ catalytic properties to convert a nonfluorescent precursor 
into fluorescent Rhodamine in-vivo. We obtained Gold nanoparticles coated polystyrene 
beads and tested its catalytic properties and biocompatibility in the zebrafish. Gold beads 
were implanted into the brain of the wild type (WIK) zebrafish larvae and were treated with 
either 20 µM prodye precursor or 1% DMSO and imaged after 24 hours. The lipophilic prop-
erties of prodye precursor allows diffusion of the reagent in the media via ingestion or ab-
sorption via the skin and distribution systemically (Perez-Lopez et al., 2017). Under physio-
logical conditions the prodye precursor is catalytically converted by the gold bead into fluo-
rescent Rhodamine which is visible under excitation by 488 nm wavelength laser (Perez-
Lopez et al., 2017). This study was the first time biorthogonal organometallic reaction was 
tested locally in an in-vivo system in the zebrafish brain with Gold beads (Figure 21) (Perez-
Lopez et al., 2017). 
 The incubation of 20 µM prodye precursor for 24 hours resulted in a strong green 
fluorescent signal observable only in the Gold bead implanted zebrafish larvae (Figure 21A). 
An increase of approximately 4 fold in mean fluorescent intensity was observed in Gold bead 
implanted zebrafish (Figure 21B). The effect was statically significant, p < 0.0001, when com-
pared to DMSO controls (Figure 21B). This study confirms the local generation of Rhodamine 
and the compatibility of Gold beads as an in-vivo catalyst to convert prodrugs in 24 hours. 
To extend this study, we further investigate the sustained functionality of the Gold beads in 
vivo. Ultimately, we tested the durability of the Gold beads to mediate the sustained release 
of fluorescent Rhodamine in an in vivo zebrafish system over three additional days. 
 Zebrafish larvae were implanted with Gold beads and were either persistently or pulse 
treated with prodye. Pulse treatment of Au bead implanted zebrafish occurred from 0 days 




included to understand if the release of fluorescent Rhodamine was mediated by Gold catal-
ysis (Figure 6). The sustained treatment of Zebrafish larvae with precursor maintained a per-
sistent generation of fluorescent Rhodamine in the brain localized in the vicinity of the Gold 
bead (Figure 22A, Group A). This was reflected by a high level of detectable fluorescence for 
Figure 22. Gold bead mediated sustained released of fluorescent Rhodamine in the 
zebrafish brain.  
Gold beads were implanted into wild type (WIK) zebrafish and were persistently treated with 20 µM prodye Rhodamine 
precursor containing 1% DMSO (Group A) or were pulse treated from 0 to 1 day post transplantation (dpt) and 3 to 4 
dpt (Group B). Bead null wild type (WIK) zebrafish werepPulse treatment with 20 µM prodye Rhodamine cotaining 1% 
DMSO from 0 to 1 day post transplantation (dpt) and 3 to 4 dpt(Group C). The fluorescent intensity were relative to 
the sum of intensity of GFP signal of Gold bead implanted wild type (WIK) zebrafish treated with 1% DMSO. All Images 
were captured using an Andor spinning disk confocal microscope with a 20X/NA 0.75 objective. Scale bars set at 20 
µm. Error bars indicated standard error. Images from left to right are in chronological order showing a time-course 
study of the release of fluorescent Rhodamine over 4 days post bead transplantation (dpt). 
(A) Group A, sustained treatment with 20 µM prodye precursor maintained the persistent generation of fluorescent 
Rhodamine in the brain localized in the vicinity of the bead. Group B, pulse treatment with prodye precursor for 24 
hours resulted in the generation of fluorescent Rhodamine which decayed over 48 hours. Second pulse treatment, 
following a 48 hour recovery phase, restored fluorescent intensity of the Gold bead. Group C, the absence of Gold 
bead led to no detectable fluorescence. Thus Gold beads were required for the generation of fluorescent Rhodamine.  
(B) The decay in fluorescent intensity, after initial pulse treatment of 20 µM Precursor Rhodamine, led to a significant 
decrease (p = 0.0449) in fluorescent intensity from 4.73 ± 0.964 to 2.91 ± 0.745. Second pulse treatment, following a 
48 hour recovery phase, restored fluorescent intensity of the Gold bead from 2.91 ± 0.745 to 5.20 ± 0.839. One way 
ANOVA statistical analysis and Tukey’s multiple comparisons test were conducted to calulate p values. p values were 
indicated where statistically significant (p < 0.05). Error bar indicated standard error.  
  
Images adapted from Perez-Lopez et al., 2017 
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the duration of the study relative to negative controls (Figure 22B). However, initial pulse treat-
ment of prodye precursor for 24 hours resulted in the initial generation of fluorescent Rhoda-
mine which decayed over time. The decay in fluorescent intensity led to a significant decrease 
(p = 0.0449) in fluorescent intensity from 4.73 ± 0.964 to 2.91 ± 0.745 (Figure 22A, Group B). 
The decrease in fluorescence intensity was most likely due to the metabolic clearance or 
diffusion into surrounding tissues of fluorescent Rhodamine in the zebrafish brain. More im-
portantly, a second pulse treatment,  following a 48 hour recovery phase, restored fluorescent 
intensity of the Gold bead to 5.19 ± 0.839 (Figure 22A, Group B). In addition, it was confirmed 
that the increase in fluorescent signal was dependent on the presence of the Gold bead. In 
the absence of the Gold bead no fluorescent signal was detected (Figure 22A, Group C).  
 This study highlighted the chemical capability of Gold as a biorthogonal catalyst to 
locally deliver caged compounds in the brain in vivo. In addition, Gold mediated catalytic 
reaction was sustainable over longer periods up to three days for this study, and may last 
even longer. This highlighted the Gold bead resin’s durability in vivo and may have future 
applications in a chronic drug delivery systems. However, the biocompatibility of these Gold 
beads for in vivo applications remained in question. It was still unknown at this point if Gold 
bead implantation would elicit an immune or anti-tumour response in zebrafish previously 
observed in Palladium trials. The associated anti-tumour responses would make xenograft 
based caged drug trials, as attempted in Palladium studies, unfeasible. However, Gold had 
been proven to be biocompatible in humans and had wide applications in medical technolo-
gies ranging from dental implants to treatment of arthritis (Yeo et al., 2018). Thus, we hypoth-
esised that Gold beads did not stimulate an anti-tumour response in the zebrafish brain. We 
aimed to do so by implanting Gold beads into the brains of mpeg1:EGFP, U87-nls-mKate2 




3.3.2. Palladium and Gold beads mediated anti-tumoral responses in 
mpeg1:EGFP zebrafish 
 To investigate the anti-tumour effects of Gold bead implantation, we compared the 
anti-tumour effects of Gold bead implantation to Palladium and Naked beads. These beads 
were implanted into U87-nls-mKate2 xenografted mpeg1:EGFP zebrafish. Naked beads 
serves as a ‘foreign body’ control to study the immune and anti-tumour response of the pol-
ystyrene bead independent of Gold or Palladium metal. These beads were implanted into the 
zebrafish at 4 dpf and imaged at 0 day post bead transplantation (dpt),1 dpt and 3 dpt (See 






   
Figure 23. Macrophage anti-tumour responses is stimulated by palladium and gold 
bead implantation leading to decreased U87-nls-mKate2 cell counts. 
(A-D) Human derived Lv-cppt-IRES-nls-mKate2-opre transformed U87-nls-mKate2 cells (White) were xenografted 
into macrophage labelled (Green) mpeg1:EGFP zebrafish (3 dpf). Xenografted zebrafish were implanted with 
Palladium bead transplantation at 4 dpf or 0 dpt. Images from left to right are in chronological order showing 0 and 
3 day post bead transplantation (dpt) of palladium bead into the zebrafish brain. Images from top to bottom showing: 
(A-D) The implantation of naked beads inhibited the increase in U87-nls-mKate2 cell number observed in bead null 
control zebrafish. The implantation of Gold and Palladium beads resulted in a decrease in glioma cell mass by 3 dpt. 
Brightfield images on the bottom right corner of each A’-D’ images and are representative of the orientation and 
imaging field of the fluorescent images. All Images were captured using an Andor spinning disk confocal microscope 
with a 20X/NA 0.75 objective. Scale bars set at 20 um.  
(E) U87-nls-mKate2 cell numbers were expressed as a ratio calculated by the number of cells at 1 or 3 dpt divided 
by the number of cells at 0 dpt. Zebrafish only xenografted with U87-nls-mKate2 (No bead) showed an increase in 
U87-nls-mKate2 cell number by 1.3 folds. Zebrafish implanted with Naked beads showed a decrease in U87-nls-
mKate2 cell count by 10%. Whereas, the implantation of Palladium or Gold bead significantly (p = 0.0001) decreased 
U87-nls-mKate2 cell count by 80% at 3 dpt. 
(F) Gold and palladium bead implanted zebrafish showed an 80% decrease in U87-nls-mKate2 cell count at 3 dpt 
when compared to Naked bead implanted zebrafish and no bead zebrafish controls (p<0.0001). Zebrafish without 
any bead showed an increase of 1.3 fold in U87-nls-mKate cell count by 3 dpt showing engraftment and proliferation 
of U87-nls-mKate2 cells. Naked bead showed no significant increase in U87-nls-mKate2 cells and a trend to indicate 
that the U87-nls-mKate2 cells were not proliferating.  
(G) Macrophage intensity are expressed as a ratio calculated by the sum of fluorescent pixel value of macrophage 
mpeg1:GFP labelled cells at 1 or 3 dpt divided by 0 dpt. Gold and Palladium bead implanted zebrafish showed 
highest levels of macrophage intensity values. A six fold increase in macrophage intensity was evident 1 dpt and the 
level of macrophage remains heightened for the duration of the experiment holding at a four fold increase at 3 dpt. 
Zebrafish implanted with naked beads showed an initial spike in macrophage levels by about four folds which 
recovered to bead null control levels at 3 dpt. Zebrafish without any beads showed a gradual developmental increase 
of macrophage levels from 0 to 3 dpt or 4 to 7 dpf. 
(H) Palladium bead implantation into the zebrafish brain results in high toxicity and poor zebrafish survival. Only 33% 
of the zebrafish implanted with palladium bead survive the treatment. Naked bead and Gold bead showed no bead 
associated toxicity as the survival rates are identical to no bead control zebrafish.  
One way ANOVA statistical analysis and Tukey’s multiple comparisons test were conducted to calulate p values. p 






As previously reported, bead null control mpeg1:EGFP zebrafish showed a 1.3 fold 
increase in cell number which indicated the engraftment and proliferation of U87-nls-mKate2 
cells in the zebrafish brain (Figure 23A-B). In addition, a developmental increase of macro-
phage intensity levels by 2 fold was observed over the course of the experiment for bead null 
controls (Figure 23G) (Xu et al., 2015). The implantation of naked beads attenuated the in-
crease in U87-nls-mKate2 cell number observed in bead null control zebrafish (Figure 23E-
F). This coincided with an increase in macrophage intensity levels by 4.5 fold (p < 0.0001) at 
1 dpt but recovered to control levels at 3 dpt (Figure 23G). This indicated that the injury and 
introduction of a foreign body in Naked bead implantations did elicit a degree of inhibitory 
effects on U87-nls-mKate2 cell proliferation. Nonetheless, when comparing Naked bead to 
Palladium and Gold bead implanted zebrafish, the inhibitory effect on U87-nls mKate2 sur-
vival and proliferative capability were only minor but was statically significant when compared 
to bead null controls at 3 dpt (p < 0.0001) (Figure 23C-C’,4D-D’). Implantation of both Palla-
dium and Gold bead implanted zebrafish resulted in a significant (p < 0.001) decrease of 80% 
in U87-nls-mKate2 cell count by 3 dpt (Figure 23E-F). In addition, a potent macrophage re-
sponse to Palladium and Gold bead was observed. Both Gold and Palladium bead implanta-
tion increased macrophage intensity values six fold at 1 dpt and the effects persisted up to 
four fold at 3 dpt (Figure 23G). When compared to Naked beads, the implantation of Gold and 
Palladium bead led to significantly elevated macrophage levels in the zebrafish brain for the 
duration of the experiment (Figure 23G). Although, in the context of anti-tumour responses, 
the effects that Gold and Palladium induced were mirrored, the survival rates of Palladium 
bead implanted zebrafish were very different. Palladium bead implantation proved to be very 
toxic to the zebrafish (Figure 23F). Only one third of the zebrafish population implanted with 
Palladium beads survived the study by 3 dpt (Figure 23F). 
In conclusion, Gold bead implantation resulted in the inhibition of U87-nls-mKate2 
cell proliferation and decreased U87-nls-mKate2 cell survival; the effects were similar to Pal-
ladium bead implanted zebrafish. While on the other hand Naked bead implantation inhibited 




survive in the zebrafish brain. The decrease in U87-nls-mKate2 cell proliferation and cell sur-
vival coincided with increased macrophage intensities only at 1 dpt. Macrophage intensities 
returned to basal level by 3 dpt. Macrophage intensities for Palladium and Gold bead im-
planted zebrafish remained elevated at 3 dpt when compared to Bead null and Naked bead 
zebrafish. This implied that Palladium and Gold bead implantation elicited an anti-tumour re-
sponse that was mediated by macrophages in the zebrafish brain. In addition, it was evident 
that Palladium bead implantation into the zebrafish was toxic, an effect not observed in Gold 
bead implantation. This highlighted the biocompatibility of Gold in biological systems. Despite 
this, the anti-cancer phenotype rendered Gold bead incompatible for the development of an 
in vivo biorthogonal catalytic cancer drug screen system in the zebrafish brain. Nevertheless, 
the discovery that Palladium and Gold bead implantation initiated an anti-tumour responses 
in the zebrafish brain, warranted further investigation. Thus further investigation was con-
ducted to elucidate the underlying mechanisms that dictated the anti-tumour milieu estab-
lished by Gold bead implantation. We speculated that Gold bead implantation, similar to Pal-
ladium bead implantation, initiated an indirect effect on U87 cells mediated by macrophages 
to elicit an anti-tumour effect. Thus, we hypothesised that macrophages contributed to Gold 
bead mediated anti-tumour responses.  
 
3.3.3. Implantation of Palladium and Gold beads in the zebrafish brain did not 
cause aberrant necrosis in surrounding tissue.  
To address if U87 cell death were the direct or indirect consequences of Palladium 
and Gold bead implantation, the necrotic effects of Palladium, Gold and Naked bead implan-
tation in the surrounding tissue were investigated. We contrasted the effects of Gold and 
Palladium bead implantation on Propidium iodide staining to understand if Gold bead implan-
tation elicited similar effects as observed previously in Palladium bead implanted zebrafish. 
Propidium iodide was applied to the zebrafish media solution of Palladium, Gold, Naked and 





The implantation of Gold resulted in an increase in propidium iodide labelling when 
compared to injured zebrafish (Figure 24.) Similar to Naked and Palladium beads, the implan-
tation of Gold bead led to Propidium iodide staining localizing at the site of incision and vi-
cinity of the beads (Figure 24A, Red Cicles). Gold (p = 0.0004) and Palladium (p = 0.0008)  
bead implantation elicited similar increase (three fold) in the number of propidium iodide la-
belled nuclei. The recovery and clearance of propidium iodide nuclei cells was evident by 1 
dpt in all bead implanted zebrafish (Figure 24A). However, Gold bead implanted zebrafish 
also showed slower recovery to injury control levels when compared to Naked bead im-
planted zebrafish (Figure 24D). The rate at which propidium iodide labelling were being 
cleared in Gold bead implanted zebrafish mirrored that of Palladium bead implanted 
zebrafish. At 1 dpt, both Gold and Palladium bead implanted zebrafish showed a 60% de-
crease in propidium iodide labelled cells while propidium iodide labelling in Naked bead im-
planted zebrafish returned to injury control levels. However, by 3 dpt, propidium iodide label-
ling in Gold and Palladium bead implanted zebrafish returned to injury control levels. A 60% 
decrease in propidium iodide labelled cells was observed by 1 dpt for Gold and Palladium 
bead implanted zebrafish. In addition, by 3 dpt, the decrease of propidium iodide labelling to 
injury control levels was recorded for all bead implanted zebrafish (Figure 24B). This indicated 






Figure 24. Implantation of Gold, Palladium and Naked beads did not initiate 
aberrant necrosis in the zebrafish brain. 
(A) Images from rows top to bottom, mpo:EGFP zebrafish, 4 days post fertilized (dpf), were implanted with Gold, 
Palladium and Naked beads. Red circles in the images denote the boundary of the implanted beads. Injured 
zebrafish underwent the same bead implantation procedure where a naked bead was inserted but was removed 
immediately. Zebrafish were treated with 1 µg/ml propidium iodide in embryo media throughout the experiment. 
Images from left to right, time lapse imaging indicated that high level of propidium iodide necrotic cell labelling 
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In conclusion, Gold bead implantation did not cause aberrant cellular necrosis. Both 
Gold and Palladium bead implantation displayed identical levels of propidium labelling over 
3 days of experimentation. We observed the clearance of necrotic cell bodies by 3 dpt for all 
bead implanted zebrafish and no new development of additional necrotic cell bodies were 
detected. Therefore, as in Palladium bead implanted zebrafish, the anti-tumour effects of 
Gold bead implantation were not a direct reaction to solidly supported Gold nanoparticles on 
the bead. These results support the hypothesis that macrophages contributed to Gold bead 
mediated anti-tumour phenotype in the zebrafish brain. 
  
implantation at 0 day post transplantation (dpt). A clearance of propidium iodide labelling was evident by 3 
dpt for all bead implanted zebrafish. All Images were captured using an Andor spinning disk confocal 
microscope with a 20X/NA 0.75 objective. Scale bars set at 50µm. 
(B) Gold, Palladium and Naked bead implantation induced an increase in the number of propidium iodide 
labelling at 0 dpt when compared to injured controls. Clearance of propidium iodide labelling occurred within 
24 hours. Although, Gold and Palladium showed slower recovery. Propidium iodide labeling returned to 
injury control levels by 3 dpt indicating clearance of necrotic cells and recovery from initial bead implantation 
procedure.  
(C) Gold (p = 0.0004) and Palladium (p = 0.0008) showed significantly higher number of propidium iodide 
labelled cells at 0 dpt. Although not statically significant (p = 0.0896), a trend inidicates that the implatation 
of Naked bead increased propidium iodide cell labelling at 0 dpt. 
(D) Gold and Palladium bead implanted zebrafish show significantly slower recovery from bead implantation 
procedure. Elevated propidium iodidie labelling was recorded at 1 dpt for Gold and Palladium implanted 
zebrafish when compared to both injury controls and naked bead implanted zebrafish.  
One way ANOVA statistical analysis and Tukey’s multiple comparisons test were conducted to calulate p 





3.4. TLR receptor family mediates anti-tumour responses in Gold bead 
implanted zebrafish.  
Macrophages can undergo significant phenotypic changes in response to molecular 
signals from their environment (Biswas et al., 2013). The biological effects of various disas-
sociated nanoparticles on macrophage polarization has been reviewed recently (Reichel et 
al., 2019) and in some cases a strong anti-tumour immunological response was initiated 
(Bastus et al., 2009b, Zanganeh et al., 2016). The degree of macrophage polarization is highly 
dependent on the nanoparticle composition and size (Reichel et al., 2019). In this study, Pal-
ladium and Gold nanoparticles were solidly supported within a polyethylene glycol (PEG)-
grafted low cross linked polystyrene matrix and not dissociated (Perez-Lopez et al., 2017). 
Macrophages were observed to form intimate interactions on the surface of Palladium and 
Gold beads (Figure 23D’). In addition, we showed macrophage numbers increased as a result 
of Palladium and Gold bead implantation (Figure 23G). Thus, there was strong evidence for 
the formation of intimate interactions of macrophages with Gold and Palladium beads. The 
effects of these interactions between macrophages and either Gold or Palladium have been 
previously reported (Bastus et al., 2009a, Reichel et al., 2019, Schmidt and Goebeler, 2015). 
The internalization of Gold nanoparticles by macrophages has been shown to induce a pro-
inflammatory response of macrophages that increased tnf-𝑎, and il-1β secretion (Bastus et 
al., 2009a). The increase in tnf-𝑎, and il-1β secretion was mediated by a pattern recognition 
receptor called tlr-4 (Bastus et al., 2009a). Similarly, Palladium metal had also been shown to 
interact with tlr-4 receptor to initiate proinflammatory gene expression of tnf-𝑎 and il-8 in mice 
(Schmidt and Goebeler, 2015). Thus there was increasing evidence to support for tlr-4 func-
tion in Palladium or Gold bead induced anti-tumour effects of macrophages. In support, we 
recorded increased cxcl8b.1 and tnf-𝑎 expression in RNA sequencing data set of Palladium 
bead implanted.  
Although the TLR protein family is conserved between mammals and teleost fish, it 
is well reported that TLR signalling pathways in the zebrafish differs in feature than those in 




the development of isoforms of tlr-4 (tlr4ba/tlr4bb), tlr5 (tlr5a/tlr5b) and tlr8 (tlr8a/tlr8b) (Li et 
al., 2017). In addition, zebrafish tlr4 does not respond to LPS stimulation unlike it’s mamma-
lian counterpart (Li et al., 2017). Nonetheless, tlr4 signalling mediates only a part of the whole 
TLR family pathway which constitutes a whole host of receptors, tlr1-11 and tlr13, that are 
capable of upregulating tnf-𝑎 and cxcl8b.1 expression. Therefore, a more generalized ap-
proach was taken to elucidate the contribution of TLR family signalling, instead of just tlr4, in 
mediating Palladium/Gold bead induced anti-tumour effects of macrophages. 
RNA sequencing of macrophages isolated from Palladium bead implanted zebrafish 
indeed was an invaluable insight into the underlying mechanisms that mediated the anti-tu-
mour phenotype. By combining evidence from the literature and RNA sequencing data, we 
hypothesis that the TLR receptor family in macrophages play a key role in mediating the ob-
served anti-tumour response in Palladium and Gold bead implanted zebrafish. This hypothe-
sis was formed based on key evidence that indicated an increase in tnf-𝑎 and cxcl8b.1 ex-
pression in macrophages of Palladium bead implanted zebrafish.  
 
3.4.1. RT-qPCR confirms upregulation of cxcl8b.1 and tnf-𝑎 expression in Pal-
ladium and Gold bead implanted zebrafish. 
Reverse transcription quantitative PCR was conducted in order to confirm upregula-
tion of cxcl8b.1 and tnf-𝑎 in Palladium and Gold bead implanted zebrafish compared to Naked 
bead implanted zebrafish. In addition, we investigated the expression of other classically in-
flammatory genes, il-4, tgfβ1-a and il1-β	 . Macrophages were isolated from mpeg1:EGFP, 
U87-nls-mKate2 xenografted zebrafish implanted with Palladium, Gold or Naked beads. The 
relative fold change for each condition was calculated using the delta-delta CT method for 
each gene of interest using beta-actin as the reference gene. Final delta-delta CT fold change 
for each condition was normalised to the expression of each gene of interest in Naked bead 
implanted zebrafish. Zebrafish implanted with Naked beads served as an ideal control as any 
measurable genetic alterations could be attributed to Gold and Palladium nanoparticles sol-






Reverse transcription quantitative PCR confirmed the upregulation of proinflammatory 
cytokines cxcl8b.1 and tnf-𝑎 in Palladium and Gold bead implanted zebrafish. In agreement 
with RNA sequencing expression data set, a 3.5 fold increase in tnf-𝑎 expression was recorded 
in Palladium (p = 0.0003) and Gold (p = 0.0658) bead implanted zebrafish (Figure 25). The 
upregulation of cxcl8b.1 in Palladium and Gold bead implanted zebrafish by six folds (p = 
0.050) and three folds (p = 0.0011) was recorded respectively. No significant difference in 







































Figure 25. RT-qPCR confirms upregulation of cxcl8b.1, tnf-𝑎 and il-1β expres-
sion in Palladium and Gold bead implanted zebrafish. 
Timeline (Blue arrows) illustrates workflow for qPCR experiment described here. RT-qPCR of each gene of 
interest (tnf-a, cxcl8b.1 il-4, tgfβ1-a and il-1β) were conducted on macrophages isolated from 5 day post 
fertilised, U87-nls-mKate xenografted, mpeg1:EGFP zebrafish implanted with either Palladium, Gold or Naked 
Beads. mpeg1:EGFP zebrafish were xenografted with U87-nls-mKate2 at 3 dpf. Bead implantation procedure 
occurred 24 hours after xenograft at 4 dpf. The relative fold change for each condition was calculated using the 
delta-delta CT method for each gene of interest using beta-actin as the reference gene. Final delta-delta CT fold 
change for Gold and Palladium bead implanted zebrafish were normalised to the expression of each gene of 
interest in Naked beads implanted zebrafish (Dotted horizontal line, Naked Beads). Two-tailed student t-test 
was conducted comparing each gene of interest to Naked bead implanted zebrafish. Macrophage were isolated 
from homogenised brain tissue from 200 embryo (n) for each biological replicates (N). One way ANOVA statistical 
analysis and Tukey’s multiple comparisons test were conducted to calulate p values. p values were indicated 
where statistically significant (p < 0.05). Error bar indicated standard error.  
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significant upregulation of a potent inflammatory cytokine, il-1β, by 2 folds was recorded only 
in Palladium bead implanted zebrafish. Thus altogether, the increase in tnf-𝑎, cxcl8b.1 and il-
1β supports the hypothesis that TLR family signaling play a key role in mediating the observed 
anti-tumour response in Palladium and Gold bead implanted zebrafish.  
 
3.4.2. IRAK-4-IN-1 Pharmacological inhibition of TLR family signalling de-
creases tnf-𝑎 and cxcl8b.1 expression. 
In order to elucidate the level of contribution of TLR family signalling on tnf-𝑎 and 
cxcl8b.1 expression in vivo, pharmacological inhibition of TLR signalling was employed using 
commercially available pharmacological inhibitor IRAK4-IN-1. IRAK4-IN-1 is a selective inhib-
itor of Interleukin-1 receptor associated kinase 4 (IRAK4) with a reported IC50 of 7 nM in-vitro 
and high bioavailability in-vivo (Smith et al., 2017). IRAK4 plays a critical role in mediating TLR 
signal transduction and innate immune responses (Gimenez et al., 2019). Ligand binding to 
TLR on the extracellular domain leads to the dimerization of TLRs which recruits and activate 
cytosolic adaptor proteins such as MyD88 that recruits IL-1 receptor associated kinase 4 
(IRAK-4) to activate MAP kinases and nuclear factor (NF)-ⲕB. Prior to in vivo experiments, we 
first confirmed IRAK4-IN-1 inhibitor efficacy in zebrafish by reverse transcription qPCR. 
Zebrafish embryos were implanted with Palladium beads and either treated with 10 µM 
IRAK4-IN-1 or 1% DMSO. The aim of this experiment was to confirm IRAK4-IN-1 inhibitor 
efficacy in zebrafish thus Palladium bead implantation was sufficient for this study. Reverse 
transcription qPCR of macrophages isolated from Palladium bead implanted zebrafish 
treated with 10 µM IRAK4-IN-1 inhibitor showed significantly downregulated expression of 
tnf-𝑎 , cxcl8b.1 and il-4 compared DMSO treated Palladium bead implanted zebrafish. The 
relative fold change for each gene of interest was normalised to Palladium bead implanted 
DMSO controls. A 70% decrease in tnf-𝑎 (p<0.0001) and cxcl8b.1 (p = 0.0017) expression 
was recorded in IRAK4-IN-1 treated zebrafish. While a 50% (p < 0.0001) decrease in il-4 




orded as a result of treatment with 10 µM IRAK4-IN-1 inhibitor. Although no significant de-
crease in il-1β expression levels was recorded, the downregulation of tnf-𝑎 and cxcl8b.1, both 
key downstream genes of TLR activity, confirms the efficacy of IRAK4-IN-1 inhibitor for the 
first time in an in-vivo zebrafish model. It also validated the contribution of TLR signal trans-
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Figure 26. IRAK-4-IN-1 pharmacological inhibition of TLR family signalling de-
creases tnf-𝑎, cxcl8b.1 and il-4 expression. 
Timeline (Blue arrows) illustrates workflow for qPCR experiment described here. RT-qPCR of each gene of 
interest (tnf-a, cxcl8b.1 il-4, tgfβ1-a and il-1β) were conducted on macrophages isolated from 5 day post 
fertilised (dpf), Palladium bead implanted, U87-nls-mKate xenografted, mpeg1:EGFP zebrafish treated with 
either 1% DMSO or 10 µM IRAK4-IN-1 inhibitor. mpeg1:EGFP zebrafish were xenografted with U87-nls-
mKate2 at 3 dpf. Bead implantation procedure occurred 24 hours after xenograft at 4 dpf. Zebrafish were 
treated with either 1% DMSO or 10 µM IRAK4-IN-1 for 24 hours between 4 dpf and 5 dpf. The relative fold 
change for each condition was calculated using the delta-delta CT method for each gene of interest using 
beta-actin as the reference gene. Final delta-delta CT fold change for IRAK4-IN-1 treated Palladium bead 
implanted zebrafish were normalised to the expression of each gene of interest in DMSO treated Palladium 
bead implanted zebrafish (Dotted horizontal line, Palladium bead 1% DMSA). Two-tailed student t-test was 
conducted comparing each gene of interest to DMSO treated zebrafish. Macrophage were isolated from 
homogenised brain tissue from 200 embryo (n) for each biological replicates (N). One way ANOVA statistical 
analysis and Tukey’s multiple comparisons test were conducted to calulate p values. p values were indicated 
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3.4.3. Pharmacological inhibition of TLR signalling promotes U87 cell survival 
in Gold bead implanted zebrafish. 
To elucidate if TLR signalling contributed to the overall macrophage mediated anti-
tumour phenotype observed in Palladium and Gold bead implanted zebrafish, the effects of 
TLR inhibition on U87 survival was investigated in vivo. mpeg1:EGFP zebrafish implanted with 
Gold, Palladium and Naked beads were either treated with 1% DMSO or 10 µM IRAK4-IN-1 
inhibitor. The effect on U87-nls-mKate2 survival was assessed for each condition as a meas-
ure for anti-tumour efficacy. We hypothesised that the inhibition of TLR signalling in the anti-
tumour phenotype would promote U87 cell survival in the zebrafish brain. 
First, it was established that IRAK4-IN-1 did not directly affect U87-nls-mKate2 sur-
vival. To do so, bead null U87-nls-mKate2 xenografted zebrafish were treated with 10 µM 
IRAK4-IN-1. The results showed that IRAK4-IN-1(10 µM) had no direct effect on U87-nls-
mKate2 cellular growth. Both DMSO and IRAK4-IN-1 treated, bead null, zebrafish conditions 
indicated identical growth rates up to 3 days post transplantation (dpt) (Figure 27A). An aver-
age increase of 30% in cell number was recorded for both IRAK4-IN-1 treated and DMSO 
bead null zebrafish conditions. Similarly, 10 µM IRAK4-IN-1 treatment of Naked Bead im-
planted zebrafish indicated no significant alterations in U87-nls-mKate2 cellular growth (Fig-
ure 27B) when compared to DMSO treated counterpart. Naked bead implanted led to an 
impairment of U87-nls-mKate2 proliferation but not its ability to survive in the zebrafish brain. 
No significant increase in U87-nls-mKate2 cell number was recorded for both DMSO and 
IRAK4-IN-1 treated Naked bead implanted zebrafish over the course of the experiment (Fig-
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Figure 27. Pharmacological inhibition of IRAK4 promotes U87 cell survival in Gold 
bead implanted zebrafish. 
Timeline (Blue arrows) illustrates workflow for in vivo IRAK4-IN-1 inhibitor experiments described here. mpeg1:EGFP 
zebrafish were xenografted with U87-nls-mKate2 at 3 day post fertilisation (dpf) and implanted with Gold, Palladium 
or Naked Bead at 4 dpf. Bead implanted and U87-nls-mKate2 xenografted zebrafish were treated with either 1% 
DMSO or 10 µM IRAK4-IN-1 for the duration of the experiment from 4 dpf to 7 dpf (0 dpt to 3 dpt). U87-nls-mKate2 
cell numbers were expressed as a ratio calculated by the number of cells at 1 or 3 dpt divided by the number of cells 
at 0 dpt. Two-tailed student t-test was conducted comparing the average cell number for each condition on each 
day. p values were shown for significant results (p<0.05) Standard error was plotted for all error bars in all graphs.  
(A) No effect on U87-nls-mKate2 cell survival was recorded following IRAK4-IN-1 inhibitor treatment. Both DMSO 
and IRAK4-IN-1 treated, bead null, zebrafish conditions indicated identical growth rates up to 3 days post 
transplantation (dpt) 
(B) Naked bead implanted led to an impairment of U87-nls-mKate2 proliferation but not its ability to survive in the 
zebrafish brain. No significant increase in U87-nls-mKate2 cell number was recorded for both DMSO and IRAK4-IN-
1 treated Naked bead implanted zebrafish over the course of the experiment 
(C) Inhbiton of TLR signalling had no significant effect on U87-nls-mKate cell survival. A significant decrease of 60% 
in U87-nls-mKate2 cell count for both DMSO and IRAK4-IN-1 treated conditions was evident by 3 dpt. 
(D) IRAK4-IN-1 treatment in Gold bead implanted zebrafish promoted the survival of U87-nls-mKate2 (p = 0.012). A 






Intriguingly, no significant effect on U87-nls-mKate cell survival was evident in IRAK4-
IN-1 treated Palladium bead implanted zebrafish. Similar to results described previously, the 
implantation of Palladium bead led to a significant decrease in U87-nls-Kate2 cell count (Fig-
ure 27C). A significant decrease in U87-nls-mKate2 cell count for both DMSO and IRAK4-IN-
1 treated conditions was evident by 3 dpt (Figure 27C). A decrease of 60% in U87-nls-mKate2 
cell count was evident by 3 dpt for both DMSO and IRAK4-IN-1 treated conditions (Figure 
27C). It is important to note that the implantation of Palladium bead in addition to IRAK4-IN-
1 drug treatment was extremely detrimental to zebrafish survival. The implantation of Palla-
dium bead led to a 33% survival rate compared to 98% in Gold bead implanted zebrafish 
(Figure 23H). The additional treatment with IRAK4-IN-1 inhibitor led to poor survival rates 
(results not shown) of Palladium bead implanted zebrafish below that of 33% threshold. This 
was evident by the low n number (n = 6) illustrated in Figure 27C. Thus this may rationalise 
the results where IRAK4-IN-1 treatment in Palladium bead implanted zebrafish had no effect 
in promoting U87-nls-mKate2 cell survival.  
In contrast, IRAK4-IN-1 treatment in Gold bead implanted zebrafish promoted the 
survival of U87-nls-mKate2 (p = 0.012). A 40% increase in U87-nls-mKate2 cell count was 
recorded when compared to DMSO treated Gold implanted zebrafish (Figure 27D). However, 
the treatment with IRAK4-IN-1 in Gold bead implanted zebrafish only elicited a partial recov-
ery of U87-nls-mKate2 cell number. U87-nls-mKate2 cell count in IRAK4-IN-1 treated Gold 
bead implanted zebrafish at 3 dpt (0.603 ± 0.0938) was at a level half that of bead null im-
planted zebrafish (1.50 ± 0.0775). Despite this, the rescue of U87-nls-mKate2 survival in Gold 
bead implanted zebrafish (0.603 ± 0.0938) was comparable to cell ratios recorded in Naked 
Bead (0.781 ± 0.197) implanted zebrafish at 3 dpt. Thus this indicated that there may be 
additional signalling pathways, outside of TLR family, that form part of the anti-tumour phe-
notype.  
In conclusion, TLR signalling did indeed contribute to macrophage mediated anti-
tumour phenotype. The results here indicated that TLR signalling consisted part of the regu-




bead implanted zebrafish. A partial recovery of U87-nls-mKate2 cell number in IRAK4-IN-1 
treated Gold bead implanted zebrafish was recorded. This highlighted additional unknown 
mechanisms, outside TLR signalling, that may have contributed to Naked bead mediated im-
pairment of U87-nls-mKate2 cell proliferation. Nonetheless, TLR receptor family in macro-






3.5. Investigating the role of tnf-𝑎 and cxcl8b.1 in the anti-tumour re-
sponses of macrophages and neutrophils using CRIPSR-Cas9 and 
genetic transgenesis overexpression strategies. 
In conjunction with the NC3Rs (National Centre for the Replacement, Refinement and 
Reduction of Animals in Research), further refinement of future experiments were conducted 
due to the innate toxicity of Palladium bead implantation. Gold bead implantation was now 
well established to initiate an anti-tumour response. Results from RT-qPCR studies had 
demonstrated that Gold bead implantation, like Palladium bead, stimulated increased tnf-𝑎 
and cxcl8b.1 expression. In addition, it was confirmed that TLR signalling in Gold bead im-
planted zebrafish, not in Palladium bead implanted zebrafish, significantly contributed to 
macrophage mediated anti-tumour responses. However, one key benefit that separated Gold 
bead from Palladium bead was lower bead toxicity. The survival rates for Gold bead implanted 
zebrafish was significant higher than Palladium bead implanted zebrafish; 98% vs 33%. In 
fact, survival rates in Gold bead implanted zebrafish were comparable to that of Naked bead 
implanted and bead null zebrafish (Figure 23H). Therefore, the refinement of future experi-
ments excluded Palladium bead implantation in order to reduce animal numbers and to refine 
the care of animals to keep suffering to a minimum. 
The results thus far concluded that TLR family signalling was an important signal 
transduction pathway that mediated Gold bead induced anti-tumour phenotype in macro-
phages. However, the exact genetic effector of TLR family activation had not been identified. 
Based on key evidence from the literature and from previous RT-qPCR results, it was well 
established that TLR signalling regulated the expression of pro-inflammatory cytokines tnf-a 
and cxcl8b.1. The upregulation of cxcl8b.1 is known to be a potent chemoattract for neutro-
phils (Manfroi et al., 2017). It is widely accepted that macrophages regulate site specific re-
cruitment of neutrophil to facilitate the inflammatory response (Kim and Luster, 2015). As a 
result, future experimental design also explored the contribution of neutrophils to Gold in-
duced anti-tumour effects. Thus, we hypothesised that Gold bead implantation recruited neu-
trophils into the zebrafish brain and that the expression of tnf-a and cxcl8b.1 in macrophages 




In order to test this, a set of experiments combining CRISPR-cas9 knock out and genetic 
overexpression strategies were employed. These experiments aimed to evaluate the effects 
of tnf-𝑎 and cxcl8b.1 expression in macrophages on the dynamics of anti-tumour responses 
of both macrophages and neutrophils in the zebrafish brain. 
 
3.5.1. Implantation of Gold beads recruit neutrophils into the zebrafish brain. 
In order to test if Gold bead implantation did indeed recruit neutrophils into the brain 
of the zebrafish, mpo:EGFP zebrafish were xenografted with U87-nls-mKate at 3 dpf and 
were implanted with Naked and Gold beads at 4 dpf. Myeloperoxidase (MPO) is a neutrophil 
specific promoter that drives EGFP expression in mpo:EGFP zebrafish. The effects on neu-
trophil recruitment after bead implantation were subsequently studied at 0,1 and 3 dpt.  
Neutrophils are an important cell type of the innate immune system. They rapidly 
migrate to tissue in response to injury or infection and are one of the first responders of the 
immune system (Kim and Luster, 2015). Thus it was unsurprising that the implantation of 
Naked and Gold bead led to the recruitment of neutrophils into the brain. When compared to 
bead null zebrafish, both Naked and Gold bead implanted mpo:EGFP zebrafish showed in-
creased neutrophil infiltration into the brain at 1 and 3 dpt (Figure 28). However, the results 
indicated that Gold bead implanted zebrafish recruited more neutrophils into the brain of the 
zebrafish than Naked bead implanted. At 1 dpt, an average of 13.2 ± 1.27 neutrophils were 
present in Gold bead implanted zebrafish versus an average of 7.00 ± 1.43 neutrophils in 
Naked bead implanted zebrafish (p = 0.0026) (Figure 28D’). Similar to macrophages, neutro-
phils were observed to localized in the vicinity of the beads in Gold implanted zebrafish (Figure 
28C’). However, by 3 dpt neutrophil level in Gold bead implanted zebrafish recovered to the 
same level as Naked bead implanted zebrafish (6.76 ± 0.633 versus 7.17 ±  1.96) (Figure 
28D’’). In addition, neutrophil numbers in the brain of both Gold and Naked bead implanted 
zebrafish remained significantly (p < 0.05) elevated for the duration of the experiment up to 3 
dpt when compared to bead null zebrafish (Figure 28D’’). This indicated that the Naked bead 




of the experiment. Thus this may indicate two distinct neutrophil recruitment events occurring 
with the first, a reaction to the foreign body (polystyrene bead) and the second, a reaction to 
Gold nanoparticles solidly supported on the beads. These results here conclude that Gold 
bead implantation recruited higher number of neutrophils than Naked bead but only at 1 dpt.  
Establishing that neutrophil infiltrated the brain as a result of Gold bead implantation 
was an important step forward in this study. It confirmed the hypothesis that neutrophils in-
filtrated the brain following Gold bead implantation, hypothesis postulated based on results 
from previous RT-qPCR studies. The increase in Gold bead induced neutrophil recruitment, 
at 1 dpt, coincided with a six folds increase in cxcl8b.1 and three folds increase in tnf-𝑎 ex-
pression in macrophages of Gold bead implanted zebrafish. The timeline of experiments for 
both in-vivo and RT-qPCR studies were aligned as RNA extraction from macrophages of Gold 
bead implanted zebrafish both occurred at 1 dpt. This solidified support for the key role of 
tnf-𝑎 and cxcl8b.1 expression in mediating the anti-tumour response of macrophages and 
neutrophils. The neutrophil study drove a paradigm shift that included both macrophages and 
neutrophils as a contributing factor in mediating Gold bead induced anti-tumour responses. 
Studies have shown that both macrophages and neutrophils had been identified to be im-
portant effector cells of the anti-tumour effect (Fridlender et al., 2009, Reichel et al., 2019). 
Thus it was important to investigate how tnf-a and cxcl8b.1 expression in macrophages in-
fluenced the dynamics of intercellular interactions that regulated the anti-tumour effect of 
these innate immune cells. We hypothesized that cxcl8b.1 and tnf-a expression in macro-
phages were important genetic mediators of Gold bead implantation that facilitated the anti-






Figure 28. Gold bead implantation promoted neutrophil infiltration at 1 day post 
transplantation in the zebrafish brain. 
(A-C) The implantation of Gold bead led to increase neutrophil infiltration into the brain at 1 dpt. Both Naked and 
Gold bead showed increased neutrophil recruitment when compared to bead null control zebrafish. Human derived 
Lv-cppt-IRES-nls-mKate2-opre transformed U87-nls-mKate2 cells (not shown) were xenografted into neutrophil 
labelled (Green), 3 days post fertilized (dpf), mpo:EGFP zebrafish. Following a 24 hour recovery phase, xenografted 
zebrafish were implanted with Gold or Naked bead. Images from left to right are in chronological order showing 
0,1 and 3 day post bead transplantation (dpt). Images from top to bottom showing: (A-A’’) U87-nls-mKate2 
xenografted mpo:EGFP zebrafish No bead control, (B-B’’) U87-nls-mKate2 xenografted mpo:EGFP zebrafish 
implanted with Naked bead, (C-C’’) U87-nls-mKate2 xenografted mpo:EGFP zebrafish implanted with Gold bead. 
Red circles in images denotes boundary of Gold or Naked beads in the zebrafish brain. All Images were captured 
using an Andor spinning disk confocal microscope with a 20X/NA 0.75 objective. Scale bars set at 50 um. 
Brightfield image is representative of the orientation and imaging field of the fluorescent images shown in images 
A-C. 
(D-D’’) Gold bead implantation (13.2 ± 1.27 neutrophils) led to a statically significant (p = 0.0026) increase in 
neutrophil infiltration into the brain of the zebrafish at 1 dpt when compared to Naked bead (7.00 ± 1.43 neutrophils). 
By 3 dpt, both Gold (6.76 ± 0.633 neutrophils) and Naked bead (7.17 ± 1.96 neutrophils) implantation had 
significantly elevated number of neutrophils when compared to bead null controls (1.55 ± 0.312 neutrophils). One 
way ANOVA statistical analysis and Tukey’s multiple comparisons test were conducted to calulate p values. p 
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3.5.2. CRISPR-Cas9 manipulation of tnf-𝑎 and cxcl8b.1 were specific to genetic 
targets. 
 To investigate the function of tnf-𝑎 and cxcl8b.1 in promoting anti-tumour effects of 
macrophages and neutrophils, tnf-a and cxcl8b.1 were targeted using CRISPR manipulation 
with a gene-specific guideRNA (gRNA). Zebrafish embryo were injected with tnf-a and 
cxcl8b.1 gRNA at the one cell stage in order to introduce mutations at specific restrictions 
sites in the genes. Due to the high efficiency of CRISPR-Cas9 system, transient knock out of 
tnf-a and cxcl8b.1 function was conducted. The tnf-𝑎 gene was targeted using gRNA de-
scribed previously and robustly reduced tnf-𝑎 protein levels in western blots (Tsarouchas et 
al., 2018). Efficient mutation of tnf-𝑎 gene was introduced into zebrafish larvae by co-injecting 
Figure 29. Restriction fragment length polymorphism (RFLP) analysis revealed that 
tnf-𝑎 CRISPR-Cas9 manipulation induced mutations in exon 4. 
RFLP analysis of wild type (WIK) zebrafish embryos (1dpf) co-injected, 24 hours prior, with tnf-𝑎 MwoI gRNA and tnf-
𝑎 BslI gRNA. gRNA injection induced site directed mutagenesis of respective restriction enzyme sites on exon 4. Each 
well represented PCR product from a single embryo.    
(A) The mutation of MwoI restriction site on tnf-𝑎 exon 4 conferred resistance to MwoI restriction endonuclease 
digestion. MwoI restriction digest of PCR product from uninjected zebrafish yielded DNA fragments at 114 bp and 92 
bp. The mutation of MwoI restriction site would yield an expected fragment of 206 bp for tnf-𝑎 MwoI (Black arrow) 
similar to uninjected and undigested control zebrafish.  
(B) The inhibition of restiction endonuclease digestion by BslI on tnf-𝑎 exon 4 was also evident. BslI restriction digest 
of PCR product from uninjected zebrafish yielded DNA fragments of 147 and 60 bp. The mutation of BslI restriction 







two gRNA directing a double mutation on exon 4 of tnf-𝑎. First we confirmed efficient intro-
duction of CRISPR-Cas9 mediated site directed mutagenesis of tnf-𝑎 gRNA by restriction 
fragment length polymorphism analysis (RFLP)(Figure 29). RFLP analysis was conducted on 
each embryo to confirm CRISPR-Cas9 mediated site directed mutagenesis. The co-injection 
of tnf-𝑎 MwoI gRNA and tnf-𝑎 BslI gRNA resulted in efficient somatic mutation at gRNA target 
sites 24 hours after injection. A resistance to restriction endonuclease digestion by MwoI 
(Figure 29A) and BslI (Figure 29B) was evident in RFLP analysis. Mutation of the MwoI re-
striction site inhibited restriction digest and resulted in a band shift on agarose gel producing 
undigested DNA fragment 206 bp long (Figure 29A). Likewise, the mutation of the BslI re-
striction site inhibited BslI restriction digest also reflected as a band shift during RFLP analy-
sis. Mutation of BslI restriction site produced a single band which indicated undigested DNA 
product 207 bp long (Figure 29B). 
cxcl8b.1 was targeted using gRNA designed specifically for this study. Several itera-
tions of the design process were required in order to achieve knock out of cxcl8b.1, albeit 
only a partial knock out of cxcl8b.1 was finally achieved. In total, three gRNAs were designed 
to target cxcl8b.1 BslI Exon 3, cxcl8b.1 RsaI Exon 2 and cxcl8b.1 AluI Exon 4. RFLP analysis 
was conducted on 1 dpf wild type (WIK) zebrafish injected 24 hours prior with each gRNA. 
cxcl8b.1 BslI gRNA injection failed to introduce any mutations at BslI restrictions sites on 
exon 3 (Figure 30A). No band shift was detected when analysing digested PCR product of 
cxcl8b.1 BslI gRNA injected and uninjected zebrafish (Figure 30A). The complete digestion of 
PCR product indicated an active BslI restriction site on exon 3 in all cells of the zebrafish. 
While on the other hand, cxcl8b.1 RsaI gRNA induced inefficient site directed mutagenesis. 
Complete RsaI digestion of PCR product (197 bp and 41 bp (not visible)) was evident for most 
injected zebrafish except two (Figure 30B). These two zebrafish sample indicated partially 
digested product (Figure 30B, Black arrow) showing very a faint band (238 bp) where mutated 
fragments were expected. However, the inefficient nature of cxcl8b.1 RsaI gRNA induced 
mutagenesis made it not viable for knock out studies. In contrast, RFLP analysis of zebrafish 




towards 181 bp where DNA fragments with mutated AluI restriction sites were expected. 
However, faint bands indicating partially digested DNA fragments at 111 bp and 70 bp were 
also visible. Thus cxcl8b.1 AluI Exon 4 mutations were not conferred efficiently into all cells 
of the zebrafish. Nonetheless, as neutrophils are highly sensitive to cxcl8b.1 cytokine, a partial 
knock out of cxcl8b.1 expression maybe sufficient to elicit a detectable phenotype.  
 
Finally, in order to confirm that site directed mutagenesis by CRISPR-Cas9 was spe-
cifically mediated by each target specific gRNA sequences. Scrambled gRNA sequence and 
Figure 30. Restriction fragment length polymorphism (RFLP) analysis revealed 
partial mutation of cxcl8b.1 AluI restriction site. 
RFLP analysis of 1 dpf wild type (WIK) zebrafish injected, 24 hours prior, with cxcl8b.1 BslI gRNA, cxcl8b.1 RsaI 
gRNA or cxcl8b.1 AluI gRNA. Each well represented PCR product from a single embryo. 
(A) No band shift was detected when analysing digested PCR product of cxcl8b.1 BslI gRNA injected and uninjected 
zebrafish. The complete digestion of PCR product indicated an active BslI restriction site on exon 3 in all cells of the 
zebrafish. Complete BslI digestion of PCR product was expected to yield DNA fragments 158 bp and 55 bp long. 
(B) The injection of cxcl8b.1 RsaI gRNA induced inefficient site directed mutagenesis. Complete RsaI digestion of 
PCR product (197 bp and 41 bp (not visible)) was evident for most injected zebrafish. Two zebrafish sample indicated 
partial ly digested product (Black arrow) showing very a faint band (238 bp) where mutated fragments were expected. 
Thus, most cells in the zebrafish contained a fully function RsaI restriction site on exon 2. 
(C) cxcl8b.1 AluI gRNA injections induced mutations of AluI restriction sites in some cells of the zebrafish. The 
mutation of AluI restriction sites induced a band shift towards 181 bp where DNA fragments with mutated AluI 
restriction sites were expected. However, faint bands indicating partially digested DNA fragments at 111 bp and 70 





the components required for CRISPR-Cas9 mutagenesis (see section 2.9.1) were injected 
into wild type (WIK) zebrafish. RFLP analysis was conducted on each specific target re-
striction site in order to determine if mutations were conferred; tnf-𝑎 BslI, tnf-𝑎 MwoI and 
Cxcl8b.1 AluI (Figure 31). RFLP analysis indicated a complete digestion of all PCR products 
by each respective restriction enzyme of scrambled gRNA injected zebrafish. Mutations of 
restrictions sites were not conferred by scrambled gRNA or any of the components of 
CRISPR-Cas9 mutagenesis. The digestion of each tnf-𝑎 PCR product by respective BslI and 
MwoI restriction enzyme produced DNA fragments that indicated active, unmutated, re-
striction sites (Figure 31). Likewise, AluI Restriction endonuclease digestion of PCR product 
emcompassing restriction site of cxcl8b.1 AluI Exon 4 produced DNA fragments of 111 bp 
and 70 bp (Figure 31). This indicated an active AluI restriction site. Together, the results im-
plied that the injection of scramble gRNA and components of CRISPR-Cas9 mutagenesis did 
not induce mutations at tnf-𝑎 MwoI Exon 4, tnf-𝑎 BslI Exon 4 or cxcl8b.1 AluI Exon 4 re-
striction sites. Therefore, gRNA directing CRISPR-Cas9 knockouts were indeed specific for 
each genetic target of interest. These experiment were vital in establishing that the CRIPSR-
Cas9 knockout strategies employed were reproducible and specific for tnf-𝑎 and cxcl8b.1. 
Next we tested the hypothesis that tnf-𝑎 and cxcl8b.1 expression in macrophages were im-
portant genetic mediator of Gold bead induced anti-tumour responses of macrophages and 






Figure 31. The injection of scramble gRNA and components of CRISPR-
Cas9 mutagenesis did not induce restriction site mutations.  
Restriction Fragment Length Polymorphism analysis showed complete digestion of all PCR products from 
specifc regions emcompassing CRISPR target restriction sites of zebrafish injected with scramble gRNA. 
(A) PCR was conducted on scramble gRNA injected zebrafish emcompassing restriction sites of tnf-𝑎 BslI 
Exon 4 (left) and tnf-𝑎 MwoI Exon 4 (right). The digestion of each PCR product by respective BslI and MwoI 
restriction enzyme produced DNA fragments that indicated active, unmutated, restriction sites. BslI 
digestion produced DNA fragments of 147 bp and 60 bp. MwoI digestion produced DNA fragments of 114 
bp and 92 bp. The injection of scramble gRNA did not induce mutations at these restriction sites. 
(B) AluI Restriction endonuclease digestion of PCR product emcompassing restriction site of cxcl8b.1 AluI 
Exon 4 produced DNA fragments of 111 bp and 70 bp. This indicated an active AluI restriction site. Thus 







3.5.3. CRISPR knockout of tnf-𝑎 and cxcl8b.1 had no effect on Gold induced 
anti-tumour responses of macrophage and neutrophils. 
The function of tnf-𝑎 and cxcl8b.1 in mediating Gold induced anti-tumour effects were 
investigated using CRISPR knock out solutions as described before. We tested the hypothe-
sis that cxcl8b.1 and tnf-a expression in macrophages were important genetic mediators of 
Gold bead implantation that facilitated the anti-tumour effects in the zebrafish brain. In order 
to do so, mpeg1:EGFP or mpo:EGFP zebrafish were co-injected with tnf-𝑎 BslI, tnf-𝑎 MwoI 
and cxcl8b.1 AluI gRNA in order to knockout tnf-𝑎 and partially knockout cxcl8b.1 expression. 
Injected zebrafish were implanted with either Gold or Naked beads and the effects on U87-
nls-mKate2 survival, macrophage number and neutrophil infiltration were evaluated at 0, 1 
and 3 dpt. RFLP analysis was conducted on all zebrafish larvae at the end of in-vivo experi-
ments to confirm knockout of tnf-𝑎 and cxcl8b.1.  
The consequences of tnf-𝑎 and cxcl8b.1 knockout on macrophage number was an-
alyzed to understand if tnf-𝑎 and cxcl8b.1 played a role in Gold bead induced macrophage 
recruitment. The implantation of Gold and Naked beads in wild type and double knockout 
mpeg1:EGFP zebrafish induced an initial spike in macrophage intensities at 1 dpt. The knock-
out of tnf-𝑎 and cxcl8b.1 in Gold bead implanted zebrafish elicited no detectable effects on 
macrophage intensities when compared to wild type (p= 0.943) (Figure 32H-I). A 12 and 10 
fold increase in macrophage intensities were recorded in, Gold bead implanted, wild type and 
knockout mpeg1:EGFP zebrafish respectively (Figure 32H). Likewise, the implantation of Na-
ked beads also induced a similar spike in macrophage intensities at 1 dpt, although to a lesser 
degree. A 6 folds and 8 fold increase in macrophage intensities of Naked bead implanted wild 
type and knockout zebrafish were recorded respectively (Figure 32H). This initial spike in 
macrophage intensities were attributed to a response to the foreign body and also the clear-
ance of necrotic tissue as a result of the injury caused by the implantation procedure. Clear-
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Figure 32. CRISPR knockout of tnf-𝑎 and cxcl8b.1 had 
no effect on Gold induced anti-tumour responses of 
macrophage. 
(A-E) tnf-𝑎 and cxcl8b.1 expression were knocked out using CRISPR in, 
macrophage labelled (Green), mpeg1:EGFP zebrafish. Human derived Lv-
cppt-IRES-nls-mKate2-opre transformed U87-nls-mKate2 cells (White) 
were xenografted into 3 days post fertilized (dpf) wild type and tnf-
𝑎/cxcl8b.1 double knockout mpeg1:EGFP zebrafish. Zebrafish embyros (4 
dpf) were implanted with Gold or Naked bead and imaged using an Andor spinning disk confocal microscope 
with a 20X/NA 0.75 objective. Scale bars were set at 50 µm. Images from left to right are in chronological 




a recovery of macrophage intensities was observed for all zebrafish genetic conditions in-
cluding both Gold and Naked bead implanted zebrafish. However, as previously reported 
(section 3.3.2), the recovery of macrophage intensities to basal levels was not evident in Gold 
bead implanted zebrafish. At 3 dpt, Gold bead implantation in both wild type and double 
knockout conditions stimulated a 2 fold increase in macrophage intensities when compared 
to Naked bead implanted zebrafish and bead null wild type controls (Figure 32H). Thus the 
implantation of Gold beads recruited macrophages and the knockout of tnf-𝑎 and cxcl8b.1 
expression had no effect on Gold bead mediated macrophage recruitment in the zebrafish 
brain.  
To understand if tnf-𝑎 and cxcl8b.1 knock out had a consequence on neutrophil re-
cruitment, Gold and Naked beads were implanted into wild type and double knock out tnf-
a/cxcl8b.1 mutant mpo:EGFP zebrafish. The effects on neutrophil recruitment were closely 
examined. Previously, we showed that the implantation of Gold bead into the brain of wild 
type zebrafish stimulated increased neutrophil recruitment into the brain of the zebrafish at 1 
cytokines tnf-𝑎 and cxcl8b.1 expression in bead null zebrafish had no effect on U87-nls-mKate2 proliferation. 
Tnf-a and cxcl8b.1 expression does not contribute to U87-nls-mKate2 survival. (B) The double knockout of 
mpeg1:EGFP zebrafish had no effect on Gold induced anti-tumour responses. (C) Gold induced anti-tumour 
responses in double knock out were identical to wild type conditions. (D) The double knockout of tnf-𝑎 and 
cxcl8b.1 in naked bead zebrafish had no effect on U87-nls-mKate2 survival. U87-nls-mKate2 survived in the 
brain but did not proliferate. (E) The implantation of Naked bead into wild type zebrafish also had no effect on 
U87-nls-mKate2. U87-nls-mKate2 also survived in the brain but did not proliferate.  
(F) U87-nls-mKate cell numbers were expressed as a ratio calculated by the number of cells at 1 or 3 day post 
transplantation (dpt) divided by the number of cells at 0 dpt.  
(G) At 3 dpt, the implantation of Gold bead elicit a potent anti-tumour effect on both wild type and double knock 
out zebrafish. tnf-𝑎 and cxc8b.1 did not contribute to the anti-tumour phenotype. 
(H) Macophage intensity were expressed as a ratio calculated by the sum of intensity at 1 or 3 day post 
transplantation (dpt) divided by the sum of intensity at 0 dpt. All bead implanted zebrafish elicit a spike in 
macrophage intensities at 1 dpt.  
(I) At 3 dpt, the implantation of Gold bead recruited more macrophages into the brain than Naked bead 
implanted zerbrafish. Knock out of tnf-𝑎 and cxcl8b.1 had no effect on macrophage recruitment into the brain 
of Gold bead implanted zebrafish. 
Brightfield image is representative of the orientation and imaging field of the fluorescent images shown in 
images A-D and A’-D’. 
One way ANOVA statistical analysis and Tukey’s multiple comparisons test were conducted to calulate p 
values. p values were indicated where statistically significant (p < 0.05). Error bar indicated standard error.  
(J) The imaging field emcompassed both optic tectums of the zebrafish brain. The red box of the schematic 





dpt (see section 3.5.1). In addition, qPCR results showed that Gold bead implantation in-
creased the expression of cxcl8b.1 and tnf-a. Thus we tested the hypothesis that tnf-𝑎 and 
cxcl8b.1 expression mediated Gold bead induced recruitment of neutrophil in the zebrafish 
brain.   
The implantation of Gold bead in double knockout tnf-𝑎/cxcl8b.1 mutant mpo:EGFP 
zebrafish showed a trend indicating attenuated neutrophil recruitment at 1 dpt (Figure 33F). 
However, two tailed students t-test revealed that the attenuation of neutrophil recruitment in 
double knock out mutants mpo:EGFP zebrafish at 1 dpt was statistically insignificant (p = 
0.108) (Figure 33F). At 1 dpt, Gold bead implantation in wild type and double mutant 
mpo:EGFP recruited an average of 13.2 ± 1.27 neutrophils and 10.3 ± 1.10 neutrophils re-
spectively (Figure 33F). Likewise, knockout of tnf-𝑎 and cxcl8b.1 had no effect on neutrophil 
recruitment in Naked bead implanted double mutant mpo:EGFP zebrafish when compared to 
its wild type counterpart (Figure 33G). At 1 dpt, an average of 9.18 ± 1.29 neutrophils and 
7.00 ± 1.43 neutrophils were present in Naked bead implanted double knockout mutant and 
wild type mpo:EGFP zebrafish respectively. Altogether, the knockout of tnf-𝑎 and cxcl8b.1 
expression had no effect on Gold bead induced neutrophil recruitment in the zebrafish brain.  
To investigate if tnf-𝑎 and cxcl8b.1 expression mediated Gold bead induced anti-
tumour phenotype, the consequences of tnf-𝑎 and cxcl8b.1 knockout on U87 survival was 
evaluated. The knock out of tnf-𝑎 and cxcl8b.1 expression had no effect on Gold induced 
anti-tumour responses. No significant difference in U87-nls-mKate cell number was recorded 
when comparing Gold bead implanted double knockout zebrafish and Gold bead implanted 
wild type zebrafish ( p = 0.227) (Figure 32G). The implantation of Gold bead led to a significant 
decrease of U87-nls-mKate2 cell count by an average of 86.9 ± 6.10%( (p < 0.0001) in knock-
out zebrafish and 66.3 ± 4.76%(p = 0.0003) in wild type zebrafish (Figure 32F-G). Likewise, 
when comparing the effects of Naked bead implantation into double knock out mutant 
zebrafish and wild type zebrafish on U87-nls-mKate survival no significant difference was 
recorded (p = 0.990) (Figure 32F-G). Naked bead implantation attenuated the proliferation of 




knockout of pro-inflammatory cytokines tnf-𝑎 and cxcl8b.1 expression in bead null zebrafish 





Figure 33. CRISPR knockout of tnf-𝑎 and cxcl8b.1 had no effect on Gold in-
duced neutrophil recruitment in the brain of mpo:EGFP zebrafish. 
(A-E) tnf-𝑎 and cxcl8b.1 expression were knocked out using CRISPR in, neutrophil labelled (Green), mpo:EGFP 
zebrafish. Human derived Lv-cppt-IRES-nls-mKate2-opre transformed U87-nls-mKate2 cells (White) were 
xenografted into 3 days post fertilized (dpf) wild type and tnf-𝑎/cxcl8b.1 double knockout mpo:EGFP zebrafish. 
Xenografted zebrafish embyros (4 dpf) were implanted with Gold or Naked bead and imaged using an Andor 
spinning disk confocal microscope with a 20X/NA 0.75 objective. Scale bars were set at 50 µm. Images from 
left to right are in chronological order showing images from 0 ,1 and 3 day post bead transplantation (dpt).  (A) 
The implantation of Gold bead into double knockout tnf-𝑎/cxcl8b.1 mutant mpo:EGFP zebrafish had no effect 
on neutrophil recruitment. (B) Implantation of Gold bead recruited neutrophils at 1 dpt and returned to basal 
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by 1.4 folds in bead null knockout zebrafish. The growth rates mirrored that of bead null wild 
type control mpeg1:EGFP zebrafish (Figure 32F). Thus, the results here indicated that tnf-𝑎 
and cxcl8b.1 expression did not contribute to mechanisms that promoted U87-nls-mKate2 
survival or Gold induced anti-tumour responses in the zebrafish brain.  
This study demonstrated that CRISPR knockout of tnf-𝑎 and cxcl8b.1 in Gold bead 
implanted zebrafish elicited no detectable phenotypic changes of the associated anti-tumour 
responses when compared to wild type. In support, the knockout of tnf-𝑎 and cxcl8b.1 did 
not alter the responses of either macrophages or neutrophils as a result of Gold bead implan-
tation. Both knockout and wild type zebrafish displayed identical kinetics for macrophages 
and neutrophils recruitment from 0 dpt to 3 dpt when comparing Gold bead implanted tnf-
𝑎/cxcl8b.1 knockout double mutant and Gold bead implanted wild type background. To con-
clude, tnf-𝑎 and cxcl8b.1 were not key mediators of Gold induced anti-tumour responses.  
  
level by 3 dpt. (C) Likewise, knockout of tnf-𝑎 and cxcl8b.1 had no effect on neutrophil recruitment in Naked 
bead implanted double mutant mpo:EGFP zebrafish when compared to (D) wild type counterpart.  
(E) The imaging field emcompassed both optic tectums of the zebrafish brain. The red box of the schematic 
image denotes boundary of the imaging region and represented the orientation of all images from A-D. 
(F) The implantation of Gold bead in double knockout tnf-𝑎/cxcl8b.1 mutant mpo:EGFP zebrafish showed a 
trend to indicated attenuated neutrophil recruitment at 1 dpt. However, two tailed students t-test revealed that 
the attenuation of neutrophil recruitment in double knock out mutants mpo:EGFP zebrafish at 1 dpt was 
statically insignificant (p = 0.108). At 1 dpt, Gold bead implantation in wild type and double mutant mpo:EGFP 
recruited an average of 13.2 ± 1.27 neutrophils and 10.3 ± 1.10 neutrophils respectively  
(G) The double knockout of tnf-𝑎 and cxcl8b.1 had no effect on Naked bead mediated neutrophil recruitment 
in the zebrafish brain. At 1 dpt, an average of 9.18 ± 1.29 neutrophils and 7.00 ± 1.43 neutrophils were present 





3.5.4. mpeg1 driven mifepristone-inducible lexPR expression of RFP in macro-
phages showed weak expression of RFP fluorophore. 
In addition to loss of function experiments, gain of function experiments were con-
ducted to further investigate the role of tnf-𝑎 and cxcl8b.1 in mediating the anti-tumour phe-
notype. Ultimately, the overexpression of tnf-𝑎 and cxcl8b.1 attempted to replicate the anti-
tumour effects observed in the brain of Gold implanted zebrafish. Spatiotemporal control of 
the expression of tnf-𝑎 and cxcl8b.1 was attempted using an inducible genetic expression 
system. An inducible system conferred the capability to replicate the conditions of bead im-
plantation at 4 dpf instead of a ‘traditional’ transgenic overexpression of a transgene con-
trolled by a constitutively active cell specific promoter.  
The mifepristone-inducible lexPR system was developed to drive and regulate the 
expression of tnf-𝑎 and cxcl8b.1 in transgenic zebrafish to no avail. The Mifepristone inducible 
LexPR system is a hormone-response transcriptional activator that confers accurate spatio-
temporal control of transgene expression (Emelyanov and Parinov, 2008). In order to demon-
strate the viability of the LexPR system in vivo, transgenic NBT:lexPR:lexOP:GFP zebrafish 
were injected with lexOP:RFP at the one cell stage. The neural beta tubulin (NBT) promoter in 
NBT:lexPR:lexOP:GFP is a neuronal lineage marker that drives the expression of 
lexPR:lexOP:GFP transgene in neurons (Peri and Nusslein-Volhard, 2008). Inducible expres-
sion of RFP and GFP was achieved at 4 dpf by adding 5 µM Mifepristone into the media and 
incubated for 24 hours. Indeed, the activation of lexPR by synthetic steroid, mifepristone ac-
tivated the expression of operator promoter (lexOP) sequence that expressed GFP and RFP 




cells that morphologically resembled neurons, based on axonal expression of RFP and GFP 
proteins. DMSO controls showed no expression of RFP or GFP (Figure 34B) which supported 
the induction capabilities of the mifepristone inducible lexPR system. 
Figure 34. mpeg1 inducible expression of RFP in macrophages showed weak 
expression of RFP protein. 
Inducible expression of RFP was achieved by adding 5 µM Mifepristone into E3 media with 4 dpf zebrafish and 
incubated for 24 hours. All images were obtained using an Andor spinning disk confocal microscope with a 
20X/NA 0.75 objective. Scale bars were set at 50 µm. All zebrafish were at 5 dpf when imaged. 
(A) Transgenic NBT:lexPR:lexOP:GFP zebrafish were injected with lexOP:RFP construct at the one cell stage. 
The activation of lexPR by synthetic steroid, mifepristone, activated the expression of operator promoter (lexOP) 
sequence that expressed GFP and RFP fluorophore in neurons. The co-expression of RFP and GFP was evident 
in cells that morphologically resembled neurons, based on axonal expression of RFP and GFP fluorophore.  
(B) 1% DMSO controls showed no expression of RFP or GFP in NBT:lexPR:lexOP:GFP zebrafish injected with 
lexOP:RFP construct. This supported the induction capabilities of the mifepristone inducible lexPR system. 
(C) Wild type (WIK) zebrafish were co-injected with mpeg1:lexPR:pA and lexOP:RFP constructs. The application 
of 5 µM Mifepristone into the embryo media from 4 dpf to 5 dpf failed to induce reliable expression of RFP 
expression in macrophages. The Mifepristone inducible expression system was not compatible with mpeg1 
promoter.  
(D) Control injections of mpeg1:EGFP plasmid into wild type (WIK) zebrafish stimulated the expression of GFP 
fluorophore in macrophages. Thus, the mpeg1 promoter was cloned into mpeg1:tnf-𝑎 and mpeg1:cxcl8b.1 




In order to achieve spatiotemporal control of tnf-𝑎 and cxcl8b.1 expression in mac-
rophages, the lexOP operator was cloned into lexOP:tnf-𝑎 and lexOP:cxcl8b.1 expression 
plasmid. In addition, lexPR coding sequence was cloned into mpeg1:lexPR:pA plasmid under 
the control of macrophage lineage mpeg1 promoter (Ellett et al., 2011). Overexpression of 
tnf-𝑎 and cxcl8b.1 would have been achieved by co-injecting mpeg1:lexPR:pA, lexOP:tnf-𝑎	
and lexOP:cxcl8b.1 transgenes into mpeg1:EGFP or mpo:EGFP zebrafish and the associated 
anti-tumour responses, macrophage and neutrophil activities investigated. In order to study 
the viability of the inducible system under a different promoter (mpeg1) as compared to pre-
vious (NBT), wild type (WIK) zebrafish were co-injected with mpeg1:lexPR:pA and lexOP:RFP 
constructs and the distribution RFP fluorophore analyzed. The application of 5 µM Mifepris-
tone into the embryo media at 4 dpf failed to induce reliable expression of RFP expression in 
macrophages (Figure 34C). Faint and weak expression of RFP signal was visible however it 
was not viable to support robust overexpression studies of tnf-𝑎 and cxcl8b.1. Thus, the Mif-
epristone inducible expression system was not compatible with mpeg1 promoter and a con-
stitutively active overexpression system was utilised instead.  
To achieve the overexpression of tnf-𝑎 and cxcl8b.1 in macrophages of the zebrafish 
brain a constitutively active overexpression system was used under the control of the mpeg1 
promoter. Indeed, control injections of mpeg1:EGFP plasmid into wild type (WIK) zebrafish 
stimulated the expression of GFP fluorophore in macrophages (Figure 34D). Therefore, the 
mpeg1 promoter was cloned into mpeg1:tnf-𝑎 and mpeg1:cxcl8b.1 plasmids in order to di-
rect tnf-𝑎 and cxcl8b.1 overexpression in macrophages. One of the caveats of a constitutively 
active promoter driven transgene expression system was the lack of temporally specificity. 
The overexpression of tnf-𝑎 and cxcl8b.1 occurred at birth and thus did not closely replicate 
the temporal conditions of Gold bead induced tnf-𝑎 and cxcl8b.1 overexpression at 5 dpf. 
Nonetheless, the mpeg1 promoter driven transgene expression system was the most reliable 




3.5.5. tnf-𝑎 and cxcl8b.1 overexpression had no effect on U87-nls-mKate2 cell 
survival or on macrophage and neutrophil number.  
To evaluate a possible role for tnf-𝑎 and cxcl8b.1 expression in macrophages on the 
anti-tumour phenotype, transgenic mpeg1:EGFP (tg(mpeg1:EGFP)) and mpo:EGFP 
(tg(mpo:EGFP)) zebrafish were co-injected with mpeg1:tnf-𝑎 and mpeg1:cxcl8b.1 plasmids 
and transplanted with U87-nls-mKate2 cell. The effect of tnf-𝑎 and cxcl8b.1 overexpression 
in macrophages on U87-nls-mKate2 survival, macrophage intensity and neutrophil infiltration 
were investigated. Zebrafish embryos (3 dpf) were xenografted with U87-nls-mKate2 cells 
and imaged at 4, 5 and 7 dpf. The timeline mirrors that of in vivo bead implantation experi-
ments in order to recapitulate the same experimental conditions as Gold bead implanted 
zebrafish. This study aimed to test the hypothesis that cxcl8b.1 and tnf-a expression in mac-
rophages were important genetic mediators of Gold bead induced anti-tumour effects of 
macrophages and neutrophils in the zebrafish brain. 
To investigate if tnf-𝑎 and cxcl8b.1 expression led to increased macrophage number, 
the effect on macrophage intensity was characterized in tg(mpeg1:EGFP) zebrafish co-in-
jected with mpeg1:tnf-𝑎 and mpeg1:cxcl8b.1 (Figure 35A-B). The overexpression of tnf-𝑎 and 
cxcl8b.1 significantly (p = 0.0318) increased macrophage intensity by 1.4 fold at 5 dpf when 
compared to wild type (Figure 35F). However, this initial spike in macrophage intensity was 
significantly lower than that in Gold bead implanted zebrafish. The implantation of Gold bead 
at 5 dpf significantly increased macrophage intensity by 13 folds when compared to bead null 
wild type mpeg1:EGFP zebrafish (Figure 32C,H). The spike in macrophage intensity in tnf-𝑎 
and cxcl8b.1 overexpressed mpeg1:EGFP zebrafish returned to basal levels by 7 dpf. How-
ever, there was a trend (p = 0.0600) to indicate that overexpression of tnf-𝑎 and cxcl8b.1 of 
macrophages led to decreased macrophage numbers. Nonetheless, the overexpression of 
tnf-𝑎 and cxcl8b.1 of macrophages in mpeg1:EGFP did not promote increased macrophage 
number in the zebrafish brain. 
To understand if overexpression of tnf-𝑎 and cxcl8b.1 in macrophages promoted the 




with mpeg1:tnf-𝑎 and mpeg1:cxcl8b.1 plasmids (Figure 35C-D). Previous study indicated that 
Gold bead implantation recruited significantly increased number of neutrophils at 1 dpt when 
compared to Naked bead implanted tg(mpo:EGFP) zebrafish (Figure 28). However, the over-
expression of tnf-𝑎 and cxcl8b.1 did not increase the infiltration of neutrophil at all time points 
(4, 5 and 7 dpf). The number of neutrophils in the zebrafish brains in mpeg1:tnf-𝑎 and 
mpeg1:cxcl8b.1 injected tg(mpo:EGFP) zebrafish were statically similar at 5 dpf (p = 0.733) 
and 7 dpf (p = 0.323) (Figure 35G). Thus tnf-𝑎 and cxcl8b1 overexpression in macrophages 
did not increase the recruitment of neutrophils in the zebrafish brain.  
The overexpression of tnf-𝑎 and cxcl8b.1 in macrophages of the zebrafish brain had 
no effect on the survival U87-nls-mKate2 cells. A notable absence of anti-tumoural effect was 
observed in tg(mpeg1:EGFP) and tg(mpo:EGFP) zebrafish co-injected with mpeg1:tnf-𝑎 and 
mpeg1:cxcl8b.1(Figure 35.. Instead, a significant increase by 27 ± 6.93 % (p = 0.0387) in U87-
nls-mKate2 cell number was observed at 4 dpf when compared to wild type background 
(uninjected, tg(mpeg1:EGFP)). However, by 7 dpf, only a trend (p = 0.201) supported the in-
crease in U87-nls-mKate2 cell number (Figure 35. Nonetheless, tnf-𝑎 and cxcl8b.1 overex-
pression in macrophages of mpeg1:EGFP zebrafish did not elicit an anti-tumour phenotype. 
In agreement with previous CRISPR double mutant knockout studies (See section 3.5.3 for 
details), the result implied that tnf-𝑎 and cxcl8b.1 were not critical genetic effectors of anti-
tumour phenotype in the zebrafish brain.   
Due to the lack of effect of tnf-𝑎 and cxcl8b.1 overexpression in macrophages, we 
confirmed the overexpression of tnf-𝑎 and cxcl8b.1 in tg(mpeg1:EGFP) zebrafish by reverse 
transcription polymerase chain reaction (RT-PCR). tg(mpeg1:EGFP) zebrafish were injected 
with either mpeg1:tnf-𝑎 or mpeg1:cxcl8b.1 plasmid constructs to drive overexpression of ei-
ther genes. Total RNA content was isolated from whole embryos and first strand cDNA syn-
thesis was performed on extracted RNA. The expression of β actin gene of injected and wild 
type (WIK) zebrafish was used as the reference gene. β actin, show no differential expression 
which indicated that global genetic expression was similar in all zebrafish samples (Figure 




zebrafish injected with either mpeg1:tnf-𝑎 or mpeg1:cxcl8b.1 when compared to wild type 
zebrafish (WIK) (Figure 36). Therefore, mpeg promoter activity in zebrafish was capable of 
driving transgene expression. 
The injection of mpeg1:tnf-𝑎  plasmid overexpressed tnf-𝑎 in the zebrafish. PCR prod-
ucts from tg(mpeg1:EGFP) zebrafish injected with mpeg1:tnf-𝑎	formed a slightly darker band 
stain than wild type (WIK) and mpeg1:cxcl8b.1 injected zebrafish (Figure 36, Black Arrow). In 
contrast, RT-PCR did not demonstrate the overexpression of cxcl8b.1 in mpeg1:cxcl8b.1 in-
jected zebrafish. No significant difference in band staining was observed for mpeg1:cxcl8b.1 
injected zebrafish when compared to wild type (WIK) and mpeg1:tnf-𝑎 injected zebrafish (Fig-
ure 36). It was important to note that the isolation of total RNA content was conducted on 
whole embryos and not on isolated macrophages. Thus the dilution of the overexpression 
effect for either tnf-𝑎 or cxcl8b.1 transcripts would occur. Nonetheless, RT-PCR validated the 
overexpression of tnf-𝑎 in mpeg1:tnf-𝑎 injected zebrafish but not for cxcl8b.1 in 
mpeg1:cxcl8b.1 injected zebrafish. 
The injection of mpeg1:tnf-𝑎  and mpeg1:cxcl8b.1 plasmid into tg(mpeg:EGFP) 
zebrafish elicited no detectable phenotypic change that indicated an anti-tumour response of 
macrophages or infiltrating neutrophils. Since only tnf-𝑎 overexpression was confirmed, the 
effects of cxcl8b.1 overexpression remained inconclusive. The overexpression of tnf-𝑎	 in 
macrophages had no effect on U87-nls-mKate2 cell engraftment and proliferation in the 
zebrafish brain. In addition, the macrophage and neutrophil response towards genetic over-
expression of tnf-𝑎 was comparable to wild type conditions. Therefore, tnf-𝑎 expression in 
macrophages was not an important genetic mediator of Gold bead induced anti-tumour re-






Figure 35. tnf-𝑎 and cxcl8b.1 overexpression had no effect on U87-nls-mKate2 
cell survival or on macrophage and neutrophil number.  
mpo:EGFP and mpeg1:EGFP zebrafish were co-injected with mpeg1:tnf-𝑎 and mpeg1:cxcl8b.1 plasmid 
constructs to overexpress tnf-𝑎 and cxcl8b.1 in macrophages. Human derived Lv-cppt-IRES-nls-mKate2-opre 
transformed U87-nls-mKate2 cells (White) were xenografted into 3 days post post fertilized (dpf) wild type and 
tnf-𝑎/cxcl8b.1 overexpressed zebrafish. Xenografted zebrafish embyros were imaged using an Andor spinning 
disk confocal microscope with a 20X/NA 0.75 objective. Scale bars were set at 50 µm. Images from left to right 
are in chronological order showing images from 4 and 7 day dpf. (A) The macrophage responses in wild type 
mpeg1:EGFP zebrafish was comparable to tnf-𝑎 and cxcl8b.1 overexpressed zebrafish. (B) The overexpression 
of tnf-𝑎 and cxcl8b.1 in macrophages did not promote increased macrophage number in the zebrafish brain. (C) 
Low number of neutrophil was present in wild type mpeg1:EGFP zebrafish. (D) tnf-𝑎 and cxcl8b.1 overexpression 
in macrophages had no effect on neutrophil infiltration in the zebrafish brain.  
(E) The overexpression of tnf-𝑎 and cxcl8b.1 in macrophages of the zebrafish brain had no effect on the survival 
of U87-nls-mKate2 cells. 
(F) The overexpression of tnf-𝑎 and cxcl8b.1 significantly (p = 0.0318) increase macrophage intensity by 1.4 folds 
at 5 dpf when compared to wild type. The spike in macrophage intensity in tnf-𝑎 and cxcl8b.1 overexpressed 
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mpeg1:EGFP zebrafish returned to basal levels by 7 dpf. No significant difference (p = 0.0600) in macrophage 
intensities was observed by 7 dpf. 
(G) The number of neutrophils in the zebrafish brains in mpeg1:tnf-𝑎 and mpeg1:cxcl8b.1 injected 
tg(mpo:EGFP) zebrafish were statically similar at 5 dpf (p = 0.733) and 7 dpf (p = 0.323). 
(H) The imaging field emcompassed both optic tectums of the zebrafish brain. The red box of the schematic 




Figure 36. Reverse transcription polymerase chain reaction revealed over-
expression of tnf-𝑎 in mpeg1:tnf-𝑎 injected mpeg1:EGFP zebrafish 
tg(mpeg1:EGFP) zebrafish were injected with either mpeg1:tnf-𝑎 or mpeg1:cxcl8b.1 plasmid constructs to 
drive overexpression of either genes. RT-PCR was conducted on total RNA content isolated from whole 
embryos of wild type (WIK) zebrafish, mpeg1:tnf-𝑎 injected tg(mpeg1:EGFP) zebrafish and mpeg1:cxcl8b.1 
injected tg(mpeg1:EGFP) zebrafish. 
Negative control, β actin, show no differential expression of genes and indicated that global genetic 
expression was similar in all zebrafish samples.  
The increase in GFP expression, darker bands, was evident in tg(mpeg1:EGFP) zebrafish injected with either 
mpeg1:tnf-𝑎 or mpeg1:cxcl8b.1 when compared to wild type.  
The injection of mpeg1:tnf-𝑎  plasmid overexpressed tnf-𝑎 in the zebrafish. PCR products from 
tg(mpeg1:EGFP) zebrafish injected with mpeg1:tnf-𝑎	formed a slightly darker band stain than wild type (WIK) 
and mpeg1:cxcl8b.1 injected tg(mpeg1:EGFP) zebrafish.  
RT-PCR did not demonstrate the overexpression of cxcl8b.1 in mpeg1:cxcl8b.1 injected zebrafish. No 






4.1.1. Palladium metal as a mediator of bioorthogonal drug catalyst in vivo 
 
In this study, we attempted to establish an in vivo bioorthogonal catalytic drug assay in 
order to test the efficacy of a novel drug delivery system that had the potential to contribute 
to the development of novel chemotherapeutics. The idea of utilising nanoparticle mediated 
drug delivery systems is not entirely novel and has been investigated in many studies 
(Sangtani et al., 2017, Wang et al., 2019, Clavadetscher et al., 2016, Tonga et al., 2015). Initial 
medical applications of nanoparticles began as a theranostic (diagnostic imaging) compound 
used on imaging platform such as MRI, PET and CT (Phillips et al., 2014). Nanoparticles have 
evolved into multifunctional nanoparticles that can serve as drug carriers and as a theranostic. 
Here, Palladium nanoparticles, solidly supported within a polystyrene matrix (bead), per-
formed as catalysts that mediated BOOM reactions in the zebrafish brain to convert a pro 
drug (POB-Vorinostat) to its active form (Vorinostat). However, preliminary experiments indi-
cated that Palladium bead implantation initiated a potent anti-tumour effect in the absence of 
the chemotherapeutic agent, Vorinostat. Although this was not the first time Palladium nano-
particles had been described to possess anti-tumour properties (Alarifi et al., 2017, Dahal et 
al., 2015), this study was the first to demonstrate Palladium mediated anti-tumour effects on 
glioblastoma cells in vivo in zebrafish. 
 
4.1.2. Investigating the effects of macrophage polarisation by Palladium beads  
 
The zebrafish model system utilised in this study facilitated the in-depth study of the ef-
fects of nanoparticle mediated macrophage polarisation on U87 glioblastoma cells. We first 
established that macrophage mpeg1:EGFP signal intensity correlated with macrophage num-
ber. This allowed for the rapid and robust evaluation of macrophage number, forgoing tedious 




ladium bead implantation initiated a potent anti-tumour effect. The anti-tumour effect re-
cruited macrophages and coincided with the decrease in U87 cell survival and an increase in 
U87 cell fragmentation when compared to the injury model. The anti-tumour effects observed 
in this study was reminiscent of macrophage polarisation described in previous studies (van 
Dalen et al., 2018, Vogel et al., 2014, Zanganeh et al., 2016) as a strong macrophage inflam-
matory response was evident. An increase in macrophage mpeg1:EGFP signal intensity was 
observed in close proximity with Palladium beads. Indeed, macrophage have been shown to 
interact with nanoparticles and these interactions have been shown to promote pro-inflam-
matory responses (Park and Park, 2009, Hutter et al., 2010, Ge et al., 2015, Kusaka et al., 
2014). Metallic nanoparticles have been previously shown to polarise macrophages and pe-
ripheral blood mononuclear cells. One study investigate the effects of titanium nanoparticles 
on alveolar macrophages (Scherbart et al., 2011). Scherbart et al,. showed that titanium na-
noparticles accumulated in macrophages and caused increased extracellular ROS, heme-
oxygenase 1 and tnf-𝑎	expression. While in another study, Palladium nanoparticles were 
demonstrated to enhance Ifn-y release in LPS stimulated peripheral blood mononuclear cells 
(Boscolo et al., 2010). Macrophage internalisation of nanoparticles has been shown to regu-
late release of pro-inflammatory cytokines such a il-1β and tnf-𝑎	(Kusaka et al., 2014, Leso 
and Iavicoli, 2018). However, one key difference that sets this study apart is the fact that 
Palladium nanoparticles were solidly supported upon a polystyrene matrix. As a result, Palla-
dium nanoparticles, in theory, would not be internalised by macrophages. Whether Palladium 
nanoparticles diffused from the bead surface remains speculatory. However, mechanical ma-
nipulation of Palladium bead may dislodge Palladium nanoparticles from the bead surface 
which may accumulate in macrophages. In addition, Palladium nanoparticles may be released 
as Palladium ions. One study concluded that Silver ions leaching from the larger fractions of 
Silver nanoparticles mediates the toxicity of Silver nanoparticles in macrophages (Pratsinis et 
al., 2013). Therefore, it would be interesting to ascertain if macrophage interacted with Palla-




particles to initiate macrophage polarisation effects. Nonetheless, there was significant evi-
dence to suggest that the implantation of Palladium bead polarised macrophages to initiate 
an anti-tumour response.  
 
4.1.3. Identifying the contributions of macrophage function in Palladium medi-
ated anti-tumour effects 
 
The tumour supporting role of macrophage function had been described previously (Noy 
and Pollard, 2014, Prionisti et al., 2019, van Dalen et al., 2018, Pyonteck et al., 2013). Conse-
quently, we demonstrate in this study that macrophage function supported U87 cell growth 
in the zebrafish brain. We observed a reduction in U87 cell survival in irf8-/- , macrophage null, 
zebrafish when compared to wild type. The inherent disability of U87 to survive in the irf8-/- 
zebrafish was reflected in all xenografted irf8-/- zebrafish including Palladium bead implanted 
irf8-/- zebrafish. A trend indicated that the survival rate of U87 cells in Palladium bead im-
planted irf8-/- zebrafish were better than that in Palladium bead implanted mpeg1:EGFP 
zebrafish. This implied that macrophage function was important in mediating the anti-tumour 
effects observed in Palladium bead implanted zebrafish. However, due to low n numbers (n 
= 4, p = 0.109), the trend was statically insignificant. Several factors contributed to the low n 
numbers described in Palladium bead implanted irf8-/- zebrafish. First, the implantation of 
Palladium bead was toxic, a 33% survival rate was recorded in Palladium bead implanted 
mpeg1:EGFP zebrafish. Intriguingly, Weiss et al. report that zebrafish larvae developed nor-
mally into the larval stages with no sign of toxicity after Palladium bead implantation (Weiss 
et al., 2014a). The differences may be attributed to the location of bead implantation as the 
authors (Weiss et al., 2014a) performed the implantation into the yolk sac of the zebrafish 
embryo. Secondly, irf8-/- zebrafish have reduced survival rates compared to wildtype (Shiau 
et al., 2015). Thirdly, the absence of macrophage function in irf8-/- zebrafish exacerbated de-
fective clearance of apoptotic cells and eliminated neuroprotective effects of macrophages 




and Peri, 2015, Herzog et al., 2019). When combined, these factors had a detrimental impact 
on the survival of Palladium bead implanted irf8-/- zebrafish reflected as low n numbers (Figure 
11). Although the results were statically insignificant, the data support the role of macrophage 
in mediating the anti-tumour effects of Palladium bead implantation.  
 
4.1.4. ROS mediated anti-tumour effects of macrophages 
 
Next generation RNA sequencing offered the opportunity to investigate key mechanisms 
underlying macrophage tumoricidal polarisation in Palladium bead implanted zebrafish. Dif-
ferential analysis of RNA sequencing expression data revealed that the implantation of Palla-
dium bead lead to a stress response of macrophages that increased expression of protein 
associated with stress tolerance (Hsp70l) and increased reactive oxygen species (ROS) gen-
eration. In addition, we also detected the increase in proinflammatory cytokine expression 
(tnf-𝑎, cxcl8b.1) and the decrease in proangiogenic factors (sema4d and sox7) in Palladium 
bead implanted zebrafish. Altogether, Palladium bead implantation lead to the polarisation of 
macrophage genetic profile towards a proinflammatory anti-tumour phenotype. 
In agreement, previous works have demonstrated that metallic nanoparticles such as Ti-
tanium, Iron oxides, Palladium and Zinc dioxide all increased intracellular ROS generation in 
macrophages (Yang et al., 2009, Dahal et al., 2015, Scherbart et al., 2011, Reichel et al., 2019, 
Alarifi et al., 2017). Myeloid cell have been shown to be an important source of ROS in acute 
and chronic inflammation (Bogdan et al., 2000). ROS are a heterogenous group of highly re-
active ions that act as both a signalling molecule and as pro-inflammatory mediators (Mittal 
et al., 2014, Thannickal and Fanburg, 2000). ROS can combine with nitric oxide to form reac-
tive nitrogen species which contributes to the overall pro-inflammatory signalling axis 
(Thannickal and Fanburg, 2000, Mittal et al., 2014). The formation of reactive nitrogen species 
in macrophages have been shown to be a source of highly toxic oxidants capable of micro-
bicidal killing (MacMicking et al., 1995). In addition, ROS secretion has been shown to medi-




et al., 1998). In addition, ROS has been shown to induce apoptosis in U87 cells (Recio 
Despaigne et al., 2014 , Wang et al., 2013). However, chronic production of ROS has long 
been hypothesised to be the central driving force leading to inflammatory diseases that con-
tributed to carcinogenesis (Hussain and Harris, 2007, Kawanishi et al., 2017, Canli et al., 
2017). ROS have been shown to induce DNA damage that could increase the mutational load 
leading to genomic instabilities and cancer initiation (Bogdan et al., 2000, Canli et al., 2017). 
ROS have also been shown to inactivate p53 tumour suppressor genes through the introduc-
tion of p53 mutations (Hussain et al., 1994). Therefore, the effects of ROS on cancer have 
been described as both tumour promoting and tumour suppressing depending on the con-
centration and duration of exposure (Galadari et al., 2017). However the relatively short dura-
tion of this study (3 days) likely initiated ROS mediated acute inflammation that promoted the 
apoptosis and cytotoxicity of U87 cells. Nonetheless, it would be interesting to investigate 
the long term chronic consequences of Palladium bead implantation in order to bridge the 
current knowledge gap. Little is known in regards to the consequences of long term immune 
responses associated with Palladium nanotherapeutics. These studies have implications in 
extending our understanding of the chronic effects of nanoparticles in medical technologies.  
 
4.1.5. Differential analysis expression data of U87 versus Control revealed no 
significant differentially expressed genes  
 
Extensive molecular profiling has been conducted to show that TAMs contribute to the 
establishment of an immunosuppressive environment through the secretion of anti-inflamma-
tory cytokines (il-10 and TGF-β ) and the inhibition of pro-inflammatory cytokines (tnf-𝑎, il-12, 
il-1β, NO and Ifn-y ) (Wu et al., 2010, Hussain et al., 2006, Komohara et al., 2008, Rodrigues 
et al., 2010, Li and Graeber, 2012). In addition, glioma associated macrophages have been 
shown to display distinct expression profiles when compared to human controls (Szulzewsky 
et al., 2016). Szulzewsky et al. identified 334 differentially expressed genes in human glio-




2016). In another study by the same authors, microarray analysis comparing glioma associ-
ated macrophages and control macrophages identified approximately 1000 differentially ex-
pressed genes (Szulzewsky et al., 2015). Therefore, overwhelming evidence exists to describe 
TAM as functionally and molecularly distinct from macrophages in the non-diseased setting. 
Thus, we hypothesised that U87 xenografts would induce genetic expression changes in tu-
mour associated microglia/macrophages. However, differential analysis of RNA seq expres-
sion datasets demonstrated that macrophages isolated from U87 xenografted and Control 
were similar in expression patterns to each other. No significant differentially expressed genes 
were recorded in comparison to controls. The results here contradicted previous studies 
which described TAM as being functionally pro-tumoural and genetically distinct when com-
pared to macrophages in the non-diseased setting (Wu et al., 2010, Hussain et al., 2006, 
Komohara et al., 2008, Rodrigues et al., 2010, Li and Graeber, 2012, Hamilton et al., 2016, 
Noy and Pollard, 2014). The contributing factors that may have led to this result could have 
originated from our macrophage isolation and bulk RNA sequencing strategy. In order to iso-
late macrophages from the zebrafish, the heads of the zebrafish were transacted above the 
yolk sac and the tissue pooled and homogenised. Therefore, isolated macrophage from 
mpeg1:EGFP zebrafish would include a pooled macrophage population encompassing those 
from the telencephalon, olfactory bulb, cerebellum, spinal cord and retina. Tumour associated 
macrophage would represent a subset of the pooled macrophage population. Consequently, 
the total RNA content extracted from the pool population of macrophages would not reflect 
the true population of tumour associated macrophages responsible for the tumour promoting 
functions in U87 xenografted mpeg1:EGFP zebrafish. Differentially expressed genes in TAMs 
would be diluted by RNA content from non TAMs resulting in a differential analysis that would 





4.1.6. Disadvantages of Bulk RNA seq reveals potential application of single 
cell RNA sequencing techniques 
 
The combination of bulk RNA sequencing strategy and the utility of a single genetic 
marker (mpeg1) to isolate macrophages was one of the major pitfalls of this study. Conse-
quently, this led to a lack of genetic sampling resolution required to differentiate infiltrating 
tumour associated macrophages from resident tumour associated microglia. In order to 
achieve high genetic sampling resolution using contemporary approaches, researchers have 
used multi-marker protocols in order to isolate several distinct populations of monocyte/mac-
rophages/microglia from tumours (Poczobutt et al., 2016). However, multi-marker protocols 
can be technically complex. In addition, the number of monocyte populations that could be 
isolated is limited by the number of established markers available for flow cytometry, a factor 
that does not affect scRNA. Therefore, there is significant scope in applying scRNA sequenc-
ing techniques to understand the functional and transcriptional dynamics between tumour 
associated macrophages and microglia in our study.  
The advent of single cell RNA (scRNA) sequencing techniques has exposed unique 
aspects of the cellular and molecular identity of TAMs. In one recent study, single cell profiling 
of human gliomas revealed distinct macrophage ontogeny that highlighted regional difference 
in TAMs activation (Muller et al., 2017). By comparing the single cell RNA expression profile 
of sequenced TAMs to known expression profiles of anatomically defined tumour compart-
ments (Ivy Glioblastoma Atlas Project) the authors were able to infer macrophage localisation 
within the tumour (Muller et al., 2017). scRNA seq confers greater genetic sampling resolution 
and higher fidelity than bulk RNA seq (Marinov et al., 2014). One study contrasting scRNA 
and bulk (cell pooled) RNA seq concluded that the transcriptomes from 30 – 100 cells as-
sessed using scRNA techniques were comparable to those of bulk RNA seq using large 
amount of genetic material (Marinov et al., 2014). Therefore, the advent of scRNA seq allows 
researchers to investigate the extensive transcriptional and ontogenetic diversity that exists 




Bowman et al., 2016). Extensive studies have been conducted to show that infiltrating tumour 
associated macrophages have distinct expression profiles and functions when compared to 
tumour associated microglia (Muller et al., 2017, Chen et al., 2017, Bowman et al., 2016, 
Szulzewsky et al., 2016). Chen et al., established that the majority of TAMs in GBMs were 
bone marrow derived (Chen et al., 2017). While in another study, it was demonstrated that 
blood derived TAMs expressed significantly higher levels of immunosuppressive cytokines il-
10 and TGFβ2 in comparison to microglia (Muller et al., 2017). Therefore, it would be interest-
ing to investigate the level of contribution of distinct populations of polarised tumour associ-
ated macrophages or microglia in mediating the anti-tumour effects in Gold or Palladium bead 
implanted zebrafish. scRNA seq would confer greater transcriptomic fidelity than contempo-
rary methods to identify macrophage genetic signatures associated with anti-tumour efficacy.  
 
4.1.7. Macrophage polarisation by Gold and Palladium beads initiates anti-tu-
mour phenotype. 
 
The anti-tumour effects of Palladium beads excluded the utility of Palladium mediated 
bioorthogonal drug assays of chemotherapeutics in the zebrafish brain. Therefore in order to 
achieve our original aim, which was to develop an in vivo bioorthogonal catalytic drug assay, 
Palladium was replaced with Gold beads. Gold nanoparticles have extensive application in 
biological and medical applications and have been used therapeutically for drug delivery 
(Niikura et al., 2013, Perez-Lopez et al., 2017, Yeo et al., 2018, Naz et al., 2016). We demon-
strated that Gold beads mediated BOOM reactions in vivo in the zebrafish brain and con-
verted precursors into fluorescent Rhodamine. Although Gold beads were biocompatible in 
mediating BOOM reaction in the zebrafish brain, it was immediately evident that Gold bead 
implantation initiated a potent anti-tumour effect that also recruited macrophages; effects 
similar to Palladium bead implanted zebrafish. Intriguingly, several studies have demon-
strated that Gold nanoparticles initiates anti-inflammatory cytokine production in macro-




il1-β and enhanced il-10 secretion in bone marrow derived macrophages in vitro cultures 
(Taratummarat et al., 2018). The authors also demonstrated that Gold nanoparticles reduced 
the percentage of pro-inflammatory macrophages and increased the percentage of anti-in-
flammatory macrophages (Taratummarat et al., 2018). Likewise, Gold nanoparticles reduced 
the expression of pro-inflammatory mediators such as prostaglandin E2, il-6 and tnf-𝑎 in 
RAW264.7 macrophages cultures (Ma et al., 2010, Ahn et al., 2017). Consequently the authors 
conclude that Gold nanoparticles resulted in the suppression of NF-kB pathway, a key tran-
scription factor mediating inflammatory response (Ma et al., 2010, Ahn et al., 2017). The no-
tion that Gold was an anti-inflammatory mediator contradicted our study. In contrast, we ob-
served a significant inflammatory response to Gold bead implantation reflected as an increase 
in macrophage number in the zebrafish brain. However, it is important to note that the afore-
mentioned studies (Ma et al., 2010, Ahn et al., 2017, Taratummarat et al., 2018) on Gold na-
noparticles were conducted in vitro and thus would not recapitulate the in vivo conditions 
reflected in Gold bead implanted zebrafish. Nanoparticles exposed to serum proteins have 
been shown to form a protein corona that has a direct effect on the inflammatory state of 
macrophages (Cedervall et al., 2007, Ge et al., 2015, Kharazian et al., 2016). Therefore, we 
speculate that both Gold and Palladium nanoparticles may interact with intracellular proteins 
to create a protein corona that initiated macrophage polarisation. The adhesion of proteins 
from the bloodstream to nanoparticles are often inhibited by modifying the surface with PEG 
to inhibit macrophage uptake (Jokerst et al., 2011, Xie et al., 2007, van Vlerken et al., 2007). 
Functionalisation of proteins or peptides to nanoparticle surface have been shown to induce 
pro-inflammatory properties in macrophages (Bastus et al., 2009a, Bastus et al., 2009b, Chen 
and Gao, 2017). One study compared the inflammatory reactions between PEG and chicken 
ovalbumin conjugated Gold nanoparticles on RAW246.7 macrophage (Chen and Gao, 2017). 
Chen et al., reported that Gold nanoparticles conjugated to ovalbumin increased cytokine 
production of tnf-𝑎, il-6 and il-1β while PEG conjugated Gold nanoparticles significantly at-




treatment of macrophages with peptide-conjugated Gold nanoparticles induced pro-inflam-
matory cytokine production in macrophages mediated by TLR-4 activation (Bastus et al., 
2009a). It was interesting to note that although Chen et al. utilised the same in vitro RAW264.7 
macrophage co-cultures described in previously mentioned studies (Ma et al., 2010, Ahn et 
al., 2017), the conjugation of albumin to Gold nanoparticles was pro-inflammatory while un-
conjugated Gold nanoparticles were anti-inflammatory. This further highlighted the significant 
of nanoparticle surface protein corona in mediating the inflammatory response of macro-
phages. In addition, the idea that Gold and Palladium nanoparticles may bind intracellular 
proteins may explain the similarities in pro-inflammatory activation profiles observed between 
Gold and Palladium implanted zebrafish. Gold and Palladium nanoparticles may recruit similar 
protein coronas leading to TLR activation. The protein corona have been shown to modulate 
the functional identity of nanoparticles (Ge et al., 2015, Kharazian et al., 2016). Therefore, 
intracellular protein-nanoparticle surface interactions may play a key role in conferring the 
pro-inflammatory tumoricidal response of macrophages to Palladium and Gold beads in the 






4.1.8. TLR family signalling in Palladium and Gold bead implanted zebrafish 
mediates anti-tumour potentiation of macrophages 
 
The activation of TLR signalling is well documented to induced a proinflammatory 
phenotype in macrophages (Beutler, 2009, Cario, 2010, Cook et al., 2004, Hanamsagar et al., 
2012, Kawai and Akira, 2010). In this context, solidly supported Gold and Palladium nanopar-
ticles used in this study may represent a novel transition metal based immunotherapeutic that 
initiates anti-tumour polarisation of TAM. Our findings indicated that the implantation of Gold 
and Palladium beads into the zebrafish brain led to the pro-inflammatory polarisation of mac-
rophages and the upregulation of key downstream mediators of TLR signalling (tnf-𝑎 and 
cxcl8b.1). In addition, we demonstrated that the inhibition of IRAK4, the downstream activator 
of TLR signalling, attenuated Gold bead mediated anti-tumour responses in vivo. Therefore, 
TLR signalling played a key role in mediating the anti-tumour responses of macrophages in 
zebrafish brain. The potential of TLR signalling in mediating anti-tumour polarisation of mac-
rophages has been explored in several studies. In particular, TLR2, TLR7 and TLR8 have 
shown promise as immunotherapeutic targets in cancer (Singh et al., 2014, Feng et al., 2019, 
Rodell et al., 2018a). By exploiting the ability of TLR to recognize PAMP structures, one study 
used specific biomimetic TLR2 agonists (acGM-1.8) to drive polarisation of primary bone mar-
row-derived macrophages (Feng et al., 2019). Feng et al., demonstrated that TLR2 activation 
led to the upregulation of anti-tumoural cytokines (tnf-𝑎, il-12 p70 and IFN-γ) and the down-
regulation of protumoural cytokines (il-10, VEGF-A and tgf-β1) (Feng et al., 2019). Conse-
quently, TLR2 activation mediated polarisation of TAMs and suppressed the growth of tu-
mours in mice in vivo (Feng et al., 2019). Furthermore, TLR7/8 agonist (R848) have been 
shown to elicit TAM polarisation and demonstrated therapeutic efficacy  (Rodell et al., 2018a). 
Drug loaded nanoparticle delivery of TLR7/8 agonist in TAMs led to a reduction in tumour 
growth rates and improved survival in in vivo mice tumour models (Rodell et al., 2018a). In 
addition to TLR2, TLR7 and TLR8, TLR4 have also been demonstrated to potentiate macro-




highlight the diversity of TLR activation pathways that can occur in order to mediate anti-
tumour potentiation of TAMs. In that respect, Gold nanoparticles have been shown to activate 
TLR3 (Rachmawati et al., 2015) and TLR4 (Bastus et al., 2009a) and suggested to activate 
TLR2 (Ng et al., 2018) while Palladium nanoparticles have been identified to activate TLR4 
(Schmidt and Goebeler, 2015, Rachmawati et al., 2013).  
 The diversification of TAM targeted therapies over the years have grown to include 
immunotherapies that targets pathways that initiates macrophage polarisation. Tumour as-
sociated target therapies have primarily sought to deplete TAM populations, with examples 
including the delivery of small molecules or antibodies that target macrophage infiltration 
(CCR2) or survival (CSF-1R) (Yao et al., 2017, Pyonteck et al., 2013, Cannarile et al., 2017). 
However, harnessing the power of innate immune cells may represent the more effective way 
to treat cancers (Mantovani and Allavena, 2015, Ruffell and Coussens, 2015, Rodell et al., 
2018a, Singh et al., 2014). Our findings highlighted the pivotal role of macrophages in medi-
tating anti-tumour efficacy following macrophage polarisation and thus could be more effica-
cious when combined with chemotherapeutics that specifically targets tumours. Here we pre-
sent a potential novel complementary system that combines the potential of Gold/Palladium 
nanoparticles to polarise macrophage function and to mediate biorthogonal catalytic drug 
delivery. It offers the possibility to not only eliminate macrophage tumour promoting functions 
but at the same time capitalise on the potential to mediate local chemotherapeutic drug de-





4.1.9. Nanoparticle composition affects macrophage responses in zebrafish 
 
Intriguingly, we observed distinct differences between the effects of Palladium, Gold and 
Naked bead implantation on macrophage polarisation in the zebrafish brain. In line with many 
studies, our assay clearly showed nanoparticle composition to be an important factor that 
regulated macrophage responses (Reichel et al., 2019, Zanganeh et al., 2016, Kharazian et 
al., 2016, Ge et al., 2015, Niikura et al., 2013). The implantation of Palladium and Gold beads 
recruited significantly higher number of macrophages in the brain of the zebrafish when com-
pared to Naked bead implanted zebrafish. Our results showed that Naked bead implantation 
initiated an injury related macrophage response that returned to basal levels. Thus macro-
phage recruitment was dependent on the bioavailability of solidly supported Palladium and 
Gold nanoparticles on the bead surface in the zebrafish brain. The consequences of macro-
phage polarisation towards the pro-inflammatory phenotype by Palladium and Gold beads 
initiated a potent anti-tumour effect leading to U87 cellular clearance and fragmentation. In 
contrast, Naked bead implantation led to the attenuation of U87 cellular proliferation. We 
speculate that U87 cells may have entered a quiescent state in response to environmental 
stressors initiated by the bead implantation procedure. By definition, quiescent cells exist in 
a temporary and reversible state of non-proliferation characterised by the maintenance of G0 
stage of the cell cycle (Cheung and Rando, 2013, Cho et al., 2019). The disruption of tissue 
integrity in the extracellular matrix has been shown to result in the release of stored growth 
factors and damage associated molecular patterns capable of regulating the quiescent state 
of cells (Cho et al., 2019, Mura et al., 2006). Therefore, the Naked bead implantation proce-
dure may contribute to environmental stresses which may drive entry of U87 cells into the 
quiescent state. In line with this, future experiment should consider the extension of experi-
mental duration of U87 xenografted Naked bead implanted zebrafish to investigate if U87 





Further evidence demonstrating the differences between macrophage responses of Pal-
ladium, Gold and Naked bead implantation were presented in qPCR analysis. In addition to 
tnf-𝑎 and cxcl8b.1, we detected evidence to suggest increased inflammatory load in Palla-
dium bead implanted zebrafish. The increase in il-1β expression in the macrophages of Pal-
ladium bead implanted zebrafish may have contributed to Palladium toxicity leading to poor 
zebrafish survival. il-1β is a potent pro-inflammatory cytokine and the transcription, synthesis 
and secretion of il-1β is tightly regulated (Garlanda et al., 2013). Increased il-1β expression 
has been associated with inflammatory diseases, including neuropathic pain and type 2 dia-
betes, and has been shown to inhibit spinal cord regeneration (Tsarouchas et al., 2018, 
Anders, 2016, Shao et al., 2015, Donath and Shoelson, 2011). One of the adverse effect of 
an excessive inflammatory response is the recruitment of plasma proteins and leukocytes 
into the extravascular tissues (Medzhitov, 2008). The increase in local protein level alters on-
cotic pressure and thus promotes oedema in the brain leading to local hypoxia and cellular 
death (Medzhitov, 2008). The combination of increased il-1β expression, ROS generation, tnf-
𝑎 and cxcl8b.1 expression can have a detrimental impact on overall survival of Palladium 
bead implanted zebrafish.  
Our findings demonstrated that Gold, Palladium and Naked bead initiated distinct inflam-
matory responses that were detected through in vivo living imaging and qPCR. This study 
highlighted the potential of the zebrafish model system as a platform to investigate the short 
term and potential long term immune consequences of nanoparticle exposure. The zebrafish 
system offers researchers a standardised, reliable and rapid platform to test associated im-





4.1.10. Cxcl8b.1 may not mediate anti-tumour efficacy in macrophages 
 
The establishment of TLR signalling in Gold bead implanted zebrafish led us to investigate 
the functions of tnf-𝑎 and cxcl8b.1 in mediating macrophage and neutrophil contribution to 
the anti-tumour phenotype. Neutrophils are one of the first responders of the immune system 
and migrate into tissue in response to injury or infection (Kim and Luster, 2015). Consequently, 
the implantation of Gold and Naked beads into the brain of the zebrafish were observed to 
recruit neutrophils. Furthermore, the upregulation of cxcl8b.1 is known to be a potent chem-
oattract for neutrophils, and macrophages are widely accepted to regulate site specific re-
cruitment of neutrophil to facilitate the inflammatory response (Manfroi et al., 2017). We 
demonstrated that Gold bead implantation led to significantly increased neutrophil recruit-
ment at 1 dpt which coincided with increased macrophage number and an increase in 
cxcl8b.1 and tnf-alpha expression in macrophages. However, our study was lacking in the 
assessment of inflammatory cytokine expression at 3 dpt. It would have been interesting to 
assess if cxcl8b.1 and tnf-a expression in macrophages was maintained or downregulated at 
3 dpt and should be addressed in future studies. Based on neutrophil dynamics observed in 
Gold bead implantation, we speculate that cxcl8b.1 expression in macrophages may be 
downregulated by 3 dpt as we observed the recovery of neutrophil counts to basal levels by 
3 dpt. Nonetheless, our findings demonstrated that the partial mutation of cxcl8b.1 gene did 
not result in attenuated neutrophil number or anti-tumour response. One of the main reason 
for the lack of phenotype may have originated from the partial mutation of cxcl8b.1 gene. 
Although it is unknown if the partial mutation of cxcl8b.1 gene led to impairment of protein 
function in this study, previous studies have established by western blots that the mutation 
of gene transcripts using CRISPR Cas9 systems have led to the knockout of protein function 
(Zabinyakov et al., 2017, Tsarouchas et al., 2018, Wu et al., 2017, Jafari et al., 2017). We 
speculate that the partial mutation of cxcl8b.1 in this study may not have met the lower ex-
pression threshold necessary to attenuate neutrophil responses in the zebrafish brain and 




to confirm cxcl8b.1 overexpression in macrophages in mpeg1 promoter driven transgenesis 
assays. This was likely attributed to the dilution of RNA content from non-macrophage cells 
during whole embryo homogenisation Therefore, the function of cxcl8b.1 in mediating anti-
tumour efficacy remains inconclusive in this study.  
 
4.1.11. tnf-𝑎 does not mediate anti-tumour effects in macrophages 
 
Tnf-𝑎 is a key inflammatory cytokine produced by circulating monocytes and tissue 
resident macrophages in response to infection and inflammation (Locksley et al., 2001). Dur-
ing acute inflammation, tnf-𝑎 expression regulates expression of inflammatory genes, apop-
tosis and the recruitment of immune cells (Locksley et al., 2001, Crisafulli et al., 2009, 
Szlosarek et al., 2006). In agreement, our findings demonstrated that tnf-𝑎 upregulation coin-
cided with a significant increase in macrophage response and the emergence of an anti-tu-
mour phenotype as a result of Palladium and Gold bead implantation. The antitumor actions 
of tnf-𝑎 have been extensively studied with the development of TNFerade, a tnf-𝑎 based ge-
netic medicine (Rasmussen et al., 2002, McLoughlin et al., 2005, Kali, 2015, Liu et al., 2004). 
TNFerade is administered as an intratumoural injection in combination with radiotherapy or 
chemotherapy and where radiation is used to induce translation of tnf-𝑎 (Kali, 2015, Senzer 
et al., 2004). TNFerade treatment induces a dose dependent potency leading to necrosis tu-
mour models (Rasmussen et al., 2002). In addition, the local administration of tnf-𝑎 promotes 
the destruction of tumour vasculature leading to tumour necrosis (Daniel and Wilson, 2008). 
The effects of tnf-𝑎 are mediated by multiple mechanisms that affect tumour cells directly and 
indirectly. The binding of tnf-𝑎 to its receptor has been identified to activate cellular apoptosis, 
stimulate T-effector cell activation and promote the polarisation of tumour associated mac-
rophages towards an anti-tumour phenotype (Nie et al., 2013, Lejeune et al., 2006, Qiao et 
al., 2011, Josephs et al., 2018). Furthermore, tnf-𝑎 has been identified to promote neutrophil 




nificant upregulation of tnf-𝑎 expression and increased neutrophil number in Gold bead im-
planted zebrafish supported the role of tnf-𝑎 in neutrophil recruitment. However, our results 
indicated that the modulation of tnf-𝑎 function had no effect on either Gold bead induced 
anti-tumour efficacy or on macrophage/neutrophil dynamics. We demonstrated that 
CRISPR/Cas9 knockout of tnf-𝑎 function in Gold bead implanted zebrafish did not promote 
U87 cell survival or impair Gold bead mediated macrophage recruitment. Furthermore, the 
overexpression of tnf-𝑎 activity in macrophages in bead null zebrafish failed to recapitulate 
anti-tumour effects of Gold bead implantation. Our findings indicated that tnf-𝑎 expression 
was not vital for anti-tumour efficacy of macrophages in the zebrafish. However, it was im-
portant to take into account that CRISPR/Cas9 gRNA injections induced a robust reduction 
in tnf-𝑎 levels but not a complete knockdown (Tsarouchas et al., 2018). Therefore, the transi-
ent CRISPR/Cas9 knockdown of tnf-𝑎 did not fully recapitulate the genetic background of a 
stable tnf-𝑎 mutant zebrafish. In addition, overexpression transgenesis of tnf-𝑎 may not have 
reached the required threshold to elicit a detectable phenotype. Thus our study did not con-
clusively exclude the role of tnf-𝑎 expression in mediating anti-tumour polarisation in macro-
phages.  
Although tnf-𝑎 remain an attractive immunotherapeutic target in cancer, several clin-
ical trials have been conducted and failed to prove therapeutic efficacy (Kimura et al., 1987, 
Blick et al., 1987). Current clinical trials indicated that tnf-𝑎 based treatments may have ther-
apeutic potential as an adjuvant in combination with standard chemotherapy (Ouyang et al., 
2018, Li et al., 2012). However, the prolonged exposure of tnf-𝑎 may have significant conse-
quences in promoting tumour progression as prolonged tnf-𝑎 mediated inflammatory re-
sponse was well recognised to promote tumour progression (Cruceriu et al., 2020, Mantovani 
et al., 2008). Therefore, tnf-𝑎 may also be considered a pro-tumorigenic molecule 
(Stathopoulos et al., 2007, Mantovani et al., 2008). Further to the role of tnf-𝑎, it was also 
identified to play a major role in priming regeneration which adds to the diverse repertoire of 




quently, the contextual expression of tnf-𝑎 both spatially and temporally in the cellular envi-
ronment guides tnf-𝑎 influence and subsequent function in the tumour microenvironment. 
Therefore further experimentation is required to elucidate tnf-𝑎 function in the tumour micro-






4.1.12. Final Conclusions 
 
The development of a chemotherapeutic bioorthogonal catalytic drug assay untaken in 
this study uncovered a novel immunotherapeutic application of Gold and Palladium nanopar-
ticles in cancer treatment. Our findings demonstrated the potent efficacy of Gold and Palla-
dium nanoparticles to induce anti-tumour polarisation of macrophages and emphasised the 
implications of TLR signalling in immunotherapy. Despite identifying key downstream TLR 
signalling genes to be upregulated in Gold bead implanted zebrafish, our results concluded 
that tnf-𝑎 was not vital for the induction of macrophage anti-tumour efficacy. It was important 
to note that RNA sequencing data revealed 1014 differentially expressed genes in Palladium 
bead implanted zebrafish therefore highlighting a complex web of intracellular signals that 
initiated the anti-tumour phenotype. Thus tnf-𝑎 signalling may only contribute to a small sub-
set of intracellular signalling that conferred anti-tumour efficacy. Furthermore, our findings 
highlighted the importance for researchers to consider the potential of nanoparticle induced 







5. List of Abberviations 
Abbreviation Full Name 
BOOM Bioorthogonal Organometallic 
CCL2 CC Chemokine Ligand 2 
CLRs C-Type Lectin Receptors 
CNS Central Nervous System 
CSF Colony Stimulating Factor 
CT X-Ray Computed Tomography 
DAMP Damage Associate Molecular Patterns  
EGF Epidermal Growth Factor  
GBM Glioblastoma 




Irf8 Interferon Regulatory Factor 8 
MMP Matrix Metalloproteinase 
MPO Myeloperoxidase 
MRI Magnetic Resonance Imaging 
NETs Neutrophil Extracellular Traps 
NK Natural Killer 
NOD Nucleotide-Binding Oligomerization Domain 
OPC Oligodendrocyte Progenitor Cells 
PEG Poly(Ethyleneglycol) 
PET Positron Emission Tomography 
sCSF-1 Soluble Colony-Stimulating Factor  
TAMs Tumour Associated Macrophages 
TH1 T Helper 1 
TLRs Toll Like Receptors 
TMZ Temozolomide  
TNF Tumour-Necrosis Factor 
VEGF Vascular Endothelial Growth Factor  




6. Supplementary Data 
 
6.1. Biorthogonal catalytic release of Vorinostat by Palladium beads in-


















































Figure S1. Biorthogonal catalytic release of Vorinostat by Palladium beads inhibits U87-
mCherry cell growth in vitro in a dose dependent manner. 
The incubation of U87-mCherry cells with 1% DMSO and Palladium beads had no effect on U87-mCherry survivial. Caged 
Vorinostat (POB-Vor) in 1% DMSO had no effect on U87-mCherry cell survival at all concentrations. The incubation of POB-Vor 
with 1 mg/ml Palladium beads with promoted the biorthogonal catalytic release of Vorinostat leading to a dose dependent 
inhibiton of U87-mCherry cell viability. As expected, the incubation of Vorinostat alone inhibited U87 cell viability in a dose 
dependent manner.  
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